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Abstract 
Spinal cord contains different types of neurons. A vast majority of these neurons are 
interneurons. Therefore, a better understanding of how interneurons in the spinal cord 
develop is particularly important, as it will hopefully enable researchers to establish better 
treatments for spinal cord injury patients.  In this thesis, I used zebrafish to study 
development of two classes of spinal cord neurons – KA cells (which correspond to 
cerebrospinal fluid-contacting neurons, CSF-cNs) and V2b cells. Both KA and V2b neurons 
are functionally important in vertebrate locomotor circuitry.  
Development of functional neurons involves progression of genetic cascades that 
lead to correct cell specification. Some of the most important genes expressed during cell 
development encode for transcription factors, which are regulatory proteins that can either 
activate or repress expression of downstream genes.  Both V2b and KA neurons in 
zebrafish express a common set of transcription factors – Tal1, Gata2a, and Gata3. These 
proteins are not present in any other spinal cord cell type. Previous work used a 
knockdown approach (morpholinos) to show that gata2a and gata3 have different 
functions in specification of KA cell types – KA” cells require gata2a and KA’ cells require 
gata3 to develop correctly.  In this thesis, I test whether the same phenotypes occur in null 
mutants. Also, I investigate the role of tal1 in specification of KA cells, and the role of all 
three (gata2a, gata3, tal1) genes in V2b specification. To do this, I used tal1, gata2a and 
gata3 zebrafish mutants. 
 
 
 
KA and V2b neurons also share another characteristic – all these cells are 
GABAergic. Therefore, I investigate whether tal1, gata2a and gata3 genes are required for 
correct specification of V2b and/or KA global cell fate and/or GABAergic phenotypes of 
these cells. In addition, I identify a subset of genes expressed by either KA”, KA’ and/or V2b 
cells and analyze the expression of some of these in these mutants. 
My results show that tal1, gata2a, and gata3 have distinct functions in each neuron 
type. In KA” cells, gata2a is required for correct expression of the majority of KA” markers 
and the GABAergic phenotype of these cells. Interestingly, both tal1 and gata3 are not 
required for correct specification of KA” cells. In KA’ cells, the situation seems to be 
reversed – tal1 and gata3 are required for correct expression of all KA’ markers, but gata2a 
is required for only some aspects of the KA’ cell fate in a subset of KA’ cells. In V2b cells, the 
phenotypic effects of these mutations are more complicated – neither tal1, gata2a nor 
gata3 are required for correct expression of all V2b genes. However, tal1 is required for 
expression of a subset of these genes, and for the GABAergic phenotype of V2b cells. 
This thesis contributes to better understanding of KA”, KA’ and V2b neuron 
specification.  Also, the presented results have broader implications, as they underlie the 
importance of cell type specificity of genetic cascades that lead to correct development of 
spinal cord neurons. 
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1. Introduction 
The spinal cord consists of nerve cells (neurons) and glia, and together with the 
brain constitutes the central nervous system (CNS). Nerve cells in the CNS consist mainly of 
motoneurons (MNs) and interneurons (INs), while most sensory neurons belong to the 
peripheral nervous system (PNS). Together, these cell types form functional neuronal 
circuitry (see Fig. 1). Sensory neurons have cell bodies outside of the spinal cord, but their 
axons terminate in the spinal cord and they primarily function to convey sensory 
information from the body towards the spinal cord and brain.  Motoneurons have their cell 
bodies in the spinal cord, but their axons project away from the spinal cord to connect to 
the muscles of the body. They play a primary role in conveying locomotory information to 
muscles and are the most broadly studied group of spinal cord cells, as they have been 
easiest to identify so far (Lewis and Eisen, 2003). However, most spinal cord neurons are 
interneurons – cells that have their cell bodies and axons within the CNS, and are crucial for 
processing and conveying information between the brain and rest of the body, as well as 
within the spinal cord as part of oscillatory networks known as central pattern generators 
(CPGs) (as reviewed in: Frigon, 2002). CPGs are neuronal networks that create timing and 
patterns of rhythmic muscle movements, without a need for sensory input (for reviews see: 
Marder and Bucher, 2001; Grillner et al., 2007). Interneurons in the dorsal part of the 
spinal cord are important for receiving and processing sensory information, while cells in 
the ventral part of spinal cord regulate locomotion (for review see: Goulding, 2009). In the 
case of some ventral cell populations, we already know their specific functions in 
locomotor circuits. For example, V0 cells regulate right-left alternation in mouse (Lanuza et 
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al., 2004; Griener et al., 2015). Also, V1 cells are important for fast movements (Gosgnach et 
al., 2006), and together with V2b cells regulate flexor/extensor muscle output in mouse 
(Zhang et al., 2014; Britz et al., 2015). 
The physiological functions of many spinal interneuron populations are already 
known, but we still don’t understand the processes by which these cells form. This 
knowledge could help develop therapeutic applications, particularly for spinal cord 
injuries. For example, understanding the genetic networks that lead to distinct, fully 
functional neurons should help researchers develop stem-cell based therapies to replace 
damaged neurons and/or circuits. In one case, expression of developmentally-
characterized morphogens at specific concentrations in cell culture has already led to the 
generation of electrophysiologically functional V2a cells (Brown et al., 2014). Another 
recent study demonstrated that expression of specific genes in stem cells led to 
development of neurons from glia that once grafted, improved the locomotion of paraplegic 
rats (Hong et al., 2014).  
Some of the most important molecules for understanding development of particular 
cell types are transcription factors. Transcription factors are proteins that bind to DNA and 
regulate expression of other genes. Due to their regulatory role, they are crucially 
important in developmental processes and often act as ‘master regulators’, sitting at the 
top of genetic networks that lead to the development of functional cell types.  
Understanding the roles that transcription factors play in spinal cord development, is key 
to understanding how mature, fully functional neurons arise. The hypothesis that underlies 
my research is that the combinatorial code of transcription factors and the temporal 
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sequence in which they are expressed, is what specifies the development of particular 
neuronal subpopulations (Lewis, 2006). My study concentrates on V2b and KA 
(Kolmer-Agduhr) neurons that are located in the ventral part of the spinal cord. V2b and 
KA neurons share a GABAergic neurotransmitter phenotype, and several transcription 
factor genes are co-expressed by both of these cell types: gata3, gata2a and tal1 are 
expressed by both KA and V2b cells, while tal2 is expressed by KA cells and a subset of V2b 
cells (Batista et al., 2008; Yang et al., 2010).  In this thesis, I will describe the expression 
patterns of additional transcription factor genes in these cells and I will also investigate the 
functions of gata3, gata2a and tal1 in development of V2b and KA cells.  Finally, I will also 
briefly examine the expression of additional genes that are good candidates for being 
expressed by either V2b and/or KA cells. As my work is informed by the findings from 
other model organisms, I will use the nomenclature that is specified in section 2.10 of the 
methods chapter. 
1.1 Zebrafish as a model organism for understanding spinal 
cord development 
Zebrafish (Danio rerio) is an excellent organism to study spinal cord development. 
The animals develop fast, gaining a heart, brain and spinal cord by 24 hours 
post-fertilization (24hpf). Importantly, external fertilization allows for easy observation of 
the embryos without the need to sacrifice adults.  Also, compared to most other animals 
that are opaque, the optical transparency of zebrafish embryos makes it especially easy to 
visualize tissues deep inside the animal, such as the spinal cord. In addition, one pair of fish 
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can potentially lay several hundred embryos at one time. This facilitates working with 
double mutant animals and genetic analyses. 
The translucent nature of zebrafish has enabled very detailed descriptions of 
individual cells in the spinal cord (e.g. Bernhardt et al., 1990) and as of now, all of the 
zebrafish spinal cord neuron types have been described based on their morphology (size 
and shape of the cell body and axon projections) and dorsoventral position in spinal cord 
(Fig. 2, adapted from: Lewis and Eisen, 2003). This is in contrast with the amniote spinal 
cord, which is more complicated and where individual cell types are more difficult to 
identify on the basis of morphology. Despite the zebrafish spinal cord being much smaller 
than that of mammals or birds, the distinct subtypes of interneurons found in amniotes 
seem to have corresponding cells in zebrafish: at least most of the currently known genes 
expressed by amniote spinal cord are also expressed in zebrafish spinal cord, and the 
dorsoventral position of those cells corresponds to that of amniote cell populations (as 
reviewed in: Lewis, 2006 and in Goulding, 2009). Therefore, it seems likely that the 
mechanism of spinal cord development is highly conserved between zebrafish, birds, and 
mammals.  
The main differences between gene expression in amniote and zebrafish spinal cord 
result from a particular evolutionary event - in the course of evolution, zebrafish (together 
with all other teleosts) underwent an additional whole genome duplication (Postlethwait et 
al., 1998). As a consequence, some genes have duplicate copies in zebrafish, as compared to 
most other vertebrates. Most often, after genome duplication one copy of the gene would 
become nonfunctional (as reviewed in: Glasauer and Neuhauss, 2014). However, 
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sometimes both copies are retained either because one of the copies acquires a novel 
function (neofunctionalization), or the functions of the gene become split between both 
copies (subfunctionalization) (as reviewed in: Glasauer and Neuhauss, 2014). Nevertheless, 
the processes of spinal cord development in zebrafish and other animals are highly 
homologous (Goulding et al., 2009, Lewis, 2006), so the results of my research are likely to 
be highly relevant to other vertebrates, including mammals.   
1.2 Overview of spinal cord development 
The spinal cord of most vertebrate animals can be divided into two regions medial-
laterally: ventricular zone/proliferating zone (medially) and post-mitotic domain 
(laterally), with floor plate and roof plate delineating the most distant boundaries of the 
spinal cord along the dorsoventral axis (Fig. 1). The most ventral part of the spinal cord, the 
floor plate, secretes sonic hedgehog (Shh), while the dorsally located roof plate and neural 
tube secrete bone morphogenetic protein (BMP) and Wnt signaling molecules (as 
described in: Lewis, 2006). In addition, retinoic acid plays an important role in both 
anterior-posterior and dorso-ventral neural tube patterning (Lupo et al., 2006; Maden, 
2002). Combined gradients of these morphogens across the spinal cord lead to the 
existence of molecularly distinct cell domains (progenitor domains) within the ventricular 
zone of the spinal cord (Briscoe et al., 2000; Lewis, 2006).  
In mouse, at least 5 types of ventral progenitor domains (p3, pMN, p2, p1, p0) and 6 
types of dorsal progenitor domains (dP6, dP5, dP4, dP3, dP2, dP1) have been identified 
based on their dorsoventral position and the specific set of genes that they express (see Fig. 
1B; also for review, see: Jessell, 2000 or Goulding and Pfaff, 2005). Progenitor cells in the 
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ventricular zone have potential to undergo mitosis (divide) and give rise to differentiated 
post-mitotic cells. When cells become post-mitotic, they exit the cell cycle, move laterally 
and begin to express a different combination of transcription factors that will lead to the 
formation of fully differentiated, functional neurons (as described in: Lewis, 2006). Specific 
progenitor domains have potential to give rise to at least one (usually more) post-mitotic 
cell types (as described in: Lewis, 2006; see Fig. 1B). In each case, these related populations 
of cells share at least a  subset of transcription factors, and often share one or more 
functional characteristics (as described in: Lewis, 2006 and in: Goulding, 2009).  
The post-mitotic interneuron subpopulations on the dorsal side are designated dI1-
d-6, while on the ventral side they include V0, V1, V2 and V3 cells. In addition, ventral 
spinal cord contains motoneurons that are located between the V3 and V2 subpopulations 
(as described in: Lewis, 2006; see Fig. 1).  So far, homologous cells for all of the ventral 
post-mitotic cells and most of the dorsal ones have been described in zebrafish (as 
reviewed in: Lewis, 2006 and Goulding, 2009, unpublished data Lewis Lab). In addition, as 
mentioned above the zebrafish spinal cord contains KA cells, which form in the most 
ventral part of the spinal cord and contact the central canal (Bernhardt et al., 1992). While 
similar cerebrospinal-fluid contacting neurons (CSF-cNs) have been described in mouse 
and other species (as desribed in: Djenoune et al., 2014), it is not clear where they form in 
these animals. I will discuss both V2 cells and KA cells in more detail below. 
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Figure 1. Schematic representation of cross-section through the spinal cord. Dorsal 
up, ventral down. (A) shows relative position of neuron types in the cross-section through 
the spinal cord. Blue neurons are sensory neurons (dorsal) and motoneurons (ventral). 
Green neurons represent interneurons, which do not leave the central nervous system. (B) 
shows position of individual neuron subpopulations in vertebrate spinal cord. The 
positions of V2 (V2a and V2b) cells and KA (KA” and KA’) cells in ventral spinal cord are 
indicated in green. (B) is adapted from: Lewis et al., 2006. 
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1.3 Specification of functional characteristics of post-mitotic 
spinal cord interneurons 
Spinal cord cells can exhibit a variety of functional characteristics, including a 
specific axon trajectory, neurotransmitter chemical messenger, and specific 
electrophysiological properties like firing intensity and duration (as reviewed in: Goulding, 
2009). Each of those characteristics is important for neurons to function correctly in 
circuitry, and therefore crucial for a correctly functioning neuronal network. In my 
research, I am interested in determining whether the transcription factors I examine are 
required for specification of global cell fate, or whether they just specify a subset of the 
functional characteristics of these cells. In terms of specific aspects of cell fate, I am 
particularly interested in identifying transcription factors that are required for the 
neurotransmitter phenotype of KA and V2b cells. However, I am also interested in 
determining whether the transcription factors I examine are required for specification of 
global cell fate, or whether they just specify a subset of the functional characteristics of 
these cells. 
Neurotransmitters are small molecules that are synthesized and released by 
neurons into the synaptic cleft to elicit a response in the postsynaptic neuron or another 
cell. Neurotransmitters can be either inhibitory or excitatory in nature, depending on the 
receptors that they bind. An inhibitory effect decreases the likelihood of the postsynaptic 
cell firing an action potential, and an excitatory effect increases the chances of firing in 
postsynaptic cells. Out of over 20 types of neurotransmitters currently known to be 
synthesized by cells, the most abundant ones in the spinal cord are GABA 
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(gamma-Aminobutyric acid), glycine and glutamate (reviewed in: Goulding, 2009). GABA 
and glycine are usually inhibitory, while glutamate is excitatory. Enzymes that limit the 
synthesis of any given neurotransmitter are usually characteristic of cells with that 
fate/phenotype and can be used to identify cells, e.g. GABA is formed by decarboxylation of 
glutamate by the enzyme glutamate decarboxylase (GAD), and GAD is therefore expressed 
in all GABAergic neurons (as reviewed in: Erlander and Tobin, 1991). Markers of 
GABAergic cells used in this thesis include gad1b (previously known as gad65; described in 
methods section 2.5), and gad2 (previously known as gad67; described in the methods 
section 2.5), and encode for GAD enzyme in zebrafish (Higashijima et al., 2004a, b). 
In addition, it is important to remember that, even though usually mature cells use 
predominantly one neurotransmitter as their primary signaling molecule, a cell can use 
more than one neurotransmitter - for example, GABA and glycine are sometimes co-
expressed by the same neurons in the spinal cord (Jonas et al., 1998; Batista and Lewis, 
2008). The inhibitory action of GABA is due to hyperpolarization of the neuron membrane 
mediated by reduction of calcium levels in the postsynaptic neuron, which depends on the 
influx of chloride into the cell (as reviewed in: Li and Xu, 2008). However, GABA can also be 
excitatory very early in development, when the concentration of chloride ions inside the 
cells is higher than outside, and GABA-mediated opening of the channels causes a chloride 
efflux, which leads to the elevation of calcium concentration and depolarization of 
postsynaptic neuron membranes (as reviewed in: Ben-Ari, 2002).  
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Figure 2. Cell trajectory and neurotransmitter phenotype of neurons found in 
zebrafish spinal cord. Schematic showing morphologies and positions of cell somas and 
axon trajectories of interneurons in zebrafish spinal cord (lateral view). Full lines indicate 
axons that are ipsilateral, and dashed lines show axons that cross the midline of spinal 
cord, becoming contralateral. Neurons that synthesize inhibitory neurotransmitters (GABA, 
glycine) are shown in orange and red respectively, while excitatory (glutamatergic) 
neurons are blue. Note that some morphological classes of neurons contain cells that utilize 
different neurotransmitters. KA and V2b (VeLD) cells both use GABA. Figure adapted from: 
Lewis and Eisen, 2003. 
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Both cell populations that I am interested in, KA cells (called Cerebral Spinal Fluid 
Contacting Neurons, or CSF-cNs in most other species) and V2b cells, are GABAergic in 
mouse (Orts-Del’Immagine et al., 2014) and in zebrafish (Bernhardt et al., 1992). These are, 
however, only two of several populations of spinal cord GABAergic neurons. In amniotes, 
other GABAergic subpopulations include dI4 and dI6 and late-born dILA neurons in the 
dorsal spinal cord, and V1 neurons in the ventral spinal cord (Hori and Hoshino, 2012). In 
mouse, all of these dorsal populations express Pax2, Pax5 and Pax8, but Pax2 is required for 
the inhibitory phenotype of only the most dorsal spinal cord cells (Pillai et al., 2007). 
Similarly, in zebrafish pax2a and pax2b (orthologs of mouse Pax2), and pax8, are expressed 
in most inhibitory cells within the V1 and dorsal spinal cord region (Batista and Lewis, 
2008), and act redundantly in those inhibitory cells to specify the inhibitory phenotype 
(Batista and Lewis, 2008). At the same time, in zebrafish pax5 is not expressed in the spinal 
cord (Batista and Lewis, 2008). However, inhibitory KA and V2b cells in zebrafish do not 
express the pax2a, pax2b or pax8, which suggests that a different mechanism must specify 
the inhibitory phenotype of those cells. In this thesis, I will investigate whether any of three 
genes expressed by V2b and KA cells, tal1, gata2a and gata3, are required for specification 
of the neurotransmitter fates of these cells.  
Another functional property of a neuron is its axon trajectory. Neurons can send 
their axons either rostrally, which is also called an ‘ascending’ phenotype, or caudally, 
which is also called a ‘descending’ phenotype (see Fig. 2, adapted from: Lewis and Eisen, 
2003). Also, the axon can cross the midline of spinal cord (contralateral), or can stay on the 
same side of the spinal cord, (ipsilateral). Axon trajectory is especially tractable in optically 
clear zebrafish. Since the cell populations that I’m investigating have different axonal 
12 
 
  
 
trajectories (KA axons are ipsilateral ascending, and V2b axons are ventral lateral 
descending), it is highly unlikely that the shared transcription factors expressed by those 
cells are responsible for specifying particular axon trajectories of either V2b or KA cells. 
Other functional properties, such as electrophysiological properties of the cell, or 
correct synapse-formation require more specialized assays and are not properties that I’m 
going to investigate. Nevertheless, they are important for a neuron to become a part of a 
fully functional neuronal circuit. 
1.4 V2 cells  
V2 cells are born from p2 progenitor domain cells. When a p2 cell divides for the last 
time, it gives rise to two immature V2 cells, which then usually develop into one V2a and 
one V2b cell (Kimura et al., 2008). In amniotes, immature V2 cells are characterized by the 
expression of transcription factor genes gata2a and lhx3, which begin to be expressed by 
late progenitor p2 cells and persist into early post-mitotic V2 cells (Zhou et al., 2000; Al-
Mosawie et al., 2007). However, after the V2 cells begin to diversify, the binary choice 
between becoming either a V2a or V2b cell is regulated by Delta-Notch signaling in both 
zebrafish (Kimura et al., 2008; Batista et al., 2008) and in amniotes (Peng et al., 2007; Del 
Barrio et al., 2007; Joshi et al., 2009). In amniotes, the mechanism that leads to asymmetric 
activation of Delta-Notch signaling is mediated via direct binding of FOXN4 and ASCL1 to 
the enhancer of Delta-like 4 (Dll4) receptor (Fig. 3, Misra et al., 2014). In amniotes, high 
levels of Delta expression (and low levels of Notch) in V2a cells leads to downregulation of 
Gata2 while high levels of Lhx3, and high levels of Notch in V2b cells results in upregulation 
of Gata2, followed by expression of Tal1 and concurrent suppression of Lhx3 (Del Barrio et 
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al., 2007; Peng et al., 2007). This leads to specification of V2a versus V2b cell fates, and a 
similar mechanism is likely to exist in zebrafish  as in both amniote and zebrafish spinal 
cord attenuation of Delta-Notch signaling leads to overproduction of V2a cells at the 
expense of V2b cells (Kimura et al., 2008; Batista et al., 2008a; Joshi et al., 2009).  
Mature V2a cells are vsx1+/vsx2+/lhx3+ excitatory interneurons (Karunaratne et al., 
2002; Kimura et al., 2006). Their sister cells, V2bs are gata2a+/gata3+/tal1+ inhibitory 
interneurons (Batista et al., 2008; Kimura et al., 2008; Joshi et al., 2009).  While differing in 
their neurotransmitter phenotype, post-mitotic mature V2a and V2b cells share a similar 
ipsilateral descending axon trajectory, at least in zebrafish, in which V2a cells develop into 
excitatory Circumferential Descending (CiD) interneurons (Kimura et al., 2006b), while 
V2b cells develop into Ventral Lateral Descending (VeLD) interneurons (Batista et al., 
2008). In their mature form, fully developed V2a and V2b cells are intermingled in a ‘salt 
and pepper’ manner and located adjacent to the p2 progenitor domain along the 
dorso-ventral axis in both amniotes (Li et al., 2005) and zebrafish (Batista et al., 2008).  
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Figure 3. Schematic representation of potential genetic hierarchy in amniote V2b 
cells. Schematic was constructed based on interpretation of results published so far in 
mouse and chicken. Arrows indicate genes that appear to be downstream of each other. 
Black color represents loss-of-function experiments, and orange arrows represents 
gain-of-function experiments. Pointed arrow indicates the activation of downstream genes, 
and line with a circle indicates downstream gene repression.  Numbers indicate studies 
that are referenced by first author on the left. 
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Interestingly, experiments using a Tg(vsx2:Kaede) transgenic line that labels V2a 
cells show that in zebrafish these cells migrate dorsally after they form (Kimura et al., 
2006). Kaede is a protein that can be converted from green to red by a particular 
wavelength of light. This can be performed at a specific time point, so cells born before the 
conversion become red, while cells born after conversion time remain green (Kimura et al., 
2006). Conversion of the Kaede chromophore at 32hpf shows that cells labeled with 
Tg(vsx2:Kaede) that are green are located more ventrally, while red cells are more dorsal 
(Kimura et al., 2006). Therefore, older V2a cells are positioned more dorsally than younger 
ones (Kimura et al., 2006). So far, it is not known whether V2b cells might also migrate 
along the dorso-ventral axis once specified. 
In addition, in some vertebrates additional V2 subpopulations have been described. 
V2c cells in mouse are born from the p2 progenitor domain, as are V2a and V2b cells, but 
they do not express Vsx2 (V2a marker) or Gata3 (V2b marker); instead, they express Sox1 
(Panayi et al., 2010). V2c cells are likely derived from V2b cells, as Sox1 is upregulated 
while Gata3 is downregulated in a subset of V2b cells (Panayi et al., 2010).  In the absence 
of Sox1 the number of Gata3+ V2b cells increases, while the number of V2a cells remains 
unchanged, further suggesting that V2c cells are specified from post-mitotic V2b cells and 
that Sox1 is required for their specification (Panayi et al., 2010). However, the precise 
mechanism by which V2c cells are specified remains to be elucidated. Also, whether V2c 
cells exist in zebrafish is currently unknown. To address this, I will investigate the 
expression patterns of sox1a and sox1b, the orthologs of Sox1 in zebrafish, in this thesis.  
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In addition, at least in mouse, yet another V2 population exists.  V2d cells are also 
born from the p2 domain, express Shox2 and contribute to central pattern generator (CPG) 
activity (Dougherty et al., 2013). V2d neurons are similar to V2a neurons in that they are 
also excitatory and project axons ipsilaterally (Dougherty et al., 2013). Even though some 
Shox2-expressing cells express V2a marker Vsx2, about a quarter of Shox2-positive cells do 
not express Vsx2 (Dougherty et al., 2013). So far, there is no evidence for presence of V2d 
interneurons in other species.  
1.5 KA cells 
A special class of spinal cord cells that contact cerebrospinal fluid was first 
described by W. Kolmer and E. Agduhr in the early 1920s and 1930s and shown to exist in 
over 200 vertebrate species (as described in (Djenoune et al., 2014). The cell bodies of KA 
neurons are contained within the spinal cord but they project their sensory cell tuft 
(dendrites) to directly contact the cerebrospinal fluid in the central canal (Bernhardt et al., 
1990). In zebrafish, as well as in frog (Dale et al., 1987), these cerebrospinal-fluid 
contacting cells are named Kolmer-Agduhr (KA) cells, after the researchers that initially 
described them. In those species at least, KA cells are ciliated GABAergic cells that and have 
ventrally projecting ipsilateral ascending axons (Dale et al., 1987; Bernhardt et al., 1992). 
KA cells are important in locomotor behaviors.  In zebrafish larva they can contribute to 
central pattern generator (CPG) activity and swimming behavior, as optical stimulation of 
those cells is sufficient to induce spontaneous swim-like behavior (Wyart et al., 2009).  
KAs are derived from two distinct progenitor domains (p3 and pMN) and 
consequently occupy distinct dorsoventral positions (Park et al., 2004). Based on those 
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differences, they have been subdivided into KA” and KA’ subpopulations (Park et al., 2004). 
Cell lineage tracing experiments show that more dorsally located KA’ cells originate from 
the olig2-expressing pMN domain, while KA” originate ventral to this domain (Park et al., 
2004).  Notch signaling is important for specification of KA’ cells – in absence of Notch 
signaling primary MNs form at the expense of KA’ cells, and when there is an excess of 
Notch signaling, KA’s form at expense of primary MNs in zebrafish (Shin et al., 2007). KA” 
cells differentiate in the lateral floorplate (LFP) region (Schafer et al., 2007) and are 
intermingled with V3 (and potentially other) interneurons. KA” differentiation is also 
dependent on Notch signaling, as KA” cells are reduced in mindbomb(mib) mutants that are 
deficient in Notch signaling (Kang et al., 2013), and also after early (7hpf) heatshock-
mediated Notch signaling ablation (Yeo and Chitnis, 2007). However, heatshock-mediated 
Notch signaling ablation at later stages (10-14hpf), as well as morpholino-induced 
knockdown of Notch receptor jagged2, both result in an increase of KA” and other cells 
including secondary MNs (Yeo and Chitnis, 2007). Interestingly, heatshock-mediated Notch 
signaling ablation at 17hpf has no effect on number of KA” cells (Yeo and Chitnis, 2007). 
This suggests that the timing of Notch signaling plays a pivotal role in specifying KA” cells 
from p3 cells (Yeo and Chitnis, 2007).  
Even though KA” and KA’ cells differ in their dorsoventral position, many of their 
properties (morphology, electrophysiological properties and molecular markers) are 
similar (Yang et al., 2010; Djenoune et al., 2014). In addition, most genes that are expressed 
by these cell types are expressed by both KA and V2b cells. 
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1.6 Expression profiles of known markers of V2b and/or KA 
cells 
Both KA and V2b cells express gata2a, gata3 and tal1 transcription factor genes in 
zebrafish (Batista et al., 2008). As I analyze mutations in all three of these genes in this 
thesis, here I will describe what is known about these genes in zebrafish and other 
vertebrate species. Since my project investigates role of those genes in the spinal cord 
development, in this introduction I will focus primarily on studies of the spinal cord and 
brain. When relevant, I will also describe briefly evidence from other tissues. In addition, I 
will describe tal2 as this is a homologue of tal1 (also called tal1) that is also expressed by 
both V2b and KA cells. Also, Table 1 outlines known genes expressed by V2b and/or KA 
cells, as well as transgenic lines used in my experiments to visualize V2b/KA cells as well as 
V2a cells. 
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Table 1. Genes expressed by V2b and/or KA cells. Summary of the reference genes and 
transgenic lines used in this thesis to visualize V2 and KA cells. All of these genes are 
expressed by the known cell populations, as described in the published literature. Note that 
Tg(gata1:GFP) might not label all of the V2b cells at 24hpf, a stage at which I performed my 
experiments. Also, I do not see clear labeling by the transgenic lines that label V2a cells 
(Tg(vsx2:GFP), Tg(vsx2:RFP), Tg(vsx2:Kaede)) before 27hpf.  
Gene name Cells in which expressed Reference Comments 
gata3 KA and V2b cells Batista et al., 2008 - 
gata2a KA and V2b cells Batista et al., 2008 - 
tal1 KA and V2b cells Batista et al., 2008 - 
tal2 KA cells 
Pinheiro et al., 2004, 
Schafer et al., 2007 
Not in all V2b cells 
at 24hpf 
gads KA and V2b cells 
Higahsijma et al., 
2004a, 2004b 
In a few additional 
cells at 24hpf 
Tg(gata1:GFP) KA and V2b Batista et al., 2008 
Not in all V2b cells 
at 24hpf 
Tg(vsx2:GFP) V2a cells Kimura et al., 2006 I don’t see cells 
labeled before 
27hpf 
Tg(vsx2:RFP) V2a cells Kimura et al., 2006 
Tg(vsx2:Kaede) V2a cells Kimura et al., 2006 
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1.6.1 Gata2a 
Gata2a (GATA-binding protein 2) is a C4 finger transcription factor from the GATA 
family of proteins which normally bind to a WGATAR (W = A or T and R = A or G) 
consensus sequences (Merika and Orkin, 1993). It was originally found as a regulatory 
sequence important in erythroid development (Yamamoto et al., 1990). It is expressed in a 
variety of cell lines and tissues, including pluripotent mouse progenitor cells, mast and 
megakaryocytic mouse cell lineages, endothelial cells, chicken early hematopoietic cells, 
and many other animal and human cell types and tissues (as reviewed in: Orkin, 1992 and 
in Burch, 2005). Gata2 has been especially widely studied in hematopoiesis, where it is 
important not only in proliferation of blood-forming cells, but also in specification of blood 
lineages as shown by cell culture experiments (Leonard et al., 1993; Briegel et al., 1993). It 
is also important for mouse urogenital development (Zhou et al., 1998) and for specifying 
mouse ventral pituitary cell types (Dasen et al., 1999). In neuroepithelial mouse cell 
culture, Gata2 acts in suppressing cell proliferation and promoting exit of the cell cycle (El 
Wakil et al., 1996). In mouse nervous system, Gata2 is expressed in both developing brain 
and spinal cord (Zhou et al., 1998). At first, it is expressed in rhombomeres 2 and 4 of the 
hindbrain, where it can be detected at day 9, and the expression in the remaining brain 
parts and in the spinal cord follows soon after that (Zhou et al., 1998).  
In mouse neural tube, Gata2 expression begins between 10 and 12 dpc in both brain 
and spinal cord (Zhou at al., 1998).  In the spinal cord, the gata2 expressing cells are 
located near the ventricular zone, but the labeling with BrdU shows that very few cells that 
express Gata2 are still dividing: the majority of Gata2-expressing cells are located more 
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laterally than the BrdU-positive cells of the ventricular zone (Zhou et al., 2000). At the early 
stage at which it was investigated (E10.5), Gata2 expression does not overlap with Nkx2.2, 
but it does overlap with dorsal Lim3- positive cells (expressed dorsally by V2 and more 
ventrally by MNs), and with Vsx2-expressing cells (Zhou et al., 2000), which were the only 
known V2 markers at the time. 
In chick spinal cord, GATA2 is present in cells located within the V2 domain, with 
some of the GATA2-positive cells co-labeled with GATA3, but not by VSX2 (also known as 
CHX10) (Karunaratne et al., 2002). Interestingly, the GATA2-positive cells that are not 
labeled with GATA3 are localized to the more medial part of the chicken spinal cord, 
especially at earlier stages, suggesting that GATA2 could potentially be expressed before 
GATA3 (Karunaratne et al., 2002). A similar expression pattern is found in mouse, where 
Gata2 is expressed closer to ventricular zone than Gata3 is (Nardelli et al., 1999).  
In zebrafish, the teleost genome duplication led to the existence of two Gata2 
paralog genes, gata2a and gata2b (Gillis et al., 2009). gata2a used to be previously known 
as gata2a, and gata2b had the name zgc:91840 (ZFIN.org). These genes share only 57% 
identity and 67% similarity, and they play different functions in tissues in which they’re 
expressed (Butko et al., 2015). Transcription of gata2b is first detected in zebrafish at 
16hpf, where it is expressed first in the posterior plate mesoderm (Butko et al., 2015). 
Later gata2b expression can be detected in dorsal aorta and branchimotor neurons (at 
20hpf) and in hematopoietic cells (at 50hpf and 72hpf), but at any of the investigated 
stages it does not appear to be expressed in spinal cord cells (Butko et al., 2015; Lewis lab 
observations). This is in contrast to gata2a, which is transcribed earlier – it is already 
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expressed at 75% epiboly in ventral ectoderm (Detrich et al., 1995), and in presumptive 
hematopoietic progenitors by around 3-somite stage (approx. 10.3hpf) (Detrich et al., 
1995; Li et al., 2009). gata2a is detected in posterior plate mesoderm earlier than gata2b, 
at 8 somite stage (13dpf) (Li et al., 2009).  Later, gata2a is also expressed in hematopoietic 
and endothelial stem cells, as well as in brain and the spinal cord (Yang et al., 2007; Batista 
et al., 2008; Kobayashi et al., 2010). Expression patterns of gata2a and gata2b are therefore 
different – for example, gata2a is expressed throughout dorsal aorta, and gata2b 
expression is limited to only the hematopoietic part of the dorsal aorta, and gata2b is not 
present in the spinal cord (Butko et al., 2015). Functions of gata2a and gata2b are also 
different in the circulatory system – loss of gata2a results in lack of trunk circulation and 
pooling of red blood cells in the trunk (Zhu et al., 2011; Butko et al., 2015), while gata2b 
morphants show normal expression of several blood cell markers, including tal1 (which is 
also expressed in spinal cord cells) and gata2a (Butko et al., 2015). gata2a and gata2b may 
represent a subfunctionalization of mammalian Gata2 gene functions, with gata2a being 
required for vascular development, and gata2b required for correct development of 
hematopoietic stem cells (HSCs) (Butko et al., 2015). Given the different expression 
patterns and functions of gata2a and gata2b in zebrafish, and no apparent expression of 
gata2b in zebrafish spinal cord, in this thesis I will only look at expression of gata2a and its 
role in the spinal cord.  
1.6.2 Gata3 
GATA3 (GATA-binding protein 3) also belongs to the GATA family of transcription 
factors that bind WGATAR (W = A or T and R = A or G) consensus sequences (Merika and 
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Orkin, 1993). GATA3 was first identified as a protein that binds to an enhancer of Delta 
gene of human T-cell receptor (Ho et al., 1991; Ko et al., 1991; Joulin et al., 1991). Since 
then, it was described to play multiple roles in development, proliferation and maintenance 
of T-cells, as well as innate lymphoid cells, with its important role in innate and adaptive 
immunity highly dependent on the dose, developmental stage, and cell lineage (reviewed 
in: Heicklen-Klein et al., 2005, in Wan et al., 2014, and in Tindemans et al., 2014).  
In mouse spinal cord, Gata3 is expressed dorsally to motoneurons and ventrally to 
V1 cells, by the same cells as Lhx3 and Gata2 which are markers of V2 cells (Ericson 1997, 
Zhou et al., 2000). Later experiments in chicken show that GATA3 labels GATA2-positive 
cells that are intermingled with cells that express VSX2, and VSX2 and GATA3 are never co-
expressed in the same cells of spinal cord (Karunaratne et al., 2002). In mouse spinal cord, 
GATA3 expression partially overlaps with TAL1 expression, with cells that express both 
markers located more medially than GATA3+/TAL1- cells (Smith et al., 2002). Similar to 
what was found in chicken, in mouse GATA3 and VSX2 expression are mutually exclusive 
but cells that express those two markers are intermingled with each other (Smith et al., 
2002).  Also, at least some gata3-expressing cells co-express gata2a and tal1 in zebrafish, 
and these cells are intermingled with vsx2-positive V2a cells (Batista et al., 2008). In 
conclusion, Gata3 is a well-established marker of inhibitory V2b cells in chicken, mouse and 
zebrafish (Karunaratne et al., 2002, Smith et al., 2002, Kimura et al., 2008; Batista et al., 
2008) 
In zebrafish gata3 is first expressed at 4hpf (Neave et al., 1995). During epiboly, 
gata3 expression is restricted mainly to the yolk syncytial layer, deep cell blastomeres, and 
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later to part of the blastula in a pattern resembling baseball stitching (Neave et al., 1995). 
Later, the expression is also detected in the intermediate mesoderm that will form 
pronephros, and in the pronephral ducts (Neave et al., 1995). In zebrafish central nervous 
system (CNS), gata3 expression can be detected in brain and spinal cord. By 15hpf gata3 is 
present in ventral spinal cord (Neave et al., 1995). At 16-somite stage gata3 is already 
present in KA domains (together with tal1 but before gata2a), begins only between 18hpf-
24hpf (after tal1 and gata2a; Batista et al, 2008). Expression in spinal cord persists until 
later stages but starts to diminish by 36hpf (Neave et al., 1995). gata3 is also expressed in 
zebrafish brain, where it can be detected in ventral midbrain and diencephalon at 20hpf, as 
well as in optic tectum by 48hpf (Neave et al., 1995). gata3 is also expressed in both newly 
formed neurons and glia of the telencephalon after injury, where it is required for both 
migration of newly born neurons and cell proliferation (Kizil et al., 2012). 
1.6.3 Tal1 
Tal1, (stem cell leukemia; also known as Scl or Tcl5), is a basic helix-loop-helix 
(bHLH) protein that was first discovered through its important role in T-cell acute 
lymphoblastic leukemia (Begley et al., 1989; Finger et al., 1989; Chen et al., 1990). Even 
though the protein contains a DNA binding domain, TAL1 has been shown in zebrafish, in 
embryonic stem cells and in human hematopoietic cell culture to be able to exert 
transcriptional activity without necessarily binding DNA (Porcher et al., 1999; Ravet et al., 
2004). Also, in mouse TAL1 DNA-binding activity is dispensable for specification of 
hematopoietic cells, but is necessary for red cell maturation, suggesting that the 
mechanisms that TAL1 uses to mediate regulation of gene expression are dependent on cell 
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type and developmental process (Kassouf et al., 2008). Mechanisms that might contribute 
to a DNA-binding independent action of TAL1 involve protein-protein interactions and/or 
sequestration of other regulators that would otherwise inhibit developmental processes 
(Kassouf et al., 2008). It is possible that TAL1 is recruited to the enhancers of the target 
genes as part of a larger complex, and that the complex can not bind to DNA in absence of 
TAL1. Such a mechanism is in place in erythroid cell formation, where the TAL1-FOG-
GATA1 complex enables expression of downstream genes (Wadman et al., 1997). Also, 
another possibility is that the proteins that would normally inhibit expression of 
downstream genes bind to TAL1 and are thus prevented from inhibiting gene expression. 
Tal1 is essential for correct specification of all haematopoietic lineages and for 
differentiation of megakaryocytes from mesoderm (Porcher et al., 1996; Gering et al., 
1998). Tal1 is also expressed in the developing nervous system, including midbrain, 
hindbrain, and spinal cord (Smith et al., 2002). In mouse spinal cord, tal1 is expressed in 
very late p2/early V2 cells, with the expression beginning at 10.5dpc in mouse, and fading 
by 14dpc (Smith et al., 2002; Muroyama et al., 2005).  
In zebrafish, tal1 is expressed in the same cells as gata2a and gata3, which includes 
V2 cells but also the KA cells that are located more ventrally (Batista et al., 2008). tal1 
mRNA is already present in zebrafish spinal cord at 16-somites in KA cells, but expression 
doesn’t begin in the V2 domain until 18-somites (Batista et al., 2008).  
1.6.4 Tal2 
TAL2, like TAL1 (TAL1), is a bHLH transcription factor and it is also implicated in 
T cell acute lymphoblastic leukemia (T-ALL) (Baer, 1993). It was first identified as another 
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protein that is activated by the common chromosomal translocation implicated in human 
T-ALL, and it is highly homologous to TAL1 (Xia et al., 1991). In mouse, Tal2 is expressed in 
testes (Xia et al., 1991), as well as in developing brain tissue including midbrain, 
diencephalon and anterior pons (Mori et al., 1999). Even though TAL2 mutations are 
associated with T-cell tumors, Tal2 is not normally expressed in blood and mouse TAL2 
mutants do not display any obvious changes in blood formation (Bucher et al., 2000). 
However, mutants display widespread malformations in CNS development including 
midbrain malformations, and do not survive longer than 32 days after birth (Bucher et al., 
2000).  
Brain expression of Tal2 in mouse partly overlaps with expression of Gata2, Gata3 
and Tal1/Tal1 (Achim et al., 2013). Interestingly, all those genes are expressed by 
GABAergic neurons of the brain, but the overlap in their expression patterns differs 
between specific areas of the brain. In the midbrain area, Tal2 is expressed more broadly 
than Tal1 (Achim et al., 2013). The opposite is true for the neighboring rhombomere 1 
region, where Tal1 is expressed more broadly than Tal2 (Achim et al., 2013). Also, in the 
midbrain almost all Tal2-expressing cells are labeled by GATA2 antibody, but only very few 
Tal2-expressing cells coincide with GATA3-positive cells (Achim et al., 2013). As will be 
described later, those differences result in different functions of those transcription factor 
genes in GABAergic neurogenesis of mouse brain (Achim et al., 2013). 
In zebrafish, tal2 is also expressed in brain, but it is also present in developing spinal 
cord (Pinheiro et al., 2004). So far spinal cord expression has not been reported in any 
other organism. It is first detected in a few cells of head and spinal cord at 13 somite 
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(15.5hpf) stage (Pinheiro et al., 2004). Expression in head proceeds from the developing 
midbrain (at 22hpf), to diencephalon of the forebrain, tectum of the midbrain and 
hindbrain structures (at 47hpf) (Pinheiro et al., 2004). The diencephalon and tectum 
expression resemble that of tal1 (tal1) (Pinheiro et al., 2004, Sinclair et al., 1999), and are 
conserved between mouse and zebrafish (Pinheiro et al., 2004; Bucher et al., 2000).  Tal2 is 
visible throughout the entire length of the spinal cord at 22hpf, in lateral floor plate cells, 
and in more dorsal sonic hedgehog-dependent cells that are located approximately in the 
V2/V1 domain (Pinheiro et al., 2004). By 44hpf, tal2 expression is already significantly 
reduced in the spinal cord (Schafer et al., 2007), and no expression of tal2 in spinal cord 
was detected at 47hpf (Pinheiro et al., 2004). tal2-expressing cells at 18-20 hpf do not 
divide, as detected by M-phase marker PhH3, suggesting that those cells may already be 
post-mitotic at this stage (Schafer et al., 2007). In addition, at 24hpf, tal2 at least partly 
co-localizes with the neuronal marker Elavl3 (previously known as HuC), indicating that 
some of the tal2-expressing cells are already post-mitotic neurons (Schafer et al., 2007). At 
24hpf, two-thirds of the cells that express tal2 also express nkx2.9 (Yang et al., 2010). Some 
of the tal2-positive cells express p3 marker nkx2.2b, which suggests that tal2 is expressed 
by some p3 progenitor cells (Schafer et al., 2007). However, other researchers also show 
that at 24hpf all of the tal2-expressing cells are already GABAergic (Yang et al., 2010), 
which would argue against the tal2-expressing cells being progenitor cells. In addition, at 
least a subset of the tal2-expressing cells develop later into V3 cells (Schafer et al., 2007). In 
fact, at 44hpf a subset of tal2-expressing cells co-expresses sim1a (previously known as 
sim1). sim1a is an ortholog of mouse Sim1 gene, which is a marker of V3 cells (Borowska et 
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al., 2013) required for correct V3 specification (Blacklaws et al., 2015). Also, earlier at 
36hpf about 25% of the tal2-positive cells also express sim1a (Yang et al., 2010).  
However, the majority of cells that express tal2 in the floor plate region seem to 
correspond to KA” cells, and more dorsally located cells correspond to KA’ cells (Yang et al., 
2010) and possibly other unidentified cell types. As mentioned before, all of the tal2-
expressing cells are GABAergic at 24hpf (Yang et al., 2010). Also, tal2 expression co-
localizes with gata2a, with the majority of cells in the floor plate region expressing both 
markers, but only a fraction of more dorsally-located gata2a+ cells expressing tal2 (Yang et 
al., 2010). Similarly, tal2 is expressed in a number of gata3-expressing cells (Yang et al., 
2010), but it is not clear whether it’s present in all or only a subset of them. Overall, these 
results suggest that tal2 is expressed in at least a subset of p3 cells, KA” and KA’ cells, 
possibly other GABAergic cells, and later in V3 cells in the floor plate region.  
1.7.1 Interactions between TAL1, GATA2, GATA3, and TAL2 in the CNS 
The role of TAL1 in amniotic spinal cord was extensively tested in mouse and chick, 
but has not been investigated in zebrafish spinal cord prior to this thesis research. In 
amniotes, TAL1 is expressed at the same time as GATA3 in a subset of mouse spinal cord 
cells (Smith et al., 2002), which raises possibility that those two proteins might interact in 
those cells. At 11.5dpc, TAL1+/GATA3+ cells are located more medially, while TAL1-
/GATA3+ cells are restricted to the more lateral edges of the spinal cord (Smith et al., 
2002), which suggests that Tal1 may stop being expressed by V2b cells earlier than Gata3 
and may be upstream of Gata3. Since TAL1 null mutant mice lack blood cells and die early 
at E8.5 (Porcher et al., 1996), a special nerve-tissue specific knockout line was constructed 
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to test the function of TAL1 in mouse spinal cord (Muroyama et al., 2005). The resulting 
experiments show that nerve tissue-specific ablation of Tal1 results in loss of Gata3 
expression in V2 cells (which was not associated with cell death), and significant 
attenuation of Gata2 expression (Muroyama et al., 2005). It’s important to note that gata2a 
attenuation in mouse could result from the mosaic nature of tissue-specific tal1 ablation, 
and gata2a might be completely lost if non-mosaic V2 cell Tal1 deletion was possible. In 
addition, the same study revealed that Tal1 ablation results in dorsal expansion of Olig2-
expressing pMN cells, and Olig2 mutation results in expansion of Tal1, Gata2 and Gata3, 
suggesting that Tal1 and Olig2 cross-repress each other (Muroyama et al., 2005). 
Also, in chicken spinal cord overexpression of full length mouse TAL1 results in 
suppression of endogenous VSX2-expresion by V2 cells, and ectopic expression of GATA3 
(Fig. 3; Muroyama et al., 2005). This suggests that TAL1 may be sufficient to potentially 
change V2a cells to V2b cells in chicken embryos (Muroyama et al., 2005). Taken together, 
these results suggest that with respect to V2b cells in amniote spinal cord, Tal1 is both 
sufficient and required for Gata3+ V2b development, and is required for maintenance of 
normal levels of Gata2 expression (Muroyama et al., 2005). 
Mutant Gata2 mice investigated at the early (E10.5) stage show a reduction in both 
Vsx2 and more dorsal Lim3, suggesting that Gata2 is required for formation of V2 cells (Fig. 
3; Zhou et al., 2000). Also, in mouse Gata3 is expressed outside of the ventricular zone (as 
opposed to Gata2 which is present closer to ventricular zone), and its expression might 
depend on presence of Gata2, as in Gata2 mutants Gata3 cannot be detected, at least in 
whole mount embryos that were analyzed (Fig. 3; Nardelli et al., 1999). In addition, a very 
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recent study performed in mouse (Fig. 3; Francius et al., 2014), confirms that Gata2 is 
required for formation of normal numbers of both V2a (Vsx2-positive) and V2b (Gata3-
positive) cells in mouse spinal cord, as the expression of each of these markers is reduced 
by about 60% in Gata2 mutant embryos. In addition, use of conditional Cre-induced 
knockdown in a Gata2loxp/loxp mouse, which removes the start codon of Gata2, shows that 
Gata2 is crucial for consolidation of the V2a/V2b fate, as many cells express both Vsx2 and 
Gata3 simultaneously in the spinal cord of E12.5 mouse when Gata2 is knocked down at 
E9.5 (Francius et al., 2014). However, it seems that Gata3-expressing neurons still form in 
large numbers in Gata2 conditional knockout mice, which is a different result to the Gata2 
complete knockout mouse reported earlier (Zhu et al., 2000), and the above study 
(Francius et al., 2014). Unfortunately, Gata3-expresing cells in the conditional knockout 
were not counted, and it is not clear how many cells still express this marker (Francius et 
al., 2014). Overall, this suggests however that Gata2 is required for correct development of 
both V2a cells and V2b cells in mouse, and that Gata2 is upstream of Gata3 in mouse spinal 
cord. The function of Gata3 in the mouse mutant spinal cord has not been investigated so 
far. 
Overexpression experiments in chicken also show that ectopic GATA2 expression is 
sufficient to induce GATA3 expression while reducing the expression of VSX2 by V2 cells, as 
well as reducing the number of ISLET1-expressing MNs in the chicken spinal cord (Fig. 3, 
Karunaratne et al., 2002). In addition, the same study shows that overexpression of GATA3 
can result in ectopic expression of GATA2, this effect is, however, less prominent. The 
expression patterns of GATA2 and GATA3, together with these overexpression experiments, 
suggest that in chicken GATA2 is upstream of GATA3 in the V2 cell domain and that once 
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expressed, GATA3 can either induce or maintain the expression of GATA2 in vivo 
(Karunaratne et al., 2002). Interestingly, both Gata2 and Gata3 have 5’ sequences that 
would potentially be able to bind proteins of the GATA  family, supporting the idea of a 
possible ‘feedback loop’(Karunaratne et al., 2002).  
During brain development in mouse, Gata2 is required for specification of 
GABAergic neurons in the midbrain (Kala et al., 2009), and both required and sufficient for 
specification of serotonergic neurons in rhombomere 1 of the hindbrain (Craven et al., 
2004). It is also required for normal development and correct migration of optic tectum 
cells in rat brain (Willett and Greene, 2011).  In chick midbrain and hindbrain, Gata2 
expression precedes that of Tal1 and Gata3, suggesting that Gata2 might be upstream of the 
other two genes in chick brain (Herberth et al., 2005). This suggests that the hierarchies of 
those transcription factors differ between the amniote spinal cord and brain. In fact, recent 
research shows that interactions between GATA- family transcription factors and TAL-
transcription factors within mouse brain may be tissue-dependent. Formation of midbrain 
GABAergic neurons seems to be differently regulated between specific subpopulations of 
cells (Achim et al., 2013).  
In midbrain, Tal2 expression seems to be Gata2a-independent, while Tal1-
expression is affected by loss of Gata2 in midbrain (and not affected in the rhombomere 1), 
as shown in gata2flox/flox conditional knockout (Achim et al., 2013). In Tal2 knockout mouse 
midbrains, Gata3 and Gad1 are still present but downregulated, whereas Gata2 expression 
persists fully (Achim et al., 2013). This expression of Gata2 remains unaffected even in 
Tal2/Tal1 double knockout embryos, but in those embryos expression of Gad1 and Gata3 is 
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completely gone (Achim et al., 2013). In addition, expression of glutamatergic markers 
PAX6 and Slc17a6 are upregulated in Tal2 single knockout, and Tal2/Tal1 double knockout 
embryos, suggesting that TAL-factors, especially TAL2, are crucial for the correct 
specification of GABAergic cells in mouse midbrain (Achim et al., 2013). Overall, in the 
mouse midbrain, where Gata2 seems to be required for formation of all GABAergic neurons 
in that region, requirement for Tal2 in specification of GABAergic cells seem to be varied 
between different midbrain sub-regions, and it could be potentially explained by partial 
redundancy with Tal1 (Achim et al., 2013). Since the expression patterns vary between 
different regions of the brain, it remains to be elucidated whether Tal2 is required for 
formation of other GABAergic cells in the brain, and in the spinal cord.  
In zebrafish, roles of gata2a, gata3 and tal1 in V2b cells of spinal cord remain 
unclear. Preliminary data in zebrafish gathered by a previous student in the lab, Jeffrey 
Jacobstein, suggests that tal1 might be upstream of gata3, but not of gata2a, in zebrafish 
spinal cord (Jeffrey Jacobstein, MSc dissertation, 2008).  He observed that in tal1 mutant 
fish, gata3 is significantly reduced, while gata2a expression remains unaffected. However, 
when I started my research, this result still needed to be confirmed, and it was not known 
whether loss of tal1 affects gata3 in all of the cells that express it, or just a subset of them. 
In my research, I repeat these experiments, and test the functions of tal1 in V2b and KA 
cells using tal1 mutant zebrafish.  
In addition, I also test the functions of gata2a and gata3 in specifying KA and V2b 
cells. Functional analysis of those transcription factor genes was previously investigated by 
a different lab using morpholino antisense knockdown experiments, as discussed below. 
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However, since the results were surprising and using morpholinos can produce non-
specific effects, I decided to further test the functions of these genes in mutant embryos. 
The function of tal2 was also tested by this other group using a knockdown morpholino 
approach (as discussed below), but currently there is no zebrafish mutant available to 
confirm these results. 
1.7.2 Functional analyses of gata2a, gata3 and tal2 
Surprisingly, evidence from another study performed in zebrafish suggests that 
gata2a and gata3 act differently in KA” cells versus KA’ cells (Yang et al., 2010). 
Knockdown of gata2a using morpholinos resulted in a loss of KA” cells and what appeared 
to be normal numbers of KA’ cells, while the opposite was true for gata3 morphants, in 
which KA’ cells did not form and KA” cells formed in what appeared to be normal numbers 
(as detected with tal2 and gad67 at 24hpf in both cases; cells were not counted in either 
case) (Yang et al., 2010). In contrast, knockdown of tal2 had no effect on expression of 
either gata2a or gata3 in KA cells (Yang et al., 2010). 
Interestingly though, tal2 knockdown via morpholino injections resulted in a loss of 
the GABAergic phenotype in KA” cells, with the KA’ and V2b GABAergic phenotype 
remaining unaffected (Yang et al., 2010). Given that, as mentioned above, injections with 
this morpholino do not affect gata2a (and gata3) expression in any of the cells (Yang et al., 
2010), but injections with gata2a abolish tal2 expression in KA” cells, these results suggest 
that tal2 is downstream of gata2a or acts in an independent pathway to specify the 
GABAergic phenotype of the cells.  
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Since morpholinos are known to sometimes have non-specific binding off-target 
effects, or induce apoptosis (Eisen and Smith, 2008), I decided to re-confirm these results 
using mutants. In addition, I examined the roles of gata2a and gata3 in V2 cells as this was 
not addressed by this previous study. Finally, I also used many more markers of KA and 
V2b cells than this previous study, which used only two molecular markers to look at KA 
cells, tal2 and gad. These additional markers enable me to assess whether KA cells require 
either gata2a or gata3 for either their global fate specification or for their GABAergic 
phenotype. 
1.7.3 Mutant alleles 
The tal1 mutant used in this study, tal1t21384 (Bussmann et al., 2007; kindly provided 
by Dr. Varga at University College of London, UK) carries a nonsense mutation at amino 
acid 183, leading to deletion of the C-terminus of the protein, including the entire bHLH 
domain (also see Fig. 4). This suggests that it might be a null mutant. The mutation results 
in abnormal vessel formation between somites, loss of tal1 expression in erythroid cells 
and reduction in tal1 spinal cord expression; all abnormal phenotypes can be rescued by 
injecting wild-type tal1 mRNA (Bussmann et al., 2007). 
The gata2um27 mutant used in this study was kindly provided by Dr. Lawson at 
University of Massachusetts Medical School, MA, US. It was created with zinc-finger 
nucleases and results in a 10bp deletion that leads to a protein truncation upstream of both 
zinc finger domains (Zhu et al., 2011; also see Fig. 4). The mutant phenotype includes 
defects in morphogenesis of dorsal aorta, and loss of trunk blood circulation (Zhu et al., 
2011). 
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The gata3sa0234 mutant used in this study was generated using zinc-finger-nucleases, 
and kindly provided by Dr. Steven Harvey at Wellcome Trust Sanger Institute, UK. The 
mutation causes deletion followed by an insertion at position 264aa, which leads to 
addition of 13 extra amino acids before reaching the stop codon (personal communication 
and my sequencing results). This causes only 8 amino acids of the first zinc finger domain 
to remain intact, and completely removes the second zinc finger from the truncated 
protein.  
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Figure 4. 
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Figure 4. Schematics showing location of gata2aum27, tal1t21384 and gata3sa0234 
mutations. Numbers indicate amino acid positions of particular protein domains. DNA-
binding domains are indicated in red (zinc finger domains) or yellow (bHLH domain).  (A) 
gata2aum27 mutation is a 10bp deletion that leads to a premature stop codon. If a protein is 
still made it will not contain either of the two zinc finger domains normally present in 
Gata2a (Zhu et al., 2011). (B) tal1t21384 mutation is an AT change that leads to formation 
of premature stop codon. If the protein is still made, it will not contain the bHLH DNA-
binding domain (Bussmann et al., 2007). (C) gata3sa0234 is a small deletion and insertion 
that leads to formation of a premature stop codon before the two zinc finger domains 
(unpublished, courtesy of Dr. Harvey and Dr. Stemple at Wellcome Trust Sanger Institute, 
UK). 
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1.8 Discovering novel candidates that may be expressed by V2 
and/or KA cells 
In addition to analyzing the functions of tal1, gata2a and gata3 in V2b and KA cells, I 
was also interested in finding new potential markers of these cells. I was particularly 
interested in finding genes that are expressed solely by either V2b or KA cells, because at 
least when I started my project there were only a few transcription factor genes known to 
be expressed by these cells, and all of them were shared between both populations. 
Literature in other organisms suggested that foxn4 and sox1a/sox1b are expressed by V2 
cells, but it was not known whether KA cells and V2b cells in zebrafish also express these 
genes. In the following sections, I will outline the current knowledge about expression 
patterns of these genes and about their role in the spinal cord development.  
1.8.1 foxn4 
Foxn4 (Forkead box N4) is a forkhead helix-loop-helix transcription factor that is 
expressed in mouse eye and spinal cord during embryonic development (Gouge et al., 
2001). It is required for correct specification of particular cell types in the eye (Li et al., 
2004). In mouse spinal cord, Foxn4 is expressed in a subset of p2 progenitor cells, and a 
small subset of Foxn4 cells also co-expresses Gata2 and Tal1 (Li et al., 2005; delBarrio et al., 
2007). Later, it was also shown that Foxn4-expressing cells give rise to all V2 cells in mouse 
spinal cord (Li et al., 2010; Misra et al., 2014; Panayi et al., 2010). In mouse spinal cord, 
Foxn4 acts upstream of Tal1, as Foxn4 null mutants show loss of Tal1 expression, while 
Tal1 knockout mice have normal Foxn4 expression (Li et al., 2005; Del Barrio et al., 2007). 
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Also, early studies in chicken indicated that foxn4 on its own may not be sufficient to 
specify V2b cells (Li et al., 2005), but later experiments show that overexpression of Foxn4 
is sufficient to induce Gata3, Gata2 and Tal1 in chicken embryos, while suppressing Vsx2 
expression, suggesting that Foxn4 is sufficient for V2b formation, at the expense of V2a cells 
(Del Barrio et al., 2007). This study suggests that Foxn4 is both sufficient and required for 
V2b formation in amniotes (Li et al., 2005; Del Barrio et al., 2007).  
In addition, Foxn4 is expressed in mitotically active cells that express Notch ligand 
delta-like 4 (Dll4) in mouse, and is often found in pairs of cells that presumably have 
recently undergone division (Del Barrio et al., 2007). A Foxn4 null mutation in mouse 
causes loss of Dll4 expression, and studies in chicken show that electroporation of Foxn4 
causes ectopic expression of Dll4, suggesting that Foxn4 is both required and sufficient for 
Dll4 expression (Del Barrio et al., 2007). It is possible that the Foxn4 and Delta-Notch 
signaling participate in a regulatory loop that specifies V2b cells, as electroporation of Dll4 
in chicken embryos causes an increase in Foxn4 and Gata2 expression, while attenuating 
the number of Vsx2-positive cells (Misra et al., 2014). Also, Notch signaling plays a crucial 
role in V2a/V2b division in both mouse and zebrafish, with Notch signaling being required 
for correct V2b specification (Del Barrio et al., 2007; Peng et al., 2007; Batista et al., 2008). 
In absence of Foxn4, more V2a cells form and V2b cells are reduced in number (Del Barrio 
et al., 2007; Peng et al., 2007; Misra et al., 2014). Taken together, these results suggest that 
FOXN4 may be a ‘master regulator’ of V2b versus V2a cell face in p2 progenitor cells and 
that it may exert its influence through Dll4 and Notch/Delta signaling. 
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In zebrafish, foxn4 is already expressed at the one cell stage, with early expression 
being presumably maternally derived (Danilova et al., 2004).  Expression of Foxn4 
continues but gradually decreases during early development (Danilova et al., 2004). Later, 
at 10hpf foxn4 is expressed in the forebrain, and by 19hpf midbrain structures also express 
foxn4 (Danilova et al., 2004). At 22hpf foxn4 continues to be expressed in the retina, 
olfactory placode, and various parts of the brain including the area where cranial 
motoneurons form (Danilova et al., 2004), but from looking at photographed embryos in 
this study I think it might also be in anterior ventral spinal cord neurons at this stage. 
Expression in the head continues until at least 7dpf (Danilova et al., 2004).  foxn4 is also 
expressed in the atrioventricular canal of heart between 24hpf-72hpf, where is required 
for correct formation of this structure, as shown by morpholino-induced knockdown 
experiments (Chi et al., 2008). In zebrafish spinal cord, expression of foxn4 has only been 
described by the one study which indicates that at 18hpf, foxn4 is expressed in spinal cord 
cells that express vsx1 corresponding to very late p2 or very early V2a/V2b cells (Kimura et 
al., 2008; Supplementary Material). foxn4 is expressed often in neighboring pairs of cells, 
and sometimes remains in only one of the cells out of the pair, which is suggested to 
become in future a V2a cell (Kimura et al., 2008). However, some of the Tg(Vsx1:GFP) pairs 
of cells express vsx1 but do not express foxn4, suggesting that foxn4 expression might be 
transient and perhaps it could be downregulated before vsx1 (Kimura et al., 2008).  
In this thesis, I will examine the expression of foxn4 in zebrafish spinal cord over 
time, and try to identify cells that express this gene. I will also test whether any of the tal1, 
gata2a or gata3 mutants affect the expression of foxn4 in zebrafish spinal cord.  
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1.8.2 sox1a and sox1b 
Zebrafish sox1a and sox1b are orthologs of mouse Sox1, and belong to the SOX family 
of transcription factors. Sox genes were first described in the mammalian genome and are 
divided into distinct groups based on their sequence similarity (Schepers et al., 2002). SoxB 
members share 85% sequence similarity within their DNA-binding domains, and the 
evolutionarily conserved SoxB1 group consists of Sox1, Sox2 and Sox3 (Harley et al., 1994; 
Bowles et al., 2000). In Drosophila, chicken and Xenopus, orthologs of these genes are 
expressed in neural primordium cells and are thought to play important role in 
specification and determination of neural cells (as described in Kan et al., 2004).  In 
chicken, members of the SoxB1 family play an important role in interpretation of the 
morphogen signal in both the limb bud and neural tube (Oosterveen et al., 2013). For 
example, one of SoxB1 family members (Sox3) appears to be sufficient to give mesodermal 
cells the potential to respond to morphogens and later express transcription factor genes 
that form neurons (Oosterveen et al., 2013).  
In mouse, Sox2 and Sox3 are expressed very early in development and are thought to 
contribute to maintenance of neural progenitor cells while inhibiting neurogenesis (Bylund 
et al., 2003; Graham et al., 2003). Sox1 is expressed later than other SoxB1 members, at the 
beginning of the formation of neural plate, and is required for formation of GABAergic cells 
in several mouse brain structures (Malas et al., 2003), as well as being sufficient for 
neuronal differentiation of cells from the P19 cell line (Pevny et al., 1998). Also, SOX1 is the 
only SoxB1 transcription factor that promotes neurogenesis via several different 
mechanisms, including binding inhibition of Notch signaling (binding to Hes1), suppressing 
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beta-catenin mediated signaling, promoting pro-neural neurogenin1 expression and 
promoting exit from the cell cycle in  cell culture (Kan et al., 2004). However, although Sox1 
seems to be downregulated in majority of post-mitotic cells, it is still expressed in scattered 
cells in several adult brain structures (Malas et al., 2003; Kan et al., 2004). 
In mouse spinal cord during early developmental stages (i.e. E9.5), Sox1 is expressed 
in the ventricular zone (VZ), and not in post-mitotic differentiated cells (Pevny et al., 1998; 
Genethliou et al., 2009). However, at later stages starting from E10.5 and peaking at E12.5, 
Sox1-expressing cells are present in the differentiated cell domain (Panayi et al., 2010). The 
origin of these cells can be traced to the progenitor p2 domain, as some of the Sox1-
expressing cells overlap with Foxn4-iCre_Rosa26stopYFP –expressing cells (Panayi et al., 
2010). Furthermore, Sox1-expressing cells seem to have once expressed Gata3 (as 
demonstrated by using GATA3-eGFP transgenic mouse) (Panayi et al., 2010). Overall, this 
suggests, that in mouse an additional group of V2 cells (V2c cells) might exist, which 
derives from V2b cells (Panayi et al., 2010). This remains to be confirmed in other 
organisms.  
In this thesis, I have investigated expression patterns of Sox1 orthologs, sox1a and 
sox1b in zebrafish, and examined whether their expression depends on presence of gata2a, 
gata3 and/or tal1.  
1.8.3 Other markers (found from microarray & literature)  
In this thesis, I will also briefly describe the expression pattern of several 
transcription factors that have been identified by other lab members as being potential 
candidate markers of either V2b and/or KA cells. Those markers have been found either 
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from literature sources or via microarray analyses performed by the lab, which profiled the 
expression pattern of V2b/KA cells versus other cells in the spinal cord, using microarrays 
that contained at least most transcription factors in the zebrafish genome. Some of these 
(sox1a/sox1b/foxn4) are also included as KA and V2b markers in my mutant studies.  
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2. Methods 
2.1 Fish husbandry 
Adult zebrafish (Danio rerio) were maintained on a 14 hours light/10 hours dark 
cycle. Embryos were collected and maintained in Embryo Medium (EM: 5mM NaCl, 0.17mM 
KCl, 0.33mM CaCl2.2H2O, 0.33mM MgSO4.7H2O + 10g HEPES/liter).  For all experiments, 
embryos were staged by hours post-fertilization at 28.5°C) or position of lateral line 
primordium over the somites (e.g. 24hpf=prim5 (Kimmel et al., 1995)). Occasionally, 
embryos were grown at 25°C or 32°C to achieve desired stages at particular times. In these 
cases developmental stages were calculated and confirmed with morphological criteria as 
described in Kimmel et al., 2005.  
2.2 Fish lines 
Wild-type embryos were obtained by mating wild type adults (AB, TL, or AB/TL 
hybrids). Transgenic embryos were obtained by mating heterozygous carriers of 
Tg(8.1kGata1:eGFP) (Kobayashi et al., 2001) and homozygous/heterozygous Tg(vsx2:GFP), 
Tg(vsx2:Kaede), Tg(vsx2:RFP) (Kimura et al., 2006) fish. Mutant embryos were obtained 
from matings of heterozygous gata2aum27 (Zhu et al., 2011), gata3sa0234 (unpublished fish 
line kindly provided by Dr. Steven Harvey at Sanger Institute, Cambridge, UK) or tal1t21384 
(Bussmann et al., 2007) mutants. Adult gata2a and gata3 mutant carriers (heterozygous 
fish) were identified by fin-clipping and PCR, followed by a restriction enzyme digest 
and/or sequencing whenever appropriate. Adult tal1 mutation carriers were identified by 
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the above method or by the observation of the morphological phenotype in approximately 
25% embryos (assumed to be homozygous mutants). The mutant morphology includes 
curved tails, smaller eyes, heart edema and no blood circulation in the trunk of embryos at 
around 48hpf (Bussmann et al., 2007).  
2.3 Embryo fixation 
All embryos were fixed in 4% paraformaldehyde (PFA; Sigma-Aldrich cat. # P6148) 
overnight at 4°C or for 4 hours at room temperature with shaking. Embryos that were to be 
used for antibody staining were washed out of 4% PFA with PBST (PBS (PBS, Sigma-
Aldrich, cat. # P4417) + 0.1% Tween 20 (Sigma-Aldrich, cat. # P1379)) 2 x 5 minutes and 
2 x 10 minutes and stored at 4°C in PBST. Embryos for in situ hybridization (ISH) were 
washed out of 4% PFA with PBST 2 x 5 minutes and 2 x 10 minutes, followed by 
dehydrating in 100% methanol (Fisher Scientific, cat. # BP1105) for 2 x 5 minutes and 2 x 
10 minutes, and stored at -20°C in 100% methanol. Embryos that were used for in situ 
hybridization followed by immunohistochemistry (ISH+IHC) were washed 2 x 5 minutes 
and 2 x 10 minutes with PBST. Then these embryos were permeabilized with proteinase K 
10μg/ml (Roche, cat. # 03115879001) diluted in distilled water for 24 minutes. The 
embryos were then fixed in 4% PFA for 20 minutes to inactivate the proteinase K, and 4% 
PFA was washed off with PBST for 2 x 5 minutes, 2 x 10 minutes. Finally the embryos were 
equilibrated in 50% cheap hybridization buffer/50% PBST. Cheap hybridization buffer is 
50% formamide (Sigma-Aldrich, cat. # F9037) plus 50% 5x SSC (from a 20x SSC stock 
which is 3M sodium chloride (Sigma- Aldrich, cat. #S5886) + 0.3M tri-sodium citrate 
(Sigma- Aldrich, cat. # W302600) and 0.1% Tween 20. The embryos were then equilibrated 
46 
 
  
 
in 100% cheap hybridization buffer and stored -20°C for less than a week in hybridization 
buffer (cheap hybridization buffer + 500 μg/ml yeast RNA (Roche, cat. # 10109223001) + 
50 μg/ml heparin (Sigma-Aldrich, cat. # H3393), final pH 6.0). 
2.4 Plasmid preparation  
All plasmids were purified using Qiagen’s QIAfilter Plasmid Midi Kit, (cat. #12243) 
according to the manufacturer’s instructions. Cells from a 150 ml (high copy plasmid) or 
250 ml (low copy plasmid) culture of an E. coli transformant were lysed by alkaline lysis. 
The protein precipitate was separated using the filter provided in the kit. 
The cleared filtered solution containing the DNA was then applied to an anion exchange 
column. After several wash steps the plasmid DNA was eluted from the column and 
precipitated using isopropanol. The pellet, obtained by high speed centrifugation, was 
washed with 70% ethanol, air dried, resuspended in dH20 and stored at -20°C. 
2.5 Probe preparation 
All probes were prepared to recognize genes described in the zebrafish community 
database (zfin.org). References to the gene ZFIN identifier number, and to the reference for 
each probe can be found in Table 2. 
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Table 2. Gene names and ZFIN identifiers. ZFIN identifiers (middle column) are 
provided for each of the genes used in this thesis along with common previous names. The 
column on the right provides the references for the RNA probes used for in situ 
hybridization experiments.  
Gene name ZFIN ID References for probe 
gata2a (previously called gata2) ZDB-GENE-980526-260 This thesis 
gata3 ZDB-GENE-990415-82 This thesis 
tal1 (previously called scl) ZDB-GENE-980526-501 (Peng et al., 2007) 
tal2 ZDB-GENE-040115-1 (Pinheiro et al., 2004) 
foxn4  ZDB-GENE-990415-277 (Danilova et al., 2004) 
sox1a  ZDB-GENE-040718-186 (England et al., 2014) 
sox1b ZDB-GENE-060322-5 (England et al., 2014) 
gad2 (previously called gad65)  ZDB-GENE-030909-9 (Higashijima et al., 2004) 
gad1b (previously called gad67) ZDB-GENE-030909-3 (Higashijima et al., 2004) 
slc32a1 (previously called viaat) ZDB-GENE-061201-1 (Kimura et al., 2006) 
nkx6.1 ZDB-GENE-040718-178 (Cheesman et al., 2004) 
nkx6.2 ZDB-GENE-070626-1 (Hutchinson et al., 2007) 
dbx1b ZDB-GENE-000128-11 (Seo et al., 1999) 
dbx2 ZDB-GENE-000128-13 (Seo et al., 1999) 
insm1a ZDB-GENE-040426-1810 (England et al., 2014) 
crb1 ZDB-GENE-050208-382 (England et al., 2014) 
her6 ZDB-GENE-980526-144 (England et al., 2014) 
mnx1 ZDB-GENE-040409-1 (England et al., 2014) 
sp8a ZDB-GENE-030131-9849 (England et al., 2014) 
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Probes were synthesized using template from either a Polymerase Chain Reaction 
(PCR) product or linearized plasmid DNA (Table 2, Table 3), followed by a probe reaction. 
For PCR, primers were designed by myself or other members of the Lewis lab and obtained 
from Integrated DNA Technologies, and the following reaction was carried out to obtain the 
template: 
 
PCR mix: 
 
dH20    27.25μL 
5x Phusion HF Buffer  10μL 
cDNA     5μL 
dNTPs    1μL 
Dimethyl sulfoxide (DMSO) 1.25μL 
Forward primer (10mM) 2.5μL 
Reverse primer (10mM) 2.5μL 
Phusion DNA polymerase 0.5μL 
Total volume    50μL 
PCR conditions: 
94°C   3 minutes 
94°C   30seconds 
56.5°C  30 seconds 
72°C   90 seconds 
72°C   10 minutes 
 
2.5μL of the PCR reaction was run on a 1% TAE agarose gel at 125 mV for 45 minutes. 
If the PCR resulted in a product was of the correct size, the remaining PCR mix volume was 
increased to 200μL with dH2O. DNA was extracted using equal volume of 
x35 
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Phenol:Chloroform:Isoamyl Alcohol followed by equal volume of Chloroform:Isoamyl 
Alcohol. After each step, aqueous layer was removed and transferred to fresh tubes, 
vortexed for at least 20 seconds, and centrifuged for 5 minutes at 13500rpm. Finally, the 
DNA was precipitated by adding 1/10 volume of 4M sodium chloride and 2 x volume of 
ethanol and placing the reaction at -20oC overnight or longer. After spinning the reaction at 
13,500 rpm for 30 minutes, the supernatant was removed and the pellet was washed with 
70% ice cold ethanol. Finally, I resuspended the DNA in 20μL of dH2O. 
When using plasmid DNA to prepare probe template, plasmid DNA in excess of 1μg 
of insert DNA was linearized with the appropriate restriction enzyme (Table 3). All 
restriction endonucleases were obtained from New England Biolabs or Roche Diagnostics 
Ltd. A 20μl reaction included 2μl buffer, DNA to give required concentration, dH20 to make 
up the volume and 0.5 μl enzyme (or 1 unit/μg DNA). The reaction mix was put at 37°C for 
2 hours then treated with proteinase K (0.05μg/μl) for 30 minutes at 37oC. DNA was 
extracted with phenol chloroform followed by chloroform and cut DNA was precipitated 
with ethanol and salts (1/10 volume of 4M NaCl + 2 volumes of ethanol) by placing the 
solution at –20°C overnight or longer, then centrifuged at maximum speed for 30 minutes 
and resuspended in dH2O. 
Probe reactions were conducted in 20μl total volume containing linearized DNA 
equivalent to 1μg insert DNA, 2μl of 10X digoxigenin-UTP from DIG RNA Labeling 
Mix  (Roche cat. # 11277073910) or 2μl of 10X fluorescein-UTP from Fluorescein RNA 
Labeling mix (Roche cat. # 11685619910) nucleotide mix, 2μl transcription buffer (40 
units of the appropriate RNA polymerase (see Table 3), T7 RNA Polymerase (New England 
Biolabs, cat. # M0251S), T3 RNA Polymerase (Roche cat. # 11031171001), SP6 RNA 
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Polymerase (Roche cat. # 10810274001) and RNAse free dH2O. The reaction mixtures were 
put at 37°C for 2 hours, then 40 units DNAse I (Roche, cat. # 04716728001) were added 
and incubated for 15 minutes. This reaction was stopped with 2μl of 200 mM EDTA pH 8.0 
(Sigma-Aldrich, cat # E5134). RNA was precipitated with 2.5μl 4M LiCl (Sigma-Aldrich, 
L9650) and 75μl pre-chilled ethanol at –20°C overnight. The solution was then centrifuged 
at maximum speed for 30 minutes at 4°C and re-suspended in 100μl RNAse free water 
containing 40 units RNAse inhibitor. 2.5 μl of this was electrophoresed in 1x TAE buffer at 
180 mV for 7 minutes to check that a reasonable quantity of RNA had been synthesized and 
had not degraded. Then 400μl of hybridization buffer (50% formamide; 50% 5x SSC; 0.1% 
Tween 20; 500 μg/ml yeast tRNA + 50 μg/ml heparin final pH 6.0) was added to the rest of 
the RNA solution (probe) before storing at –20°C. 
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Table 3. Restriction enzymes, primer sequences and RNA polymerases used to 
prepare in situ hybridization probes used in this thesis. Reagents that were used for 
making each of the in situ hybridization probes used in this thesis are listed. RNA 
polymerases are listed in each case. When PCR primers were used for making in situ 
hybridization probes, each forward and reverse primers are shown. Whenever plasmid 
constructs were used, restriction enzymes used to linearize the plasmid are provided. 
Gene name Polymerase PCR primers 
gata2a T3 
GTGAGGGTTTCGAGGAGCTC 
AATTAACCCTCACTAAAGGGAAGCAACATCGCCTTGGCTAG 
gata3 T3 
CTGCTACCTCCAATCTCCCAC 
AATTAACCCTCACTAAAGGGACAACCATTCAGTCTGCATTACATAAAG 
insm1a T3 
GCGAAATAAGAAAGCGACACCTG 
AATTAACCCTCACTAAAGGGATAAGTCCCGGCGAGCTATAAAAC 
crb1 T3 
TACTCAAGACCTCAACACTCTGC 
AATTAACCCTCACTAAAGGGAACATTCACTGACGTCTACCTCAC 
her6 T3 
ACCAGTTGAACTCGGGACAC 
AATTAACCCTCACTAAAGGGAGGAATCAAAAAGGCGAACTG 
mnx1 T3 
TCCATATCCTCCTCTTCCGACAG 
AATTAACCCTCACTAAAGGGATGTCATTGGTTCGTTCATCCTCAG 
sp8a T3 
ACACAGAACCCGTCCAGAAC 
AATTAACCCTCACTAAAGGGAGCGCTTTTAACCTCCAGATG 
    
 
Gene name Polymerase Restriction enzyme 
tal1 T7 SalI 
tal2 T3 EcoRI 
foxn4  T3 XhoI 
sox1a  T3 XhoI 
sox1b T3 HindIII 
gad2 T3 EcoRI 
gad1b T3 EcoRI 
slc32a1 T3 XhoI 
nkx6.1 T7 XbaI 
nkx6.2 T7 NotI 
dbx1b T7 BamHI 
dbx2 T7 BamHI 
  
52 
 
  
 
2.6 in situ hybridization and immunohistochemistry 
procedures 
2.6.1 Single in situ hybridization 
Embryos (including some for antibody pre-absorption) were rehydrated through a 
MeOH/PBS series: 5-10 minutes each in 75:25 50:50 25:75 and 100% PBST. Embryos 
fixed at 24 h or older stages were treated with proteinase K at 10μg/ml for the length of 
time that was pre-determined as most suitable by other lab members (our Proteinase K 
stock solutions are calibrated each time a new stock is made), or for 1-2 minutes longer in 
cases where staining had been weak in previous experiments and I wanted to check if more 
permeabilization would improve probe penetrance. The following times were normally 
used: 22hpf embryos 12 minutes, 24hpf embryos 24 minutes, 27hpf embryos 27 minutes, 
72hpf embryos (for preabsorption of antibody) 1 hour (also see Table 4). Then all embryos 
were re-fixed in 4% PFA for 20 minutes and washed 2 times for 5 minutes and 1 time for 
10 minutes in PBST. All embryos were equilibrated in 50% cheap hybridization buffer 
(50% formamide; 5x SSC; 0.1% Tween 20): 50% PBST. They were then equilibrated in 
100% cheap hybridization buffer. This was replaced with fish hybridization buffer (cheap 
hybridization buffer + 500 μg/ml yeast tRNA + 50 μg/ml heparin, final pH 6.0) in which 
embryos were pre-hybridized at 70°C for at least 4 hours. Embryos were hybridized with 
RNA probes (1:20000 dilution of the synthesized probe) in hybridization buffer overnight. 
Probes in hybridization buffer solution were placed at 70°C for at least one hour before use. 
Washes were also prepared and placed at 70°C overnight to equilibrate to temperature 
(70°C). On the next day the embryos were washed at 70°C with 1 ml of the following 
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solutions: 2 times with cheap hybridization buffer for 5 minutes each; 1 time with 50% 
cheap hybridization buffer: 50% 2x SSC for 5 minutes; 3 times with 2x SSC for 20 minutes 
each; 2 times with 0.2x SSC for 20 minutes each; 1 time with 0.1x SSC for 20 minutes; 3 
times with PBST 5 minutes each. The embryos were then washed with 1 ml of PBST at 
room temperature and incubated with sheep in situ block (PBST + 2 mg/ml BSA (Sigma-
Aldrich -Aldrich, cat. # A7906) + 5 % sheep serum (Sigma-Aldrich, cat. # S2263) + 1% 
DMSO (Sigma-Aldrich -Aldrich, Cat. # D5879)) for 1 hour at room temperature. Sheep anti-
Dig AP conjugated antibody (Roche, cat # 11093274910), which had previously been 
added to permeabilized embryos and preabsorbed over night at 4C in sheep in situ block, 
was then added to the experimental embryos at a concentration of 1/2000 and incubated 
for two hours at room temperature. The embryos were then washed 8 x 15 minutes with 
PBST and left washing over night at 4oC in PBST. Next morning the embryos were washed 3 
times in NTMT (0.1 M NaCl + 0.05M MgCl + 0.1M Tris pH 9.5 + 0.1% Tween 20, all diluted 
in dH2O) buffer and stained with 20 μl of NBT/BCIP stock solution (Roche, cat. # 
11681451001) per ml of NTMT. To stop the staining reaction, embryos were washed twice 
for 5 minutes and then twice for a minimum of 10 minutes in NTMT, followed by being 
washed twice for 5 minutes and then twice for a minimum of 10 minutes in PBST.  
Embryos were then kept in PBST at 4oC for short-term storage and or in PBST+azide 
for long-term storage. For photography, embryos were passed through a glycerol series 
(30% glycerol in PBS; 50% glycerol in PBS; 70% glycerol in dH2O). However embryos that 
needed to be genotyped were kept in PBST and then put straight into 70% glycerol in dH20 
after being genotyped, before counting cells and photographing.  
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Table 4. Permeabilization times used for in situ hybridization and 
immunohistochemistry experiments in this thesis. Permeabilization times at room 
temperature with proteinase K (10μg/ml) times are stated for in situ hybridization 
experiments. Permeabilization times at -20°C with acetone are stated for 
immunohistochemistry experiments. All stages are shown in hours post-fertilization 
(hpf), and all times are shown in minutes (mins).  
Stage of embryo (hpf) 
Incubation with Proteinase K  
at 10μg/ml (mins) 
less than 24hpf 10 mins 
24 hpf 24 mins 
27 hpf 27 mins 
30 hpf 30 mins 
36 hpf 36 mins 
72hpf and older 
(for preabsorption) 
60 mins 
 
Stage of embryo (hpf) Acetone permeabilization (mins) 
24 hpf 12 mins 
27 hpf 18 mins 
30 hpf 21 mins 
36 hpf 25 mins 
48 hpf 30 mins 
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2.6.2 Double fluorescent in situ hybridization 
For double fluorescent in situ hybridization, both RNA probes (one digoxigenin and 
the other fluorescein labeled) were hybridized simultaneously and the protocol was 
initially the same as for single in situ hybridization (see above). However before incubation 
with blocking solution, embryos were treated with Image-iT FX Signal Enhancer 
(Invitrogen, cat. # I36933), by removing all PBST from the embryos and adding 2 drops of 
Image-iT FX Signal Enhancer and incubating at room temperature for 30 minutes.  
The embryos were then washed with PBST twice for 5 minutes, and once for 10 minutes. 
Embryos were then incubated with goat in situ blocking solution (1x PBST + 2 mg/ml BSA + 
5% goat serum (Sigma-Aldrich, cat. # G6767) + 1% DMSO diluted in PBST) for 1 hour at 
room temperature. The embryos were then incubated with the primary antibodies Mouse 
anti-Dig (1/5000, Jackson ImmunoResearch, West Grove PA, cat. # 200-002-156) and 
Rabbit anti-Flu (1/2500, Molecular Probes, cat # A889) simultaneously for 4 hours at room 
temperature. The embryos were washed in PBST 8 x 15 minute intervals and left washing 
over night at 4°C in PBST. One of the primary antibodies was detected with Anti-Mouse-
HRP or Anti-Rabbit-HRP (both from Invitrogen TSA kit number 5 cat. # T20922 and kit 
number 12 cat. # T20915, respectively) at a concentration of 1/200 in blocking solution 
during a 5 hour incubation period at room temperature. The embryos were again washed 
in PBST 8 times for 15 minutes and left washing over night at 4°C in PBST. 
The next morning embryos were then incubated 10 minutes with amplification 
buffer (Invitrogen TSA kits mentioned before) and then incubated for 52 minutes with 
Alexa Fluor 488 (Invitrogen TSA kit number 12 cat. # T20915) or Alexa Fluor 594 
(Invitrogen TSA kit number 5 cat. # T20922) tyramide reagents at a concentration of 1/100 
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diluted in amplification buffer with 0.0015% hydrogen peroxide. The embryos were then 
washed with PBST 8 times for 15 minutes.  The HRP antibody from the first antibody 
staining was then inactivated before starting the second antibody incubation, by treating 
the embryos for 30 minutes with 3% hydrogen peroxide in PBST. After the inactivation 
step the embryos were washed with PBST 8 times for 15 minutes and left over night at 4°C 
in PBST. On the following morning the embryos were incubated with the complementary 
antibody to the previous reaction, either Anti-Mouse-HRP or Anti-Rabbit-HRP (both from 
Invitrogen TSA kit number 5 cat. # T20922 and kit number 12 cat. # T20915, respectively) 
for 2 hours at room temperature. The embryos were washed 8 times for 15 minutes and 
then left washing over night at 4°C in PBST. Finally, the next morning the staining 
procedure with the tyramide reagent was repeated as described above with the other Alexa 
reagent. The embryos were washed for 8 times for 15 minutes with PBST at room 
temperature and then all the PBST was removed and 2 drops of DABCO were added to 
protect the embryos’ fluorescence from quenching. Embryos were mounted in DABCO for 
photography and analysis on a compound microscope and/or confocal microscope. Yolks 
were always removed from embryos for further analysis and photography. 
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2.6.3 Immunohistochemistry 
Embryos stored at 4°C in PBST (or PBST + sodium azide if stored for longer than 2 
weeks) and were washed 3 times with PBST. The embryos were then incubated with 
distilled water for 5 minutes at room temperature, then incubated with acetone at -20°C for 
the time indicated in Table 4, and then incubated again with distilled water for 5 minutes at 
room temperature. The embryos were then washed in PBS for 5 minutes and treated with 
Image-iT FX Signal Enhancer (Invitrogen, I36933), by removing all PBS from the embryos 
and adding 2 drops of Image-iT FX Signal Enhancer to the embryos and incubating at room 
temperature for 30 minutes. The embryos were then washed with PBS twice for 5 minutes, 
and once for 10 minutes. The embryos were incubated with goat antibody blocking 
solution (2% goat serum, 1% BSA, 2% DMSO, 0.2% Triton-X in PBS) for 1 hour at room 
temperature. Then a primary antibody diluted in goat antibody block at the appropriate 
concentration was added to the embryos and incubated for 5 hours at room temperature. 
The embryos were then washed 8 times every 15-20 minutes with PDT (2% DMSO; 0.1% 
triton-X in PBS). The embryos were left washing over night at 4°C in PDT. The next 
morning, the secondary antibody diluted in goat antibody block at the appropriate 
concentration was added to the embryos and incubated for 5 hours at room temperature. 
The embryos were then once again washed 8 times every 20 minutes with PDT and finally 
all the PDT was removed from the embryos and they were stored in DABCO (Acros 
Organics, AC11247-1000).  
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2.6.4 Single fluorescent in situ hybridization followed by 
immunohistochemistry 
This protocol is similar to the double fluorescent in situ hybridization protocol 
described above, however, before the first antibody incubation and staining was 
inactivated with 3% hydrogen peroxide in PBST, the immunohistochemistry procedure 
was started.  A primary antibody was added to the embryos (usually chicken anti-GFP 
(Abcam, ab13970) diluted 1:1000) in goat antibody block solution (PBS + 2% DMSO + 1% 
BSA + 2% goat serum + 0.2%Triton-X (Sigma-Aldrich, cat. # X100)) and incubated for 5 
hours at room temperature. The embryos were then washed at least 8 times for 15 minutes 
each with PDT (PBS + 2% DMSO + 0.1% Triton X) over a period of two hours. The embryos 
were left washing over night at 4°C in PDT. The next morning the secondary antibody was 
added to the embryos (usually a Goat Anti-Rabbit Alexa 488 diluted 1:1000 in goat 
antibody block solution) and incubated for 5 hours at room temperature. The embryos 
were then once again washed 8 times every 15 minutes with PDT and finally all the PDT 
was removed from the embryos and they were stored in 2 drops of Vectashield Mounting 
Medium (Vector laboratories H-1000). 
2.6.5 Use of antibodies in immunohistochemistry  
GFP was detected with Rabbit Anti-GFP (Molecular Probes, A-6465), or Chicken 
anti-GFP (Abcam, ab13970). Kaede was detected with Rabbit Anti-Kaede (MBL 
International Corporation (cat. # PM012), RFP was detected with Living Colors anti-
mCherry antibody (Clontech, 632496). All of the above primary antibodies were used at a 
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(1/1000) concentration. The primary antibodies used in this work were revealed using 
complementary combinations of the following secondary antibodies:  
Alexa-Fluor Goat-Anti-Chicken 488 (1/1000) from Invitrogen Corp., (cat. # A11039); 
Alexa-Fluor Goat-Anti-Rabbit 488 (1/1000) from Molecular Probes (cat. # A11034);   
Alexa-Fluor Goat-Anti-Mouse 488 (1/1000) from Molecular Probes (cat. # A11029);  
Alexa-Fluor Goat-Anti-Rabbit 568 (1/1000) from Molecular Probes (cat. # A11036);  
Alexa-Fluor Goat-Anti-Mouse 568 (1/1000) from Molecular Probes (cat. # A11031). 
2.7 Genotyping 
For the first part of research leading to this thesis I used one DNA isolation method, 
and later I used the second method.  Both methods are described below, and I have used 
the new method since 28th November 2014. I verified that the new method worked as well 
as the older method by testing the same samples side by side but since the newer method 
was much more reproducible (PCR worked with newer method much more frequently than 
with the older one), as well as being more time-efficient, easier and requiring fewer 
reagents, I then switched to always using it.  
2.7.1 Fin-clipping adult zebrafish 
Adult fish were placed into tricaine solution and approximately one-third of the 
caudal fin was clipped off.  
Older method of DNA isolation: Fins were placed in lysis buffer (10 mM Tris-HCl, pH 
8.2, 10 mM EDTA, 200 mM NaCl, 0.5% SDS, 200 µg/ml proteinase K in dH20) + 100 µg/ml 
Proteinase K and incubated at 55ºC for 2 hours. The Proteinase K was inactivated by 
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heating to 90°C for 10 minutes. The debris was centrifuged for 10 minutes at 13500rpm, 
and the supernatant transferred to a new tube. The DNA was precipitated by adding 200μL 
isopropanol at -20°C overnight. Next day, the solution was centrifuged at 4°C for 30 
minutes. The pellet was washed with 70% ethanol and centrifuged for another 20 minutes 
at 4°C. The DNA was resuspended in 100μL dH2O and stored at -20°C. Supernatant was 
transferred to fresh tubes, and stored at 4°C (short-term) or at -20°C (long-term) and 3μL 
of this was used for a PCR reaction.  
New method of DNA isolation: Fins were placed into 100μL 50 mM sodium 
hydroxide and incubated at 90°C for 20 minutes. Tubes were cooled by placing them on ice 
for 10 minutes, followed by adding 10 μL (1/10 volume) 1M Tris-HCl, pH 7.4 to neutralize 
the sodium hydroxide and centrifuged at 13500rpm for 10 minutes at room temperature. 
Supernatant was transferred to fresh tubes, and stored at 4°C (short-term) or at -20°C 
(long-term) and 0.5-1μL of supernatant was used for a PCR reaction.  
2.7.2 Tissue extraction from individual zebrafish embryos 
Embryos were placed in 70% glycerol on a glass coverslip and part of the tissue was 
carefully removed usually from head, but sometimes from tail region. Procedure to extract 
DNA from tissue was very similar to that described above for fin-clipping, with following 
exceptions: In the newer method, 20μL of 50 mM sodium hydroxide was used for 
incubation at 90°C, and 1M Tris-HCl was reduced to 2μL. As with fin-clips, 3μL of 
supernatant extracted with older method, and 0.5-1μL of supernatant from newer method 
was used for a PCR reaction.  
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2.7.3 PCR protocols 
2.7.3.1 gata2a 
Primers used: 
Forward: 3254- gata2genoFOR:  AATTCTGCACAGAGGGGCGTGAATGTGTG (Tm = 64.2˚C)  
Reverse: 3255- gata2genoREV:  GTACAGGCCGCACGCGTTGCAGA  (Tm = 66.4˚C) 
 
PCR mix: 
10xTaq buffer  2μL 
50mM MgCl₂  1μL (old protocol) or 0.6μL (new protocol) 
10mM dNTPs  0.5μL 
10μM Fwd primer 1μL 
10μM Rev primer 1μL 
H₂0    to 20 μL 
Taq Polymerase 0.1μL 
DNA   0.5-3μL (usually 1μL with new protocol) 
   Total: 20μL 
PCR program used: 
98˚C 1 minute 
94˚C 30 seconds 
65˚C 45 seconds 
72˚C 45 seconds 
72˚C 5 minutes 
The resulting PCR product was run on a high resolution 2% SFR gel (Amresco, J234-100G) 
for at least 60 minutes at 60 mV, and the resulting bands were 108bp for wild-type, and 
98 bp for mutant (Fig. 5; as described in: Zhu et al., 2011).  
x35 
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Figure 5.  
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Figure 5. Genotyping gata2aum27, tal1t21384 and gata3sa0234 mutants. (A) gata2aum27 
mutation results in 10bp deletion, which produces a 98bp PCR band (mutant) in 
comparison to 108bp PCR band (wild-type). Bands are separated on a 2% SFR agarose gel. 
(B) tal1t21384 mutation produces a DdeI restriction site, which after PCR amplification and 
restriction enzyme digestion produces 180+20bp cut bands (mutant), in comparison to 
180bp uncut band (wild-type). The 20bp fragment is too small to see on a 2.5% agarose gel. 
(C) gata3sa0234 ‘method 1’ protocol inserts the BserI restriction enzyme site into the wild-
type sequence after a nested PCR. Digestion with BserI enzyme produces 233+300bp bands 
(wild-type), as opposed to uncut 533 band (mutant) visible on 1% agarose gel. As shown in 
figure, some bands are ambiguous and in these cases PCR products were sequenced to 
confirm the genotype. (D) gata3 ‘method 2’ protocol takes advantage of Hinf1 restriction 
enzyme site present in the wild-type, but removed after mutation (which is a deletion 
followed by an insertion). Digestion results in 159bp+81bp bands (wild-type), as opposed 
to uncut 240bp band (mutant). All PCR bands are visible on a 2% SFR agarose gel. (E) 
Example of sequencing result after using gata3sa0234 ‘method 1’ protocol. Upper panel 
shows the wild-type sequence, in which BserI restriction enzyme cutting site is introduced 
by the first primer set of the protocol. Lower panel shows the mutant sequence, in which 
the BseRI restriction site is not introduced. Second PCR in this protocol adds M13(-21) 
primer site which enables efficient sequencing. 
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2.7.3.2 tal1 
Primers used: 
Forward: tttcatgcgcatatccaaaa (Tm = 50.7˚C) 
Reverse: gaaaatccgtcgcacaactt (Tm = 53.9˚C) 
PCR mix: 
10xTaq buffer  2μL 
50mM MgCl₂  1μL 
10mM dNTPs  0.6μL 
10μM Fwd primer 1μL 
10μM Rev primer 1μL 
H₂0    to 20μL 
Taq Polymerase 0.1μL 
DNA   0.5μL-3μL (usually 1μL with new protocol) 
   Total: 20μL 
PCR program used: 
94˚C 3 minutes 
72˚C 5 minutes 
94˚C 30 seconds 
54˚C 45 seconds 
72˚C 30 seconds 
Digest: 
10xCutsmart buffer  2μL 
H₂0    13.6μL 
DdeI enzyme (10 000 U/μL) 0.3μL 
DNA(PCR product)  4μL 
    Total: 20μL 
x35 
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The resulting digested product was run on a 2.5% agarose gel for 60 minutes at 80mV, and 
the resulting bands were 180bp for wild-type, and 160bp+20bp for mutant (Fig. 5; as 
described in: Bussmann et al., 2007).  
2.7.3 gata3  
gata3 mutants were genotyped using two separate protocols. The first protocol was 
developed by Henry Putz, and involved a nested PCR that produces a final product of 
533bp, which can be cut into 2 fragments of 233bp and 300bp length (wild-type), or 
remain uncut (mutant). However, the BseRI enzyme used in this method is not always 
effective, so this method can produce ambiguous results (Fig. 5, details described above). In 
these cases, we re-confirmed the results by sequencing the PCR products. The sequencing 
method is reliable, but overall it makes the experiment time-consuming and expensive.  
To avoid this issue, Dr. Santanu Banerjee developed a method that is faster and does not 
need sequencing. The final PCR product is 240bp in length, and it will be cut with Hinf1 
enzyme into 159+81bp (wild-type), or will not be cut (mutant). After incubation for at least 
6 hours at 37°C, the digest can be easily resolved on gel 2% SFR agarose (run for 60 
minutes at 80 mV) in 0.5 x TBE (Fig. 5). 
Primers used: 
Method 1 
10030 Forward 1: tgtttagatccagcgcattg (Tm = 53.3˚C) 
10031 Reverse 1: tgtccctgatgaatggcata (Tm = 53.6˚C) 
10026 Forward 2:  tatgtaaaacgacggccagtagtgcgactcttcagcctgt  (Tm = 67.7˚C) 
10027 Reverse 2:  tacaggaaacagctatgactgacacctgcgcttggcgag  (Tm = 68.5˚C) 
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Method 2 
11341 Forward 1:   GGTTGTGTAGTTGTGCTTGC (Tm = 53.3˚C) 
11342 Reverse 1:  TTCTGTCCGTTCATCTTGTG (Tm = 52.6˚C) 
PCR Mix: 
Method 1 
PCR1:  PCR2: 
10xTaq buffer  2μL 10xTaq buffer   2μL 
50mM MgCl₂  1μL 10mM dNTPs   0.6μL 
10mM dNTPs  0.6μL 10μM Fwd primer  1μL 
10μM Fwd primer 1μL 10μM Rev primer  1μL 
10μM Rev primer 1μL H₂0     14.3μL 
H₂0    11.3μL (heads)  Taq Polymerase  0.1μL 
OR 14.3 μL (fins) DNA (1:3 diluted PCR1) 1 μL 
Taq Polymerase 0.1μL Total: 20μL 
DNA   3μL (fins) OR 1μL (heads) 
Total: 20μL 
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Method 2  
PCR: 
10xTaq buffer  2μL 
50mM MgCl₂  1μL 
10mM dNTPs  0.5μL 
10μM Fwd primer 1μL 
10μM Rev primer 1μL 
H₂0    to 20μL 
Taq Polymerase 0.1μL 
DNA   3μL (fin) OR 1 μL (heads)   
Total: 20μL 
PCR programs used: 
Method 1 
PCR1:   
94˚C 3 minutes 
94˚C 30 seconds 
52˚C 30 seconds 
72˚C 75 seconds 
72˚C 5 minutes 
 
PCR2:  
98˚C 1 minute 
94˚C 30 seconds 
58˚C 45 seconds 
72˚C 30 seconds 
72˚C 5 minutes 
 
 
x35 
x35 
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Method 2 
98˚C 1 minute 
94˚C 30 seconds 
58˚C 45 seconds 
72˚C 30 seconds 
72˚C 5 minutes 
 
Digest: 
Method 1 
For Method 1, the amount of PCR product used in the digest was varied between 
experiments to maximize the efficiency of the enzyme. Concentration of DNA was 
estimated depending on the brightness of the band in a PCR gel and usually the amount 
was chosen to be around 200ng. Ambiguous results were always confirmed with 
genotyping (M13(-21) forward primer). Original recommendations from Henry Putz were 
to use 10 l of PCR product in a 20l reaction. 
 
Method 2 
Hinf1 enzyme   0.3 l  
10xCutsmart buffer  3 l  
H₂0    21.7 l  
DNA (PCR product)  3μL  
    Total: 30μL 
x35 
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2.8 Imaging  
Photographs were taken using an Zeiss Axio Imager M1 compound microscope or a Zeiss 
LSM 710 confocal microscope and processed using Adobe Photoshop and ImageJ software. 
Most images are projections of multiple focal planes, unless otherwise stated.  
2.9 Cell counts and row numbers 
In all cases, cell counts are for both sides of a 5-somite length of spinal cord adjacent to 
somites 6-10. Cell row numbers are assigned ventral to dorsal (e.g. cells directly above the 
notochord are in row 1). Error bars show standard error of the mean (SEM). Results were 
analyzed using the students’ T test. All statistical analyses was performed using Microsoft 
Excel. When appropriate, the following symbols were used to denote significance found 
level found by the Student’s t-test (Table 5). 
Table 5. Symbols used to indicate different p-values. All p-values were obtained from 
the Student’s t-test. NS (not significant) test results are not denoted on graphs. All other 
values were represented by the stars as shown here.  
NS p ≥ 0.05 
* p < 0.05 
** p < 0.01 
*** p < 0.001 
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2.10 Nomenclature for gene, mutant and protein names 
The nomenclature for gene and protein names throughout this thesis is consistent 
with current guidelines for each organism. The basic nomenclature rules are outlined in 
Table 6. 
Table 6. Nomenclature guidelines. Summary of nomenclature guidelines for gene and 
protein names for specific organisms. Rules are illustrated for a fictional gene/protein ABC. 
Gene symbols are always italicized, while protein symbols are not italicized. Rules about 
capital letters differ between organisms. When I refer to a protein or gene in more than one 
animal, I use just one of these conventions (usually the mouse or human). Current as of 
November 2015.  
  
Organism 
Gene symbols 
(always italicized) 
Protein symbols 
(not italicized) 
Reference 
Zebrafish 
Lowercase 
(e.g. abc) 
Only first letter 
uppercase (e.g. Abc) 
zfin. org 
Frog 
Lowercase 
(e.g. abc) 
Only first letter 
uppercase (e.g. Abc) 
www.xenbase.org 
Mouse 
Only first letter 
uppercase 
(e.g. Abc) 
All letters uppercase 
(e.g. ABC) 
www.informatics.jax.org 
Rat 
Only first letter 
uppercase (e.g. Abc) 
All letters uppercase 
(e.g. ABC) 
rgd.mcw.edu 
Chicken 
All letters uppercase 
(e.g. ABC) 
All letters uppercase 
(e.g. ABC) 
birdgenenames.org 
Humans 
All letters uppercase 
(e.g. ABC) 
All letters uppercase 
(e.g. ABC) 
www.genenames.org 
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3. Results 
3.1 Identifying and characterizing the expression of genes that 
label V2 and/or KA cells in zebrafish embryos 
3.1.1 Investigating the relative numbers of KA’, KA’’ and V2b cells 
3.1.1.1 Expression of gata2a, gata3 and tal1 
As mentioned in the introduction, gata2a, gata3 and tal1 are expressed in KA and 
V2 cells in zebrafish spinal cord (Batista et al., 2008). To characterize in detail where these 
cell types are located dorso-ventrally in the spinal cord, I performed in situ hybridization 
with all three of these genes at 24hpf (Fig. 6A-C). I then counted how many cells were 
present in the region of the spinal cord adjacent to somites 6-10, on both sides of the spinal 
cord, in each dorsal-ventral row from the most ventral row just above the notochord (row 
1) until there were no more labeled cells.  As shown in Fig. 7, my cell counts show that at 
24hpf, tal1, gata2a and gata3 are primarily expressed in rows 1-5, with very occasional 
cells found in row 6. This is consistent with these markers being expressed by both of the 
KA subpopulations (KA’ and KA’’; probably all cells in rows 1 and 2 and some cells in row 3; 
Batista et al., 2008), as well as V2b cells (probably some cells in row 3 and almost all cells 
more dorsal; Batista et al., 2008). This established an expression profile that I could then 
compare to, to establish whether other genes are also expressed in V2 cells and/or KA cells.  
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Figure 6. 
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Figure 6. Genes expressed by V2b and/or KA cells in the wild-type embryos at 24hpf. 
Lateral views of zebrafish spinal cords at 24hpf. (A-C) show expression of established 
genes expressed by both V2b and KA cells, gata3, gata2a and tal1, respectively (D) tal2 is 
expressed by KA cells and only some V2b cells (E, F) sox1a and sox1b respectively are 
expressed in KA and V2b cell domains (G) gads label GABAergic cells. All panels show the 
merged view of several planes from one side of the spinal cord from the compound 
microscope. Scale bar: 50μm 
 
74 
 
 
 
 
Figure 7. Number of cells that express established V2b and KA genes in wild-type embryos at 24hpf.  Graphs shows 
average number of cells in each row labeled by in situ hybridization for different genes (represented by different colors). This 
data is a compilation of all the genotyped wild-type embryo cell counts from incrosses of heterozygous mutants (from at least 
2-3 separate experiments). Lines above the bars indicate the expected positions of KA”, KA’ and V2b cells in the zebrafish 
spinal cord based on current knowledge.  
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Table 7. Number of cells labeled by in situ hybridization experiments in wild-type embryos. Numbers represent average 
values of cells labeled by in situ hybridization experiments in genotyped wild-type embryos. This data is a compilation of all 
the genotyped wild-type embryo cell counts from incrosses of heterozygous mutants (from at least 2-3 separate experiments). 
Number of embryos counted is indicated in the last column. Numbers represent average ± SEM.
 
1 2 3 4 5 6 7 8 TOTAL 4+ 
n 
values 
gata3 20.75±0.45 8.75±0.59 15.38±0.42 11.38±0.73 6.13±0.44 1.75±0.31 0 0 64.13±0.67 19.25±0.53 n=8 
gata2a 20.4±0.43 10.7±0.56 14.1±0.69 12.7±0.56 5.5±0.37 0.8±0.25 0 0 64.2±0.88 19±0.6 n=10 
tal1 20.33±0.45 8.42±0.72 12.75±0.3 11.92±0.34 7±0.73 2.17±0.41 0.25±0.13 0 62.83±1.16 21.33±1.1 n=12 
tal2 21.07±0.46 9.33±0.42 9.87±0.6 5.73±0.45 3.8±0.37 0.67±0.25 0 0 50.53±0.89 10.2±0.82 n=15 
sox1a 20.93±0.35 8.57±0.48 12.43±0.5 10.93±0.45 8.07±0.58 3.57±0.44 0.5±0.14 0 65±1.23 23.21±0.91 n=14 
sox1b 21.17±0.63 9±0.66 12.67±0.74 9.58±0.51 6.08±0.43 2.33±0.26 0.92±0.34 0 61.75±1.19 18.92±0.89 n=12 
foxn4 0 0 3.33±0.47 10.33±0.39 1.93±0.21 0 0 0 15.6±0.25 12.27±0.44 n=15 
gads 21.3±0.56 10.75±0.51 13.67±0.61 12.58±0.71 7.25±0.43 3.83±0.8 1.33±0.48 2.5±0.48 73.42±1.48 27.5±1.11 n=12 
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My cell counts in the region of the spinal cord adjacent to somites 6-10 in wild-type 
embryos suggest that at 24hpf the largest number of cells that express all three gata3, 
gata2a and tal1 genes are located in row 1 (Fig. 7, Table 7, also see Fig 6A-C). gata3 is 
expressed by an average of 20.75 cells, gata2a by an average of 20.4 cells, and tal1 by an 
average of 20.3 cells (Fig. 7, Table 7). These results show that at 24hpf there are about 21 
KA” cells in the region of spinal cord adjacent to somites 6-10. There are fewer labeled cells 
in row 2 where KA’ cells are located, with an average of 8.75 cells expressing gata3, 10.75 
cells expressing gata2a and 8.4 cells expressing tal1(Fig. 7, Table 7). The slightly larger 
number of gata2a-expressing cells in this row compared to other markers suggests that 
gata2a might be expressed slightly earlier in KA’ cells than tal1 and gata3. Row 3 probably 
corresponds to a mixed population of V2b and KA’ cells, as KA’ cells can also be found in 
row 3, although they are still located medially and are in contact with central canal (Dr. 
Claire Wyart, personal communication; Djenoune et al., 2014; my cell counts discussed 
later and shown in sections 3.2.1.2 and 3.2.1.3). In row 3, more cells express gata3, (15.3 
cells), followed by gata2a (14.1 cells), and tal1 (12.7 cells) (Fig. 7, Table 7; also Fig. 6 A-C; 
13A-C, 15A-C; 19A-C). Expression of all of these genes is approximately equally distributed 
between medially located cells (KA’) and more laterally positioned cells (V2b), suggesting 
that KA’ and V2b cells form in similar numbers in this row (As discussed later in chapters 
3.2.1.1 and 3.2.1.3).  This suggests that the overall number of KA’ cells is slightly smaller 
than number of KA”s (approximately 18 versus 21). Alternatively, KA’ cells may be born 
later than KA” cells, in which case some KA’ cells may not yet express the investigated 
genes at 24hpf. Rows 4 and above contain no KA cells based on our current knowledge, and 
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all of the cells labeled by tal1, gata2a and gata3 in these dorsoventral rows should be V2b 
cells (Batista et al., 2008).  Similar numbers of cells express all three markers in row 4 (Fig 
7, Table 7). An average of 11.3 cells express gata3, 12.7 cells express gata2a, and 11.9 cells 
express tal1 (Fig. 7, Table 7). Row 5 contains less V2b cells, with gata3 being expressed by 
only around 6.1 cells, gata2a by 5.5 and tal1 by 7.25 cells (Fig. 7, Table 7). Only occasional 
cells are labeled by these genes in row 6, with no more than 3 cells labeled by either of the 
genes (Fig. 7, Table 7). These results provide a reference point for the approximate 
numbers of KA and V2b cells present in this region of zebrafish spinal cord at 24hpf 
throughout the rest of this thesis.  
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3.1.1.2 Expression of tal2 
As discussed in the introduction, tal2 is expressed by at least some KA cells and also 
by other cells, some of which are likely to be V2b cells, whereas others may be p3 or V3 
cells in the lateral floor plate (Pinheiro et al., 2004; Schafer et al., 2007). This data does not 
clearly establish whether this gene is expressed by all KA and V2b cells. Therefore, I 
performed tal2 in situ hybridizations and compared the number of cells that express this 
gene in each dorsal-ventral row with the number of cells labeled with known KA/V2b 
markers. My cell counts suggest that at 24hpf tal2 is expressed by a similar number of cells 
to those expressing gata3/gata2a/tal1 in row 1 (Fig. 8, Table 7). At this developmental 
stage, V3 cells have probably not yet formed (Schafer at al., 2007), which could explain why 
there are not more cells that express tal2 in this row. Similarly, in row 2 an equivalent 
number of cells express tal2 as express other KA’ markers (Fig. 8, Table 7). However, in 
rows 3 and above, tal2 is expressed by far fewer cells than those expressing gata3, gata2a 
and tal1. In row 3 around 9.8 cells express tal2, compared to 12.7-15.4 cells labeled by tal1, 
gata2a and gata3. The difference is even more prominent dorsal to row 3, with tal2 only 
being expressed by around half of the cells that are labeled by other markers (Fig. 8, Table 
7).  This leads me to conclude that even though tal2 is expressed by both KA cell 
populations and probably by all KA cells, it is only expressed by a small subset of V2b cells. 
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Figure 8. Number of cells that express tal2 in wild-type embryos at 24hpf. Graph shows average number of cells in each 
row labeled by in situ hybridization for different genes (represented by different colors).  tal2 is expressed by KA cells and 
some V2b cells (Pinheiro et al., 2004; Schafer et al., 2007).  This data is a compilation of all the genotyped wild-type embryo 
cell counts from incrosses of heterozygous mutants (from at least 2-3 separate experiments). Lines above the bars indicate the 
expected positions of KA”, KA’ and V2b cells in the zebrafish spinal cord based on current knowledge. 
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3.1.1.3 Expression of sox1a and sox1b  
As mentioned in the introduction, Sox1 is expressed in early spinal cord progenitor 
cells (Pevny et al., 1998), but also in post-mitotic spinal cells in mouse (V2c cells, Panayi et 
al., 2010). To investigate whether sox1a and sox1b, zebrafish orthologs of mouse Sox1, are 
expressed by V2 cells in zebrafish I performed in situ hybridization for each of these genes 
at 24h and compared the number and location of labeled cells to the expression patterns of 
tal1, gata2a and gata3. Interestingly, I found that sox1a and sox1b are expressed not only in 
the V2 domain but also in KA domains (Fig. 9, Table 7). The spinal cord expression patterns 
of sox1a and sox1b are very similar to each other, and to that of other KA and V2b markers 
(tal1, gata2a and gata3). In rows 1 and 2, similar numbers of cells express each of these 
sox1 genes, and similar numbers of cells are labeled by tal1, gata2a and gata3 (Fig. 9, Table 
7). In row 3, the average number of cells that express sox1a (12.4), and sox1b (12.6), is 
closest to the number of tal1-expressing cells (12.75) than to that of other V2b/KA 
established markers which are expressed in more cells (Fig. 9, Table 7). This suggests that 
both tal1 and sox1 genes may be expressed later in row 3 cells, or not in all cells. In row 4, 
sox1a and sox1b are expressed by only approximately 1-2 cells less than other V2b 
markers. Interestingly, in rows 5 and 6, similar number of cells expresses sox1b to the 
number expressing tal1, gata2a and gata3, but sox1a is expressed by approximately 1-3 
cells more (Fig. 9, Table 7). Occasional sox1a and sox1b-expressing cells can also be found 
in row 7, which is more dorsal than expression of the other markers.  
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Figure 9. Number of cells that express sox1a and sox1b in wild-type embryos at 24hpf. Graph shows average number of 
cells in each row labeled by in situ hybridization for different genes (represented by different colors). This data is a 
compilation of all the genotyped wild-type embryo cell counts from incrosses of heterozygous mutants (from at least 2-3 
separate experiments). Lines above the bars indicate the expected positions of KA”, KA’ and V2b cells in the zebrafish spinal 
cord based on current knowledge. Both sox1a and sox1b appear to be expressed by a similar number of KA and V2b cells as the 
established KA and V2b genes, and potentially be a few more V2b cells in most dorsal rows.  
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 To further confirm that sox1a and sox1b are expressed by KA and V2b cells I 
performed double labeling experiments with the Tg(gata1:GFP) line that labels V2bs and 
KAs in zebrafish spinal cord (Batista et al, 2008). Even though gata1 is not normally 
expressed in zebrafish spinal cord (Detrich et al., 1995), the Tg(gata1:GFP) line used in this 
study labels gata3-expressing KA and V2b cells (Batista et al., 2008). Most likely, 
Tg(gata1:GFP)  is missing a repressor  element that would normally prevent gata1 from 
being expressed in a similar way to other spinal cord gata genes – gata2a and gata3, or it 
could act as an enhancer trap (Batista et al., 2008). However, it seems that at 24hpf, the 
stage at which my experiments were performed, Tg(gata1:GFP) labels only a small subset 
of V2b cells. This might be due to delay in the labeling of the cells by GFP.  In the region of 
the spinal cord that I usually analyze I could only identify about 5-10 GFP-expressing V2b 
cells on the basis of their dorsoventral position and characteristic axon trajectory. 
Therefore, we cannot exclude that additional cells that do not co-localize with 
Tg(gata1:GFP)-positive cells are V2b cells not labeled at this stage by this transgenic line. 
However, the results of my in situ hybridization followed by GFP immunohistochemistry 
staining experiment still help us to understand the identity of the sox1a- and sox1b-
expressing cells. As shown in Fig. 10, both sox1a-expressing and sox1b-expressing cells co-
localize with Tg(gata1:GFP) cells. In fact, when I analyzed three representative embryos for 
each experiment and counted the number of cells that co-localize, I discovered that all of 
the GFP-positive Tg(gata1:GFP) most ventral cells (corresponding to rows 1, 2, and to a 
lesser extent row 3) also express sox1a (Fig. 7A, Table 7), and sox1b (Fig. 7B, Table 7). This 
demonstrates that all KA cells express both sox1a and sox1b at 24hpf.  
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However, the identity of the more dorsal sox1-expressing cells is less clear. All of the 
more dorsal Tg(gata1:GFP) GFP-positive cells also express sox1a (Fig. 10A), and sox1b (Fig. 
10B), showing that at least a subset of the dorsal  sox1-expressing cells are V2bs. There are, 
however, many sox1a or sox1b-positive cells at a similar dorsoventral position that do no 
co-express Tg(gata1:GFP). My analyses show that the number of non GFP-positive cells that 
express sox1a is on average 16, while on average 10 cells express sox1b but not GFP (Table 
8). The difference in these numbers probably reflects the fact that generally sox1a labels a 
few more cells than sox1b at this stage, as indicated by cell counts in single in situ 
hybridization experiments on wild-type embryos (Fig. 9; Table 7). These non-GFP cells 
could be additional V2b cells (that don’t yet express Tg(gata1:GFP), V2c cells if such cells 
exist in zebrafish spinal cord, another spinal cord cell type or a combination of these.  
Table 8. Number of co-labeled cells in Tg(gata1:GFP) with sox1a and sox1b. Number of 
cells labeled within in a 5 somite length of spinal cord adjacent to somites 6-10. Green 
indicates number of Tg(gata1:GFP) cells, and red indicates sox1a or sox1b-labeled cells at 
24hpf. Number of embryos counted is indicated at the end of each row. Numbers represent 
average ± SEM. 
 
 
GREEN GREEN ONLY RED RED ONLY n values 
sox1a 43±1.15 0 59.33±0.33 16±1.15 n=3 
sox1b 42.33±1.2 0 51.67±1.45 10±0.58 n=3 
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Figure 10.
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Figure 10. Expression of sox1a and sox1b in Tg(gata1:GFP) embryos at 24hpf. sox1a 
and sox1b label KA cells, a subset of V2b cells and potentially an additional population of 
cells. Lateral views of spinal cords of Tg(gata1:GFP) embryos after immunohistochemistry 
followed by in situ hybridization labeling sox1a (A), or sox1b (B) mRNA. Anterior left, 
dorsal up. Panels in A and B show merged view of multiple confocal planes in half of the 
spinal cord. In each case, expression of sox1a or sox1b (red) and Tg(gata1:GFP) (green) are 
followed by the merged image of both red and green channels. Panels in A’ and B’ show 
single confocal plane of the area marked with white box in panels A and B, respectively. 
Stars (*) mark cells that are double labeled by both Tg(gata1:GFP) and sox1a or sox1b 
probes. Scale bar: 50μm  
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3.1.1.4 Expression of foxn4  
As discussed in the introduction, foxn4 is expressed in the V2 domain of zebrafish spinal 
cord, possibly early in the differentiation of V2 cells. Co-expression of foxn4 and the V2a 
specific gene vsx1 was shown by Kimura et al., (2006). However, the V2b marker gata2a 
was also shown to be expressed by Tg(vsx1:GFP) cells (Kimura et al., 2006), so this 
transgenic line may label both V2a and V2b cells, making it unclear exactly which cells 
express foxn4. Whether foxn4 is co-expressed with any markers of V2b cells has not been 
investigated. To further confirm that foxn4 is expressed by V2 cells and to investigate 
whether foxn4 is expressed by V2b cells and/or KA cells, I performed in situ hybridization 
at 24hpf. My results and cell count data show that foxn4 is not expressed in rows 1 and 2 
where KA cells form, but it is expressed in a subset of cells in the usual location of V2b cells 
(Fig. 11; Table 7; also photographs in Fig. 12C and in section 3.2). However, cell counts at 
24hpf in wild-type embryos (Fig. 11; Table 7) show that foxn4 is expressed primarily in 
row 4, with only a few cells in rows 3 and 5. Only about 3 cells in row 3 express foxn4 at 
this stage, while an average of 1.7 cells in row 5 express foxn4. In row 4, where the majority 
of foxn4-expressing cells are found, the average number of cells (10.3 cells) is comparable 
with that of other V2b markers tal1, gata2a and gata3. Given that V2b cells are also found 
in other rows, and that foxn4 may also be expressed by V2a cells (Kimura et al., 2006), 
foxn4 appears to be expressed only in a small subset of V2 cells.  
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Figure 11. Number of cells that express foxn4 in wild-type embryos at 24hpf. Graph shows average number of cells in 
each row labeled by in situ hybridization for different genes (represented by different colors). This data is a compilation of all 
the genotyped wild-type embryo cell counts from incrosses of heterozygous mutants (from at least 2-3 separate experiments). 
Lines above the bars indicate the expected positions of KA”, KA’ and V2b cells in the zebrafish spinal cord based on current 
knowledge. Only a subset of cells in V2b domain express foxn4. Note that this panel may be compared to the cell counts in Fig. 
12 (Expression of foxn4 in zebrafish wild-type embryos at different stages), but the numbers in this figure and in Fig. 12 come 
from separate experiments. 
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Figure 12.   
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Figure 12. Expression of foxn4 in zebrafish wild-type embryos at different stages. (A-
E) show lateral views of spinal cords expressing foxn4 at 20hpf (A), 22hpf (B), 24hpf (C), 
27hpf (D) and 30hpf (E). Anterior left, dorsal up. (F-H) show examples of cells labeled with 
foxn4 that appear to be in the process of division at 24hpf. (I) shows number of cells 
labeled with foxn4 in situ hybridization in wild-type embryos at indicated stages. Cell 
counts are an average of 4 embryos for each stage. (J) shows the total number of cells that 
express foxn4 at any given stage. The only statistically significant difference found by 
Student’s t-test is indicated by a bracket and star. Values in (I) and (J) come from the same 
cell count data. In both cases, error bars represent SEM. Scale bar: 50μm
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To test whether foxn4 is expressed by V2b cells I performed double labels with 
Tg(gata1:GFP). To my surprise, Tg(gata1:GFP) and foxn4-expression did not overlap at 24h 
(Fig. 13). In addition, foxn4 was expressed more dorsally than Tg(gata1:GFP) cells, 
suggesting that either foxn4-expressing cells are more dorsal than V2b cells, or that the 
Tg(gata1:GFP) line labeled only KA cells and a small ventral subset of V2b cells in this 
experiment (which is possible – see also earlier discussion in 3.1.1.3 section describing 
sox1a and sox1b expression in this transgenic line). To further test whether foxn4 might be 
expressed by V2b cells I also performed double labels with slc32a1, which labels all 
inhibitory post-mitotic cells (as V2b cells are GABAergic).  As shown in Fig. 14F, foxn4 is not 
co-expressed with slc32a1. Even though the cells that express slc32a1 are in the same 
dorsoventral position as the cells that express foxn4, none of the inhibitory cells co-express 
foxn4. Given the results of Kimura at al., 2006 that suggest that foxn4 is expressed by early 
forming V2 cells one possible explanation of my results would be that foxn4 is 
downregulated in older V2b cells. If this is the case, then zebrafish V2b cells appear be 
specified primarily in row 4 at 24hpf.   
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Figure 13. Expression of foxn4 in Tg(gata1:GFP) at 24hpf. Lateral view of 
Tg(gata1:GFP) embryo after GFP immunohistochemistry and in situ hybridization for foxn4 
mRNA. Panels show a projection of multiple planes taken from half of the spinal cord. 
Anterior left, dorsal up. Expression of foxn4 (red) and cells labeled by Tg(gata1:GFP) 
(green) are followed by a merged image of both channels. No cells were found to co-
express Tg(gata1:GFP) and foxn4. Scale bar: 50μm 
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Figure 14. Expression of foxn4 and other markers of the cell populations in the 
zebrafish spinal cord at 24hpf. Lateral views of spinal cords expressing foxn4 in green 
and dbx1b (A), dbx2 (B), nkx6.1 (C), nkx6.2 (D), gata2 (E), and slc32a1 (F) in red at 24hpf. 
Anterior left, dorsal up. (A-F) show a merge of multiple projections from one side of the 
spinal cord followed by a merged image of both green and red channels. White stars 
indicate cells that are double-labeled. (C’-E’) show close-up single confocal planes of the 
area marked by the white dashed box in (C-E) respectively. Close-ups are shown only in 
cases where co-labeled cells were identified in single confocal planes. Scale bar: 50μm  
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Since foxn4 is expressed more dorsally than Tg(gata1:GFP) cells, it is also possible 
that the V2b cells form more dorsally over time or migrate ventrally once they have 
formed. To try and investigate this I examined foxn4 expression and counted the number of 
cells at 20hpf, 22hpf, 24hpf, 27hpf and 30hpf (Fig. 12). I predicted that if foxn4 is expressed 
only transiently by V2b cells, the total number of foxn4-expressing cells might not change 
much over time as “older” cells would be turning it off as “younger” cells are turning it on. 
This would be in contrast to other genes that are expressed for longer in these cells, where 
the number of cells expressing the gene increases over time (Batista et al., 2008). In 
addition, if the dorsal-ventral position at which V2b cells form changes over time, the 
location of foxn4-expressing cells should also change. In contrast, if “older” V2b cells 
migrate ventrally, the location of foxn4-expressing cells should remain the same at different 
stages.  
As shown in Fig. 12A, foxn4 is expressed already at 20hpf in cells located mainly in 
row 3, with several cells expressed in row 4 (Fig. 12I). A similar pattern of expression is 
observed at 22hpf (Fig. 12B), however, more cells are labeled in row 4 at this stage 
(Fig. 12I). By 24hpf, foxn4 is expressed mainly in row 4, with some cells still in row 3, and 
some cells in row 5 starting to express foxn4 (Fig. 12C, I). Since both post-mitotic V2 cells 
and p2 progenitor domain cells are found in row 4 at 24 hpf (Batista et al., 20008; England 
et al., 2011), this would be consistent with foxn4 being expressed mainly by early V2 cells, 
or late p2 progenitor cells. Interestingly, by 27hpf similar numbers of cells in rows 4 and 5 
express foxn4, with an occasional cell in row 6 expressing this marker (Fig. 12D, I). By 
30hpf expression of foxn4 persists mainly in row 5, but there are also similar number of 
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cells labeled by foxn4 in rows 4 and row 6 (Fig. 12E, I). This shows that the dorsoventral 
position at which foxn4 is expressed does indeed move dorsal over time. 
I also compared the total number of foxn4-expressing cells at different stages (Fig. 
12J). Although there is a slight trend towards an increase in the total number of cells, the 
only statistically significant difference was between 22hpf and 30hpf (Appendix Table 2, 
bolded value). However, the differences between 20hpf and 30hpf, and between 22hpf and 
27hpf are approaching the significance threshold of p=0.05 (p=0.069 for 20hpf vs 30hpf, 
and p=0.063 for 22hpf vs 27hpf, see Appendix Table 1). This suggests that the number of 
foxn4-expressing cells may increase slightly in zebrafish spinal cord over these time points, 
but it is a very subtle trend. Since the difference is so subtle and I only counted cells in 4 
embryos at each stage, it is possible that examining a larger number of embryos would 
result in more of these differences becoming statistically significant.  
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Also, I observed that foxn4 is often present in cells that are either very large, 
compared to their neighboring cells, or by pairs of neighboring cells, as shown in (Fig. 12F-
H). This suggests that foxn4 is expressed by cells that are undergoing division, or have just 
divided and both sister cells are still expressing foxn4. This is consistent with data from the 
previous zebrafish study (Kimura et al., 2008 supplementary material), which observed 
foxn4 in Tg(vsx1:GFP)-expressing cells, often in pairs of neighboring cells that both 
expressed vsx1 at 18hpf.  
 Since foxn4 is expressed soon after cell division, it is possible that it is already 
expressed by late stage progenitor cells. In order to investigate whether foxn4 is expressed 
in the p2/V2 region, and also to determine whether it is expressed in progenitor cells, in 
post-mitotic cells, or in both populations, I performed double in situ hybridizations with 
molecular markers that mark different dorsal-ventral progenitor domains. First, I tested 
whether the dorso-ventral position of foxn4 coincides with V0 progenitor markers, dbx1b 
and dbx2. While dbx1a is expressed solely by V0 progenitor cells, dbx2 has a wider 
expression domain, which includes the p0 and p1 and part of the dp6 progenitor domains 
(see England et al., 2011). As shown in Figs 14A and 14B, foxn4 is expressed more ventrally 
than these markers.  
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Therefore, I used markers of p2 progenitor cells nkx6.1, and nkx6.2 to test whether 
foxn4 is expressed by V2 cells. nkx6.1 is expressed by p2 cells and also by more ventrally 
located pMN cells and p3 cells, while nkx6.2 is expressed by all those cells but also more 
dorsally located p1 cells (see England et al., 2011). In addition to being expressed in 
progenitor cells, at least nkx6.1 is also thought to persist in a subset of very early V2 
interneurons (Cheesman et al., 2004; Kimura et al., 2006). As shown in Fig. 14C, many 
nkx6.1-expressing cells do not express foxn4. However, there is a slight overlap between 
the dorso-ventral position of nkx6.1 and foxn4. This prompted me to examine single 
confocal microscope focal planes and investigate whether any of the foxn4-expressing cells 
also express nkx6.1. I found that several cells co-expressed both markers, an example of 
which is shown in panel 10C’. Similarly, foxn4-expressing cells overlap with the dorso-
ventral position of nkx6.2, as shown in panel 10D. Even though many progenitor nkx6.2-
expressing cells do not express foxn4, some foxn4-cells  express nkx6.2, as shown in single 
confocal section panel 10D’. This suggests that foxn4 is expressed by very late p2 
progenitor cells, and/or by very early post-mitotic V2 cells. 
To further test whether foxn4 is expressed by early V2 cells, particularly early V2b 
cells I performed double in situ hybridization experiments with gata2a. gata2a is expressed 
before gata3 in V2b cells in zebrafish (Batista et al., 2008), and it is also expressed early on 
by Tg(vsx1:GFP) cells (Kimura et al., 2008), suggesting that it might be expressed initially 
by all early V2 cells, as it is in amniotes (Peng et al., 2007) before it resolves into just being 
expressed by V2b cells. I found that all of the foxn4-expressing cells co-express gata2a, 
although there are many more gata2a-positive cells that do not express foxn4 (Fig. 14E). 
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This is consistent with foxn4 being expressed only in more recently-born V2b cells and 
gata2a single-expressing cells down-regulating foxn4.  
To summarize, my results show that foxn4 is expressed in very early V2 cells that 
express gata2a, nk6.1 and nkx6.2. It also can not be ruled out that foxn4 may also be 
expressed by very late p2 cells, since nkx6.1 and nkx6.2 are expressed by p2 progenitor 
cells. However, foxn4 is not expressed by post-mitotic, gata3-expressing inhibitory V2b 
cells, or any other inhibitory cells in zebrafish spinal cord at 24hpf. Expression of foxn4 is 
located more dorsally over time, suggesting that position at which V2 cells form changes 
over time. However, the gene appears to be expressed only transiently by maturing V2 
cells.  
3.1.1.5 GABAergic cells 
 Since V2b and KA cells are GABAergic, as discussed in the introduction, I decided to 
also use expression of gad genes (which are expressed by GABAergic cells; Higashijima et 
al., 2004) as a method of examining both of these cell populations. However, there are also 
other GABAergic cells in zebrafish spinal cord, including V1 cells that are generally found 
slightly dorsal to V2 cells, but that probably also partly overlap with the V2 domain (Batista 
and Lewis, 2008; England et al., 2011). According to my cell count data, at 24hpf gads are 
expressed by numbers of cells that are very comparable to the number of cells that express 
gata2a/gata3/tal1 in rows 1-5, with the differences between the average number of 
labeled cells never being larger than 2 cells in each of those rows (Fig. 15; Table 7). Even in 
row 6, the number of GABAergic cells seems to be larger than that of V2b markers, but only 
slightly. As expected, there are additional sporadic GABAergic cells present in rows 7 and 8, 
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where V2b cells are not found. However, these are only few (average of 1.5 cells in row 7, 
and 3.5 cells in row 8), and likely reflect more dorsally located cells that are beginning to 
acquire a GABAergic phenotype (many of the dorsal inhibitory cells in zebrafish spinal cord 
are glycinergic (Higashijima et al., 2004a). Overall, I conclude that gads are a good marker 
for estimating the number of V2b and KA cells at 24hpf, and that V2b and KA cells can be 
easily distinguished at this stage from other GABAergic cell populations based on the 
dorsoventral location of the cells. More importantly though, use of this marker in 
experiments on mutant embryos discussed later will also help me to assess whether KA 
and V2b cells have lost their GABAergic phenotype, which is a key functional aspect of both 
of these cell types.  
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Figure 15. Number of GABAergic cells in wild-type embryos at 24hpf. Graph shows average number of cells in each row 
labeled by in situ hybridization for different genes, as indicated by colors. GABAergic cells are labeled by mixture of gads 
probes, and the numbers are shown in comparison to most established KA and V2b markers (gata3, gata2a, tal1). Only very 
few additional GABAergic cells are present at 24hpf in the zebrafish spinal cord. This data is a compilation of all the genotyped 
wild-type embryo cell counts from incrosses of heterozygous mutants (from at least 2-3 separate experiments). Lines above 
the bars indicate the expected positions of KA”, KA’ and V2b cells in the zebrafish spinal cord based on current knowledge.  
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3.1.2 Transgenic lines that could potentially label V2a cells. 
V2b cells are formed by a division of one p2 cell into a V2a cell and a V2b cell 
(Batista et al., 2008; Kimura et al., 2008). Some genes are expressed by both V2 cell types 
early in differentiation (e.g. lhx3, vsx1; gata2a; Batista et al., 2008; Kimura et al., 2008). I 
was, therefore, interested in whether the new markers of V2b cells that I had identified 
(sox1a, sox1b, foxn4) are also expressed by V2a cells. I hoped to perform double labeling 
experiments with a transgenic line that labels V2a cells, Tg(vsx1:GFP) (Kimura et al., 2006) 
to test this. In addition, since V2a/V2b cells form from a single division, I was hoping to 
establish whether mutations in genes expressed in V2b cells (analyses discussed later in 
thesis) might result in V2a cells forming at the expense of V2b cells.  For these purposes, I 
was hoping to use the Tg(vsx1:GFP) line (Kimura et al., 2008). To my surprise, my first 
experiments at 24hpf (when many V2a cells are already mature) did not reveal many cells 
labeled in the spinal cord by this transgenic line. To test whether this was the result of a 
delay in GFP expression I examined this line at 27hpf, 30hpf, 36hpf and 48hpf.  
As shown in Fig. 16A, at 27hpf I could see only a background-like haze and only 1-2 
cells in the anterior of the embryo on the compound microscope. At 30hpf I could see many 
more cells (see also Kimura et al., 2006). However, the background haziness did not allow 
me to clearly see cells and their axons on the compound microscope (Fig. 16B), and a 
similar effect was observed at 36hpf on the compound microscope (Fig. 16C). The 
experiment on embryos at 48hpf did not work, most likely because it is harder to 
permeabilize the embryos at this stage, and I was not able to see the GFP in the spinal cord 
(Fig. 16D). Therefore, I examined the embryos where the results appeared most promising 
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(30hpf and 36hpf) on the confocal microscope to see whether I could see cells with better 
resolution. As shown in Fig. 16E, at 30hpf even the confocal microscope did not let me see 
cell axons very clearly (likely due to the surrounding haze), but I was able to better see cell 
somas. At 36hpf the cell soma was completely visible (Fig. 16F), and the largely reduced 
haze at that stage enabled me to examine the axons of Tg(vsx2:GFP) cells. However, the 
number of cells that are labeled at that stage made it very difficult to distinguish between 
individual cells and/or follow individual axons. These limitations would make it very 
difficult to perform double labels, count cells or examine axon phenotypes in mutant 
embryos. 
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Figure 16. Assessment of Tg(vsx2:GFP) zebrafish line. Lateral views of spinal cord of 
transgenic Tg(vsx2:GFP) embryos following GFP immunohistochemistry at 27hpf (A), 
30hpf (B, E), 36hpf (C, F) and 48hpf (D). Anterior left, dorsal up. (A-D) were taken using a 
compound microscope. (E and F) show pictures of embryos from the same experiment 
taken using a confocal microscope. Scale bar: 50μm 
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Other alternatives for labeling V2a cells are two other transgenic lines, 
Tg(vsx2:RFP), and Tg(vsx2:Kaede) (Kimura et al., 2006). These lines were made in a similar 
way to Tg(vsx2:GFP), but as they are the result of separate BAC insertions, they might have 
slightly different expression patterns. I was hoping that at the earlier stages (27hpf, 30hpf, 
36hpf), the haziness seen in Tg(vsx2:GFP) would be reduced and I would be able to see cells 
more clearly, in numbers that would allow for easier counts and/or analyzing axons. 
Unfortunately, this is not the case (Fig. 17), although these embryos were analyzed only on 
the compound microscope. At 27hpf Tg(vsx2:Kaede)-labeled cells are slightly more visible 
(Fig. 17A, compare to Fig. 16A)  but they still have a ‘halo’ around their cell bodies, and the 
cell axons are not clearly visible. Tg(vsx2:RFP) cells look similar but are even dimmer at 
27hpf, as shown in Fig. 17D. The haze is still present at 30hpf in Tg(vsx2:Kaede). Even 
though more cells seem to be labeled at this stage (Fig. 17B), I still could not see cell axons 
in those embryos. In Tg(vsx2:RFP) at 30hpf, the cells begin to be brighter and more cells are 
labeled, but the haze makes it possible to see only a few clear cell body shapes and none of 
the axons (Fig. 17E). At 36hpf the Tg(vsx2:Kaede)-labeled cells have largely reduced 
background (Fig. 17C), and many more cells are visible. This looks more suitable for 
experiments, as compared to Tg(vsx2:GFP) pictures from the compound microscope 
(Fig. 16C). The Tg(vsx2:RFP) line shows many cells at 36hpf (Fig. 17F), but since the cells 
are much dimmer and more difficult to see, even at this stage this line seems the least 
suitable for experiments.  
  
104 
 
  
 
Figure 17. Assessment of Tg(vsx2:Kaede) and Tg(vsx2:RFP) zebrafish lines. Lateral views of spinal cords of 
transgenic Tg(vsx2:Kaede) and Tg(vsx2:RFP) embryos following RFP or Kaede immunohistochemistry. Anterior left, 
dorsal up. (A-C) show Tg(vsx2:Kaede) embryos at 27hpf (A),  30hpf (B),  36hpf (C). (D-F) show Tg(vsx2:RFP) embryos at 
27hpf (D), 30hpf (E) and 36hpf (F). All photographs were taken using a compound microscope. Scale bar: 50μm
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Overall, I conclude that the Tg(vsx2:Kaede) line might be the best out of the three 
lines for examining V2a cells, and the likely best stages to investigate would be between 
30hpf and 36hpf. However, at those stages cells might be difficult to count, and it is still not 
clear whether all of the V2a cells are labeled. The Tg(vsx2:GFP) line could potentially be 
used between 30hpf and 36hpf depending on nature of experiments, but it is probably less 
clear than the Tg(vsx2:Kaede) line. The Tg(vsx2:RFP) line seems least likely to clearly show 
V2a cells due to both the background and how dim the cells are, making it even more 
difficult to distinguish cells from the surrounding background. However, at 24hpf those 
lines do not label sufficient number of V2a cells to perform double-staining, or to assess the 
phenotype caused by the mutation in the gene. None of the lines seemed sufficiently 
suitable for my experiments and I did not pursue using these lines any further.  
3.2 Roles of gata2a, tal1 and gata3 transcription factor genes in 
development of zebrafish spinal cord 
3.2.1 Roles of gata2a, tal1 and gata3 in V2b and KA cell specification 
As mentioned several times previously, gata2, tal1 and gata3 are all expressed in 
post-mitotic V2b and KA cells in zebrafish spinal cord at 24hpf (Batista et al., 2008; this 
thesis). To test whether any of these transcription factor genes are required for correct 
specification of these cells, I examined the expression of different V2b and/or KA marker 
genes in mutants for each of these genes. In each case, I performed in situ hybridization in 
embryos from an incross of two heterozygous parents and then determined the number 
and location of labeled cells in the region of the spinal cord adjacent to somites 6-10.  
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3.2.1.1 gata2a 
As discussed in the introduction, the gata2a mutant used in this study should result 
in a truncated protein that lacks both of the functional zinc finger domains (Fig. 4A; Zhu et 
al., 2011). Therefore, it is highly likely that gata2um27  is a null mutant allele. Based on 
results from a previous study in zebrafish using morpholinos designed to knock down 
gata2a (Yang et al., 2010), we would expect KA” cells not to form in gata2a mutants, and 
KA’ cells to form normally. The effects of loss of Gata2a function on zebrafish V2b cells, 
however, were unknown before my study.  
In gata2a mutants, the number of cells expressing gata3, tal1, sox1a, and gads seems 
to be severely reduced in the row directly above the notochord where KA” cells are located 
(Figs 18 and 19) but there is no statistically significant change in the number of cells 
expressing most of these markers in more dorsal rows. More specifically, gata3 and tal1 
expression is only altered in row 1, where on average only about 1 cell remains in the 
mutants (Figs 18A, 18I, 18C, 18K, 19A, and 19E). In addition, sox1a and gad expressions are 
lost in row 1 (about 1 sox1a-expressing cell remains and about 3 gad-expressing cells), and 
also significantly decreased in row 2 (Figs 18D, 18L, 18G, 18O, 19C and 19D). These results 
are consistent with the prediction that gata2a is required for KA” cells to form properly 
and they also suggest that gata2a may be required for the correct expression of some genes 
in KA’ cells.  
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Figure 18.  
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Figure 18. Expression of V2b and/or KA markers in gata2aum27 mutant and sibling 
embryos at 24hpf. Lateral views of zebrafish spinal cords at 24hpf. (A-H) show expression 
of indicated genes in wild-type sibling embryos, and (I-P) show expression in mutant 
embryos. In most cases (tal1, sox1a, sox1b, tal2, gads, foxn4) embryos shown here were 
genotyped as wild-type or mutant. Occasional photographs (gata3, gata2a) are of embryos 
that were not genotyped. In these cases, pictures are representative of the phenotype that 
was observed in genotyped wild-type and mutant embryos and these phenotypes were 
observed in appropriate Mendelian ratios in the photographed experiment. Embryos were 
always genotyped if there was no obvious phenotype. All panels show the merged view of 
several planes from one side of the spinal cord from the compound microscope. Scale bar: 
50μm. 
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Figure 19. 
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Figure 19.Number of cells labeled in the gata2aum27 mutant and sibling embryos at 
24hpf. Graphs show average number of cells expressing indicated gene in the spinal cord 
region adjacent to somites 6-10. Cell counts were performed on genotyped mutant and 
wild-type embryos, apart from one case (gata2a) where the cell count of mutant embryos 
is compared to a mixture of heterozygous mutant and wild-type embryos at 24hpf. At least 
four embryos were counted in each case. Cell counts from rows 4and above are shown as 
‘4+’. Statistically significant (p<0.05) differences as assessed by Student’s t-test are 
indicated by brackets and stars (* p<0.05, **p<0.01, ***p<0.001). Error bars indicate SEM.  
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To my surprise however, tal2 expression in the KA” domain is unchanged in mutant 
embryos (Figs 18F, 18N and 19F). My cell counts show that there is only a small, not 
statistically significant decrease in the number of tal2-expressing cells in row 1 where KA” 
cells are found (Fig. 19F). This very small difference is in sharp contrast to the loss of other 
markers discussed above. These results also contrast with findings from gata2a 
morpholino knockdown studies that showed loss of tal2 expression in row 1 (Yang et al., 
2010).  
Similarly, the number of cells expressing sox1b in this domain remains unchanged 
(Figs 18E, 18M and 19G) and, there is no obvious sox1b expression phenotype in gata2a 
mutant embryos (Fig. 19G). My cell counts show that the numbers of cells labeled with 
sox1b do not differ significantly in any row. Given that sox1b is expressed by KA” cells, as I 
previously demonstrated with the Tg(gata1:GFP) co-expression experiments in Fig. 10B, 
this result is also surprising. It shows that Gata2a function is dispensable for expression of 
sox1b in either KA or V2b cells. It also suggests that sox1a and sox1b are regulated 
differently in KA” cells.  
In addition, I found no change in the number of foxn4-expressing cells in mutant and 
wild-type embryos (Figs 18H, P and 19H), despite the fact that gata2a and foxn4 are co-
expressed in the spinal cord (Fig. 14). This suggests that Foxn4 might be upstream of 
Gata2a in those cells – or that these two transcription factors act independently of each 
other. 
Taken together, my data suggest that either KA” cells still form in the absence of 
gata2a, but the cells lose expression of some of the markers normally expressed by those 
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cells (i.e. gata3, tal1 and sox1a), as well as their GABAergic phenotype, or that KA” cells 
become a different type of cell that does not express gata3, tal1 or sox1a but still expresses 
tal2 and sox1b.  
I also examined at the expression of gata2a in gata2a mutants (Figs 18B, 18J and 
19B). Because of time constraints, in this experiment I did not genotype sibling embryos 
but just identified them by their phenotype (this is the only marker that I did this for with 
this mutant). Therefore, while the mutant cell counts from this experiment are genotyped 
mutant embryos, the ‘sibling’ cell counts are a mixture of wild-type and heterozygous 
mutant embryos. As shown in Fig. 19B, I saw a decrease in number of gata2a-expressing 
cells in all rows, compared with sibling embryos. Also, the expression is much weaker in all 
remaining cells (Figs 18B and 18J). This could be due to nonsense-mediated decay of the 
RNA, where the RNA molecule within the cell is detected as erroneous and targeted for 
degradation. However, if this is the case, it is surprising that while expression of gata2a is 
almost completely lost in KA” and KA’ cells, expression in V2b cells is diminished but 
persists in many cells. All of the above cell counts in gata2a wild-type and mutant embryos 
are summarized in Table 9. 
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Table 9. Summary of the phenotype observed in gata2aum27 mutant embryos and 
their siblings. Values represent average numbers of cells expressed in each row of the 
spinal cord for any given marker. First value corresponds to genotyped mutant embryos, 
and second value represents number of cells in genotyped wild-type embryos, apart from 
gata2 expressing cells, where values are an average from heterozygote and wild-type 
embryos. Values of rows 1-8 show cell numbers in individual spinal cord rows. Row ‘4+’ 
represents values from rows 4-8 grouped together, and ‘2+’ represents values from rows 2-
8 grouped together. Total number of cells from rows 1-8 is shown in the last row, but no 
colors were used in this case. In other cases, colors indicate whether the differences are 
statistically significant. Red and grey colors show no statistically significant difference 
between wild-type and mutant cell counts using Student’s t-test. Also, grey color indicates 
values where very few cells were present in either wild-type or mutant embryos (less than 
2 cells). Other colors denote a statistically significant difference (p ≤0.05) between the 
numbers of cells in wild-type and mutant embryos. Dark green = cells almost completely 
lost in mutants (less than 15% cells left in mutants), light green = cells significantly reduced 
(less than 33% cells left in mutants), blue = cells reduced (more than 33% cells left but 
statistically significant difference between mutant and wild-type). p-values that approach 
0.05 significance cut-off are indicated in brackets. 
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Table 9. 
Row/Marker gata3 gata2a tal1 sox1a sox1b tal2 gads
✗ SR ✗ ✗ ✔ ✔ (NS, p =0.06) SR
1.2/20.75 4.75/20 0.5/21.25 1.2/21.8 21/22.5 19/21.6 3.25/21.25
✔ ✗ ✔ SR ✔ ✔ R
8.4/9.75 0.5/6 4/6.25 2.6/9.8 11.25/10.75 7.4/8.8 5.25/11
✔ R ✔ ✔ ✔ ✔ ✔
14.8/15 3.25/12 10.25/12.75 15.6/13.8 13.25/10.5 11.2/9.6 15/13.75
R ✔ ✔ (NS,p =0.054) ✔ ✔ ✔ ✔
9.8/12.75 12.25/14.6 14.0/11.75 12.4/10.4 10.25/10.25 5.8/4.4 9/11.75
✔ R ✔ ✔ (NS, p =0.08) ✔ ✔ ✔
5/5.5 3.25/7.6 9.0/9.5 11.0/9.0 6.25/7.5 2.8/3.4 4.5/6.75
− − R ✔ ✔ − ✔
0.8/1.25 0.25/1.6 1/3.5 4.0/3.6 1.75/2.5 0.6/0.4 2.5/1.75
− ✔ − (NS, p =0.06)
0 0 1.0/0.8 2/0.75 0 0/2
SR
0 0 0 0 0 0 1.75/3
4+ R R ✔ ✔ (NS,p =0.055) ✔ ✔ ✔
TOGETHER 15.6/19.5 15.75/23.8 24/24.75 28.4/23.8 20.25/21 9.2/8.2 17.75/25.25
2+ R R ✔ (NS, p =0.01) ✔ ✔ ✔ ✔
TOGETHER 38.8/44.25 19.5/41.8 38.25/43.75 46.6/47.4 44.75/42.25 27.8/26.6 38/50
40/65 24.25/61.8 38.75/65 47.8/69.2 65.75/64.75 46.8/48.2 41.25/71.75
R R R R ✔ ✔ R
TOTAL
8
6
7
2
3
4
5
gata2a mutant
1
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In addition, I examined whether the gata2a mutation causes a phenotype in heterozygous 
embryos. In order to test this, I examined expression of gads in genotyped heterozygous 
embryos and compared them to genotyped wild-types. I chose to examine expression of 
gads because they label the largest number of cells, including all KA and V2b cells, and 
these genes have a pronounced and obvious expression phenotype in homozygous 
mutants. No statistically significant difference was found between heterozygous gata2um27 
carriers and wild-type embryos (Fig. 20D), suggesting that there is no heterozygous 
phenotype caused by this mutation in spinal cord.  
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Figure 20. Heterozygous mutants have no phenotype. No heterozygous mutant 
phenotype was found in tal1t21384, gata2aum27 or gata3sa0234 mutants. Graphs show number 
of cells that express the gene indicated, as assessed by in situ hybridization. Embryos were 
identified as heterozygous carriers of mutations in tal1t21384 (A-C), gata2aum27 (D), or 
gata3sa0234 (E) and compared with genotyped wild-type siblings. Values show average of 
cell counts from at least 4 embryos in each case. Error bars represent SEM. No significant 
differences were found with Student’s t-test (p>0.05 in all cases). 
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3.2.1.2 tal1 
As described in the introduction, the tal1 mutant used in this study results in a 
protein truncation, which removes the entire helix-loop-helix DNA binding domain (Fig. 
4B; Busssman et al 2007). Homozygous mutants also lack blood circulation, and have heart 
edema at 48hpf (Bussmann et al., 2007). Given the loss of functional domains and the 
severe phenotype in homozygous mutant embryos, it is likely that the tal1 mutant used in 
this study is a null mutant. I used the blood phenotype to identify mutant embryos in in situ 
hybridizations with genes expressed in blood where the blood phenotype is obvious (tal1), 
but also genotyped those embryos afterwards for cell counting. The heart edema 
phenotype was visible too late for my analysis, so I genotyped embryos expressing genes 
not expressed in blood, to identify mutants. Before this work, the role of tal1 in zebrafish 
spinal cord development had not been investigated, even though we know from previously 
published studies that tal1 is expressed in V2b and KA cells at 24hpf in zebrafish (Batista et 
al., 2008).  
My studies show that expression of gata3, gata2a, sox1a, sox1b, tal2 and gads  in tal1 
mutants is unchanged in row 1 where KA” cells are located, but is severely reduced in rows 
2 and 3, where KA’ cells are found (Figs 21A-B, 21D-I, 21K-O and 22A-D, 22F, 22G). 
However, the degree to which expression in those rows is reduced varies between different 
markers. To resolve whether remaining cells are medial and belong to the KA’ population, 
or lateral and are more likely to be V2b cells, I recounted a subset of genotyped embryos 
looking at the medial/lateral position of cells. The cells that remain in rows 2 and 3 in 
mutant embryos are located laterally, suggesting that they belong to V2b population, and 
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are not KA’ cells (Fig. 23, Table 10). Therefore, expression of all of these genes is lost in KA’ 
cells in tal1 mutants. This data is also summarized in Table 11, in which a lack of medially 
located cells in mutant embryos is indicated by ‘(0m)’. In rows 4 and above, no significant 
difference was found in the number of cells expressing gata3 or gata2a (Fig. 22A and 22B, 
respectively). In contrast, expression of sox1a was slightly reduced, and the number of 
GABAergic cells was reduced to an even larger extent (Fig. 22C and 22D, respectively). 
Interestingly, expression of sox1b and tal2 was almost completely abolished in rows 4 and 
above in tal1 mutants (Fig. 22F and 22G, respectively).  
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Figure 21. 
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Figure 21. Expression of V2b and/or KA markers in the tal1t21384 mutant and sibling 
embryos at 24hpf. Lateral views of zebrafish spinal cords at 24hpf. (A-H) show expression 
of indicated genes in wild-type sibling embryos, and (I-P) show expression in mutant 
embryos. In some cases (gata2a, tal1, foxn4) embryos shown here were genotyped as wild-
type or mutant. Other photographs (gata3, sox1a, sox1b, tal2, gads) are of embryos that 
were not genotyped. In these cases, pictures are representative of the phenotype that was 
observed in genotyped wild-type and mutant embryos and these phenotypes were 
observed in appropriate Mendelian ratios in the photographed experiment. Embryos were 
always genotyped if there was no obvious phenotype. All panels show the merged view of 
several planes from one side of the spinal cord from the compound microscope. Scale bar: 
50μm 
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Figure 22.  
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Figure 22. Number of cells labeled in the tal1t21384 mutant and sibling embryos at 
24hpf. Graphs show average number of cells expressing indicated gene in the spinal cord 
region adjacent to somites 6-10. Cell counts were performed on genotyped mutant and 
wild-type embryos at 24hpf, and at least four embryos were counted in each case. Cell 
counts from rows 4 are shown as ‘4+’. Statistically significant (p<0.05) differences as 
assessed by Student’s t-test are indicated by brackets and stars (* p<0.05, **p<0.01, 
***p<0.001). Error bars indicate SEM. 
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Figure 23. 
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Figure 23. Number of cells labeled in the tal1t21384 mutant and sibling embryos at 
24hpf with distinction between lateral and medial position of the cells. Graphs show 
the average number of cells expressing indicated genes in the spinal cord region adjacent to 
somites 6-10. Cell counts were performed noting the medial/lateral position of labeled 
cells. These counts are independent of the previous cell counts that did not address 
medial/lateral position of the cells. Whenever possible, embryos from the previous cell 
count were included. If this was not possible, additional embryos were genotyped. For scl 
expression, only sibling (mixture of genotyped heterozygous mutant and wild-type) 
embryos were available for cell counts, as indicated in the graph. Cell counts from rows 4 
and above were gathered together and are shown as ‘4+’. At least four embryos were 
counted in each case.  
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Table 10. Lateral/medial cells counts in tal1t21384 mutant embryos and their siblings. 
Values represent average numbers of cells expressed in each row of the spinal cord for any 
given marker. Columns in yellow color show mutant values, and no color shows wild-type 
(or sibling, in a case of tal1 marker) values. First value in each cell represents number of 
medial cells, and second value represents total number of cells in a specific row. Number of 
embryos counted is indicated at the bottom of each column.  
Row 
number 
gata3 
(tal1MUT) 
gata3 
(tal1WT) 
gata2a 
(tal1MUT) 
gata2a tal1 tal1 sox1a sox1a 
(tal1WT) (tal1MUT) (tal1SIB) (tal1MUT) (tal1WT) 
1 19 21.25 20.25 19.5 17.2 17.75 19.75 20.25 
2 0/1.67 5.75/7 0/0.25 8.25/9.85 0 5.25/7.5 0.5/1.25 8.25/8.25 
3 0/2.33 7.75/15 0/7 6.75/14.55 0.4/3.4 6.75/13.5 0/4.5 6.75/12 
4 0/9.33 2/11 0/12 2/12.6 0/8.45 0/10.25 0/9 2/10.5 
5 0/5.67 0/5.5 0/4.75 0/4.6 0/1.5 0/3 0/5 0/6.25 
6 0 0/1.5 0/0.25 0/0.6 0 0 0/1.25 0/2 
7 0 0 0 0 0 0/0.5 0 0/0.5 
8 0 0 0 0 0 0 0 0 
n 
values 
n=3 n=4 n=4 n=4 n=5 n=4 n=4 n=4 
         
Row 
number 
sox1b 
(tal1MUT) 
sox1b 
(tal1WT) 
tal2 
(tal1MUT) 
tal2 
(tal1WT) 
gads 
(tal1MUT) 
gads 
(tal1WT) 
1 20.33 20.25 18.75 20.5 21 21.5 
2 0 7.75/11.75 0 8.75/10.75 0/0.25 10/12 
3 0/2 9.25/12.25 0 7.25/10.75 0/0.25 7/13.75 
4 0/1.67 0.5/6.5 0 1.5/7.75 0/2 1/10.75 
5 0 0/5 0 0/3.75 0/6.75 0/8 
6 0 0/1.25 0 0/0.5 0/0.75 0/7 
7 0 0/0.5 0 0.5/0.5 0/0.5 0/2 
8 0 0 0 0 0/2.25 0/3 
n 
values 
n=3 n=4 n=4 n=4 n=4 n=4 
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Table 11. Summary of the phenotype observed in tal1t21384 mutant embryos and their 
siblings. Values represent average numbers of cells expressed in each row of the spinal 
cord for any given marker. First value corresponds to genotyped mutant embryos, and 
second value represents number of cells in genotyped wild-type embryos. Values of rows 1-
8 show cell numbers in individual spinal cord rows. Row ‘4+’ represents values from rows 
4-8 grouped together. Total number of cells from rows 1-8 is shown in the last row, but no 
colors were used in this case. In other cases, colors indicate whether the differences are 
statistically significant. Red and grey colors show no statistically significant difference 
between wild-type and mutant cell counts using Student’s t-test. Also, grey color indicates 
values where very few cells were present in either wild-type or mutant embryos (less than 
2 cells). Other colors denote a statistically significant difference (p ≤0.05) between the 
numbers of cells in wild-type and mutant embryos. Dark green = cells almost completely 
lost in mutants (less than 15% cells left in mutants), light green = cells significantly reduced 
(less than 33% cells left in mutants), blue = cells reduced (more than 33% cells left but 
statistically significant difference between mutant and wild-type). p-values that approach 
0.05 significance cut-off are indicated in brackets.  
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To determine whether expression of tal2 is delayed in V2b cells, or whether cells 
initially express tal2 but then quickly lose expression in mutants, I examined expression of 
tal2 at 22hpf and at 27hpf. In both cases, the phenotype was similar to 24hpf, with only the 
most ventral row of cells retaining tal2 expression in tal1 mutants (Fig. 24). I did not count 
the cells in embryos of these stages, but it seems that at 22hpf, 24hpf, and 27hpf the tal1 
mutation abolishes tal2 expression in cells dorsal to KA” cells.  
Also, I was intrigued by the very pronounced decrease in the number of GABAergic 
cells in rows 4 and above. Since there are other GABAergic cells in the zebrafish spinal cord 
that express gads, it was surprising that very few cells persisted in tal1 mutants. 
Importantly, the remaining cells express gads only very weakly in all rows dorsal to row 1. 
One possible explanation is that cells initially express gads, but expression is then down-
regulated either because cells are changing their fates or becoming sick. To test this, I 
examined expression of gads at 22hpf (Fig. 24A, B). No cells dorsal to KA” cells express gads 
at 22hpf in tal1 mutant. Another explanation could be that V2b cells are delayed in 
becoming GABAergic, which I tested by investigating expression at 27hpf (Fig. 24C, D). 
Even though a few sporadic cells express gads at 27hpf, the expression is still weaker than 
in KA” cells and the cells are not positioned in the usual row pattern (Fig. 24C, D). This 
suggests that these cells are not V2b cells but are instead more dorsal GABAergic cells. In 
conclusion, V2b cells lose their GABAergic phenotype and expression of sox1b and tal2, but 
expression of other markers persists in absence of Tal1.  
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Figure 24.  
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Figure 24. Expression of gads and tal2 in tal1t21384 mutant and sibling embryos at 22hpf and 27hpf. Lateral views of 
zebrafish spinal cord at indicated stages. Anterior left, dorsal up. Expression of gads  in tal1t21384 sibling embryo at 22hpf (A), 
tal1t21384 sibling embryo at 24hpf (B), tal1t21384 sibling embryo at 27hpf (C) and tal1t21384 mutant embryo at 27hpf (D). 
Expression of tal2 in tal1t21384 sibling embryo at 22hpf (E), tal1t21384 mutant embryo at 22hpf (F), tal1t21384 sibling embryo at 
27hpf (G) and tal1t21384 mutant embryo at 27hpf (H). In all cases pictures are representative of the phenotype that was 
observed in appropriate Mendelian ratios in the photographed experiment.  Scale bar: 50μm 
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I also examined expression of tal1 in tal1 mutants (Figs 20E, 21E, 22E). I initially 
found mutants based on their obvious blood phenotype, but confirmed the genotype before 
counting cells. I observed an expression pattern similar to that seen for other genes. 
Expression is unchanged in KA” cells, reduced in rows 2 and 3 where KA’ cells are found, 
and only slightly reduced in cells of rows 4 and above where most V2bs are located (Fig. 
21C, 21K and 22E). This suggests that tal1 is not required for its own regulation in KA” cells 
and V2b cells, and that there is no significant RNA-mediated decay of the tal1 mutant RNA 
in zebrafish spinal cord.  
Expression of foxn4 remains unchanged in tal1 mutants. There is no statistically 
significant difference in the number of cells in any of the rows that express foxn4, or in the 
total number of cells that express foxn4 (Figs. 20H and 21H). This suggests that tal1 is not 
upstream of foxn4 in the pathway that leads to formation of V2b cells.   
I also examined whether the tal1 mutation has a heterozygous phenotype. Given 
that the phenotype in V2b cells is different for different genes in tal1 mutants, I examined 
genes that had the most dramatic phenotype in both KA’ and V2b cells (sox1b, tal2 and 
gads), as I reasoned that if there was a  heterozygous phenotype it was most likely to be 
detected with one or more of these genes. However, none of these genes had an expression 
phenotype in heterozygous tal1 mutation carriers (Figs. 20A, 20B and 20C). This suggests 
that the tal1t21384 mutant does not cause a heterozygous phenotype in zebrafish spinal cord.  
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3.2.1.3 gata3 
The gata3 mutant, as discussed in the introduction, has not been published and was 
kindly provided by Dr. Steven Harvey in Derek Stemple’s lab at the Wellcome Trust Sanger 
Institute, UK. This mutant is also likely to be a null allele because the deletion/insertion 
change in the gene sequence results in a premature stop codon before both of the zinc 
finger domains (Fig. 4C).  
The phenotypes that I observed in gata3 mutant embryos resemble those seen in 
tal1 mutants for KA cells, but there are some notable differences between the two mutants 
with respect to V2b cells. However, as shown in Fig. 25 and my cell counts in Fig. 26, the 
lack of gata3 does not affect the formation of KA” cells, as assessed by expression of all of 
genes expressed by KA” cells that I investigated in this study. This result is consistent with 
observations made in morpholino-injected embryos (Yang et al., 2010), and this aspect of 
the phenotype is similar to the phenotype observed in tal1 mutant embryos described 
earlier.  
The pattern of KA’-specific gene expression in gata3 mutants is also similar to tal1 
mutants in several aspects. In gata3 mutants, KA’ cells in row 2 are lost, as assayed by all of 
the genes used (Figs 25, 26 and 27). In row 3, there is a reduction in the number of cells 
expressing all of the genes, but still many cells express tal1 and gata2a, and a smaller 
number of cells express gads. When I recounted cells based on their medial/lateral 
position, I saw that the cells that remain in row 3 are all lateral (Fig. 27, Table 12). Also, an 
average of one cell remained labeled in row 3 by tal2, sox1a and sox1b (Fig. 27, Tables 12 
and 13). In these cases, instead of re-counting cells in those embryos based on the 
lateral/medial position, I checked the location of these occasional cells in row 3. The 
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remaining cells in row 3 were always laterally located, and this is indicated by ‘0m’ in 
Table 13. 
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Figure 25. 
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Figure 25. Expression of V2b and/or KA markers in the gata3sa0234 mutant and 
sibling embryos at 24hpf. Lateral views of zebrafish spinal cords at 24hpf. (A-H) show 
expression of indicated genes in wild-type sibling embryos, and (I-P) show expression in 
mutant embryos. In most cases (gata3, tal1, sox1a, sox1b, foxn4) embryos shown here were 
genotyped as wild-type or mutant. Occasional photographs (gata2a, tal2, gads) are of 
embryos that were not genotyped. In these cases, pictures are representative of the 
phenotype that was observed in genotyped wild-type and mutant embryos and these 
phenotypes were observed in appropriate Mendelian ratios in the photographed 
experiment. Embryos were always genotyped if there was no obvious phenotype. All panels 
show the merged view of several planes from one side of the spinal cord from the 
compound microscope. Scale bar: 50μm  
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Figure 26.   
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Figure 26. Number of cells labeled in the gata3sa0234 mutant and sibling embryos at 
24hpf. Graphs show average number of cells expressing indicated gene in the spinal cord 
region adjacent to somites 6-10. Cell counts were performed on genotyped mutant and 
wild-type embryos, apart from one case (of gata3) where the cell count of mutant embryos 
is compared to a mixture of heterozygous mutant and wild-type embryos (indicated as 
‘sibling’) at 24hpf. At least four embryos were counted in each case. Cell counts from rows 4 
are shown as ‘4+’. Statistically significant (p<0.05) differences as assessed by Student’s t-
test are indicated by brackets and stars (* p<0.05, **p<0.01, ***p<0.001). Error bars 
indicate SEM.  
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Figure 27. Number of cells labeled in the gata3sa0234 mutant and sibling embryos at 
24hpf with distinction between lateral and medial position of the cells. Graphs show 
average number of cells expressing indicated genes in the spinal cord region adjacent to 
somites 6-10. Cell counts were performed noting the medial/lateral position of labeled 
cells. These counts are independent of the previous cell counts that did not address 
medial/lateral position of the cells. Whenever possible, embryos from the previous cell 
count were included. If this was not possible, additional embryos were genotyped. Cell 
counts from rows 4 and above were gathered together and are shown as ‘4+’. Cells in at 
least four embryos were counted in each case.  
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The phenotype of V2b cells in gata3 mutants is less clear. The number of cells that 
are in rows 4 and above labeled by gata2a and tal1 is partially reduced (Fig. 26A, 26F). 
Only around 2 cells less express gata2a in those rows (reduction from average of 19.2 to 17 
cells), which suggests that gata3 might slightly affect gata2a expression in cells of rows 4 
and above. tal1-expressing cells display a larger reduction of around half the cells (from 
average of 22 to 13.25 cells) in mutants compared to wild-type embryos, suggesting that 
gata3 is required for expression of tal1 in at least a subset of V2b cells of rows 4 and above, 
or that it is required for tal1 expression to be maintained in V2b cells.  
In addition, results differ between expression of sox1a and sox1b in cells located in 
row 4 and above. The number of sox1a-expressing cells in those rows in mutant embryos 
was unchanged, but only around a half of cells still express sox1b (Fig. 26C). This suggests 
that tal1 is required for expression of sox1b in some V2b cells or it is required for 
maintenance of sox1b expression in those cells, but that tal1 is not required for sox1a 
expression in V2b cells. This result also suggests that sox1a and sox1b genes are regulated 
differently in zebrafish spinal cord. However, it should also be noted that the numbers of 
cells in those rows differ greatly in wild-type siblings from both experiments. As shown 
later in this results chapter (in section 3.2.3), sox1a-labeled cells coming from gata3 incross 
are among the highest number out of all three mutant crosses investigated, whereas sox1b-
labeled cells coming from gata3 incross are among the lowest. This could partly be due to 
very small differences in the developmental staging of embryos and/or in how well the 
staining worked in each case. This results in a difference of almost 10 cells on average 
labeled in wild-type embryos with sox1a versus sox1b RNA probes. This indicates that 
careful conclusions should be made when comparing results from different experiments. 
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However, within an experiment mutant embryos are always compared with wild-type 
siblings with identical experimental treatment, so these results should still be helpful in 
understanding the phenotypic change in mutants. 
Interestingly, expression of both tal2 and gads in cells in row 4 and above remains 
unchanged in gata3 mutants (Fig. 26). This is in striking contrast with the phenotype 
observed earlier in tal1 mutants in this domain, where all the cells of row 4 and above were 
lost in the mutant embryos (Figs. 21-24). Since tal2 likely represents only a subset of V2b 
cells, this suggests that gata3 is not required for tal2 expression in a sub-population of V2b 
cells. Given that the GABAergic phenotype also remains unchanged, it appears that gata3 is 
not required for V2b cells to acquire their neurotransmitter phenotype.   
Expression of foxn4 remains unchanged in the gata3 mutant embryos (Figs 25H, 
25P and 26G). This suggests that either Foxn4 is upstream of Gata3, which would be 
consistent with the fact that I did not observe any co-expression of foxn4 and gata3 or that 
the two genes act independently of each other in V2b cells.  
I also performed an in situ hybridization for gata3 in gata3 mutants. In a manner 
similar to assessing expression of gata2a in gata2a mutants, I just identified the embryos 
by their phenotype (this is the only marker that I did this for with this mutant). Therefore, 
while the mutant cell counts from this experiment are genotyped mutant embryos, the 
‘sibling’ cell counts are a mixture of wild-type and heterozygous mutant embryos. (i.e. 
denoted ‘siblings’). Interestingly, mutant embryos show a weaker expression of gata3 in 
V2b cells and KA” cells, but the number of those cells is still similar to the number of cells 
labeled in sibling embryos (Fig. 25A 25I and Fig. 26A). However, there are no cells 
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expressing gata3 in the locations where KA’ cells are normally found in rows 2 and 3, 
which is consistent with expression of other markers. This suggests that gata3 is required 
for correct expression of gata3 in KA’ cells, and may be required for normal levels of 
expression in KA” and V2b cells (or there could be some nonsense mediated decay of the 
gata3 transcript).  
As was the case for other mutants, I also tested whether there is a heterozygous 
phenotype for this gata3 mutant allele. Since the phenotype in homozygous mutant 
embryos was most obvious in KA’ cells, with only slight changes in V2b cells, I decided to 
look at expression of gads in genotyped heterozygous gata3 mutation carriers. Again, no 
statistically significant phenotypic difference was found between heterozygous mutants 
and wild-type embryos (Fig. 20E). This suggests that the gata3sa0234 mutation does not have 
a heterozygous phenotype in zebrafish spinal cord.  
 Overall, these results show that gata3 is not required for correct formation of KA” 
cells, but is required for correct formation of KA’ cells, which is in agreement with previous 
descriptions of gata3 morpholino knock-down phenotypes (Yang et al., 2010). The 
mutation in gata3 appears to have only a partial effect on expression of markers in the V2b 
domain. Slight, statistically significant reductions were found in expression of gata2a and 
sox1b, while larger reductions of around half of the cells were observed for tal1. No 
statistically significant difference between expression patterns in V2b cells of mutant 
embryos compared to wild-type was found in the expression of gata3, sox1a, tal2, foxn4, or 
gad. Also, gata3 appears to be expressed more weakly in mutant embryos but in a similar 
number of KA” and V2b cells compared to the sibling embryos. Taken together this 
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suggests that gata3 is required for the formation of KA’ cells and for expression of a small 
subset of genes in V2b cells. While the KA” and KA’ phenotype in gata3 mutants is 
comparable to that in tal1 mutants, the V2b phenotypes are different as in tal1 mutants 
V2b cells are no longer GABAergic and they also have a more dramatic loss of expression of 
several other genes, most markedly tal2 and sox1b (Fig. 26F, 26G). The lateral/medial 
position of cells in each row is shown in Table 12, and all above results are also 
summarized in Table 13.  
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Table 12. Lateral/medial cells counts in gata3sa0234 mutant embryos and their siblings. Values represent average 
numbers of cells expressed in each row of the spinal cord for any given marker. Columns in yellow color show mutant values, 
and no color shows wild-type values. First value in each cell represents number of medial cells, and second value represents 
total number of cells in a specific row. Number of embryos counted is indicated at the bottom of each column.  
Row 
number 
gata2a 
(gata3MUT) 
gata2a 
(gata3WT) 
tal1 
(gata3MUT) 
tal1 
(gata3WT) 
gads 
(gata3MUT) 
gads 
(gata3WT) 
1 21.33 20.33 20.5 20.5 22 21 
2 0/0 8.33/9.33 0 7.75/8.75 4.75/7.5 8.33/8.33 
3 0/8.67 7.67/14.33 0/4.75 6.75/12 5.75/12 6.67/14 
4 0/12.33 3.33/14.33 0/9.5 1.75/11.5 0.25/10.25 0/14.67 
5 0/4.66 0/6 0/2.75 0/6.5 1.25/7.25 0/6.67 
6 0/0.67 0/0.33 0/0.5 0/0.75 0/2.75 0/3 
7 0 0 0 0 0/0.25 0/0 
8 0 0 0 0 0/1.25 0/2 
n values n=3 n=3 n=4 n=4 n=4 n=3 
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 Table 13. Summary of the phenotype observed in gata3sa0234 mutant embryos and 
their siblings. Values represent average numbers of cells expressed in each row of the 
spinal cord for any given marker. First value corresponds to genotyped mutant embryos, 
and second value represents number of cells in genotyped wild-type embryos, apart from 
gata3 expressing cells, where values are an average from heterozygote and wild-type 
embryos. Values of rows 1-8 show cell numbers in individual spinal cord rows. Row ‘4+’ 
represents values from rows 4-8 grouped together. Total number of cells from rows 1-8 is 
shown in the last row, but no colors were used in this case. In other cases, colors indicate 
whether the differences are statistically significant. Red and grey colors show no 
statistically significant difference between wild-type and mutant cell counts using Student’s 
t-test. Also, grey color indicates values where very few cells were present in either wild-
type or mutant embryos (less than 2 cells). Other colors denote a statistically significant 
difference (p ≤0.05) between the numbers of cells in wild-type and mutant embryos. Dark 
green = cells almost completely lost in mutants (less than 15% cells left in mutants), light 
green = cells significantly reduced (less than 33% cells left in mutants), blue = cells reduced 
(more than 33% cells left but statistically significant difference between mutant and wild-
type), yellow=statistically significant increase between mutant and wild-type. p-values that 
approach 0.05 significance cut-off are indicated in brackets. 
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Table 13. 
ROW/Marker gata3 gata2a tal1 sox1a sox1b tal2 gads
✔ ✔ ✔ ✔ ✔ ✔ ✔
20.5/20 21.75/21 20.5/20.75 20.83/20.6 21.4/21.25 21/20 20.25/21.25
✗ ✗ ✗ ✗ ✗ ✗ ✗
0/5.5 0/10.16 0/10.25 0/7.6 0/5.5 0/10 0/8.25
3 ✗ R R ✗ ✗ ✗ ✗
0/11.75 9.5/13.33 5/12.25 0.17/11.4 0.2/14.25 0.25/10 1.75/13.5 
(0m) (0m) (0m) (0m) (0m) (0m)
✔ ✔ R R ✔ ✔(NS, p =0.07) R
10.5/12 12.25/13.17 9.0/13 11/11.8 7.8/9.75 9.0/7.0 11.25/15.25
(0m)
✔ ✔ ✔(NS, p =0.06) INC R R ✔
5.25/5.75 4.75/5.67 3.75/6.75 12/8.6 2/5 1.50/4 8.5/7
(0m)
✔ − SR ✔ R − R
1.25/2.5 0/0.33 0.5/2.25 5.5/4.8 0.6/2 0.25/0 1/2.75
−
0 0 0.17/0.2 0 0 0
✔
0 0 0 0 0 1.75/1.25
4+ ✔ ✔ R ✔ R ✔ R
TOGETHER 17.5/20.25 17/19.17 13.25/22 28.67/25.4 10.4/16.75 10.75/11 22.5/26.5
Presumed not ✔ R not not not R
V2b cells established 26.33/28.33 17.5/25 established established established 24.25/31.67
R R R R R R
48.25/63.67 38.75/65.25 49.83/65 32/57.75 31/52.5 44.5/69.5
4
gata3 mutant
1
2
6
7
8
TOTAL
5
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3.2.2 There is no obvious developmental delay in gata2a, gata3 or tal1 
mutants 
Sometimes mutations can cause an overall delay in development. Given that KA and 
V2b cells form gradually over time, differences in the developmental stage of embryos 
could result in different numbers of KA and V2b cells being present. Therefore, to exclude 
the possibility that some of the phenotypes described above could be the result of a 
developmental delay specifically in mutant embryos, I examined the position of lateral line 
primordium in identified wild-type and mutant embryos. The lateral line primordium is a 
structure that moves along the embryonic trunk at both sides of the embryo at a well 
characterized pace (Kimmel et al., 1992), and its position is one of the most precise ways to 
assess developmental stage of zebrafish embryos between 24 and 30hpf. Conveniently, one 
of the probes that I used as a marker of V2b and KA cells, sox1a, also labels the lateral line 
primordium (Fig. 28A). When I examined the position of this structure on both sides of 
spinal cord, I saw no statistically significant difference between the stages of wild-type and 
mutant embryos in either gata2a, tal1 or gata3 mutant lines (Fig. 28B, 28C and 28D, 
respectively). This shows that mutations in those genes do not cause a developmental delay 
in zebrafish embryos. 
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Figure 28. Position of lateral line primordium in wild-type and mutant zebrafish embryos at 24hpf. (A) sox1a 
expression in 24hpf zebrafish trunk with arrow indicating lateral line primordium. Anterior left, dorsal up. The dots in the 
upper half of the embryo are spinal cord cells. (B-D) Graphs representing position of lateral line primordium in genotyped 
wild-type and mutant embryos from incrosses of gata2aum27 (B), tal1t21384 (C) or gata3sa0234 (D) heterozygous parents. The 
average was calculated using single values that represent position of primordium on each side of the embryo. At least 4 
embryos were analyzed in each case, resulting in at least 8 single values used for calculations. Error bars represent SEM.          
Scale bar = 50μm
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3.2.3 Comparison of cell count numbers of wild-type embryos from 
different experiments 
All of my interpretation of results from mutant embryos assumes that the number of 
cells labeled by certain RNA probes is consistent between different in situ hybridization 
experiments. To test this, I assessed the reproducibility of my in situ hybridization 
experiments by comparing the number of cells labeled with each marker gene used in wild-
type sibling embryos from the different experiments described above (Figs 29, 30).  
For gata3-labeled cells, I compared the expression pattern in genotyped wild-type 
embryos from both an incross of heterozygous tal1 mutants and an incross of heterozygous 
gata2a mutants (Fig. 29A). I found no statistically significant differences between the 
overall number of cells labeled or the number of cells labeled that were located specifically 
in row 1 (p= 1, Appendix Table 2), row 2 (p=0.099, Appendix Table 2) or row 3 (p=0.423, 
Appendix Table 2). However, in row 4, there was a statistically significant difference 
between number of cells labeled in both experiments (average of 10 cells labeled in tal1 
incross experiment, and 12.75 cells in gata2a incross experiment, p=0.048). This is likely to 
be because it becomes more difficult to accurate assign cells to a particular row, in more 
dorsally located positions. Cell counts are more difficult to perform consistently when cells 
are further away from the notochord, partly because of the cuboidal shape of cells. Cells are 
not always arranged in clear/neat rows, especially in more dorsal positions where their 
dorso-ventral position depends on more ventrally located cells. Consistent with this 
hypothesis – if I compare the number of cells in row 4 and above (identified as ‘4+’ in 
figures), these numbers (19 for wild-type embryos from the tal1 mutant incross, and 19.5 
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for wild-type embryos from the gata2a incross) are not statistically significantly different 
(Fig. 29E; p=0.94, Appendix Table 2).  
In a similar way, I compared the number of gata2a-labeled cells in genotyped wild-
type embryos from gata3 and tal1 incross experiments. In rows 1-5, no significant 
difference was found between experiments, although in row 1 the p value was approaching 
significance (Fig. 29B, p=0.053, Appendix Table 2). In row 6, there is a statistically 
significant difference between gata2a-expressing cells in both experiments (p=0.017; 
Appendix Table 2). Again, when the values from rows 4 and above are gathered together, 
no significant difference can be found between wild-type embryos from both experiments 
(Fig. 28F), which is consistent with hypothesis presented earlier that slight differences in 
cell counts in these more dorsal rows reflect a difficulty with precisely identifying rows far 
away from notochord. Taken together, these results indicate that similar numbers of both 
KA cells and V2b cells are labeled in both experiments.  
For tal1 I compared expression in genotyped wild-type embryos from gata2a, gata3 
and tal1 incrosses of heterozygous parents. Pairwise comparison with Student’s t-test 
showed no significant differences between average values in rows 1-3, but the gata2a 
versus gata3 incross comparison for row 2 approached significance (p=0.055; Appendix 
Table 2). Small significant differences were found between various experiments in rows 4, 
5 and 6 (Fig. 29C; Appendix Table 2). In row 4 the difference in the number of cells labeled 
in tal1 wild-type siblings versus gata3 wild-type siblings were statistically significantly 
different (p=0.12, Appendix Table 2). Also, in row 5 there were statistically significant 
differences found. gata2a wild-type siblings had significantly more cells expressing tal1 in 
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row 5 (average of 10.25 cells, Fig. 29C), than in gata3 wild-type siblings (average of 6.75 
cells, p=0.01), or tal1 wild-type siblings (average of 4.75 cells, p=0.07). Also, in row 6 
significant differences were found between all three of the pairwise comparisons 
(Appendix Table 2). In addition, my comparison of cell counts from row 4 and above shows 
that the number of cells in tal1 wild-type siblings is significantly lower than in the other 
two experiments (16.5 cells in the tal1 incross, versus 25.75 cells in gata2a incross 
(p=0.09) and 22 cells in gata3 incross (p=0.006) (Fig. 29G, Appendix Table 2). Since cells 
are usually specified from the ventral to dorsal, with older cells located more dorsally, this 
suggests to me that potentially the embryos from the tal1 incross experiment might have 
been slightly younger than in the other two experiments. This hypothesis would be 
supported by the fact that the numbers of more dorsal (rows 5 and 6), as well as to a 
smaller extent the number of KA” cells labeled by tal1 is smaller in these wild-type siblings. 
 Analysis of tal2-labeled wild-type mutants shows a similar trend. The only 
statistically significant difference that could be found in the cell counts by row from three 
individual experiments was in row 6, where tal1 wild-type siblings have more cells labeled 
than gata3 wild-type siblings (Fig. 29D). However, when the values from row 4 and above 
were combined, there was no statistically significant difference between any of the 
experiments (Fig. 29H, Appendix Table 2). 
 Therefore, given that the differences within individual cell populations do not differ 
to a large extent, and that I am comparing embryos of the same stage within each 
experiment (by comparing mutants to their wild-type siblings from the same cross), I 
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believe that we can still draw conclusions about Tal1 function from the tal1 mutant 
experiments.   
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Figure 29. 
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Figure 29. Expression of gata3, gata2a, scl and tal2 in wild-type embryos from 
different experiments. Graphs show average number of cells that express indicated genes 
in a 5 somite length of spinal cord adjacent to somites 6-10. Counts are for both sides of the 
spinal cord and at least 4 embryos were counted in each case. Cells were counted in 
individual rows along the dorsal-ventral axis with row 1 being the most ventral row, which 
is located just above the notochord. Embryos are from incrosses of tal1t21384, gata2aum27 
and gata3sa0234 heterozygous mutants and were either genotyped (wild-type), or assessed 
by the clearly visible phenotype in approx. 25% of embryos (sibling). (A-D) show cell 
counts in each individual row. (E-H) show the same values for rows 1, 2 and 3, with values 
from row 4 and above grouped together. Statistically significant (p<0.05) differences as 
assessed by Student’s t-test are indicated by brackets and stars (* p<0.05, **p<0.01, 
***p<0.001). Error bars represent SEM. 
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I also compared sox1a expression in genotyped wild-type embryos from incrosses of 
heterozygous parents of all three mutants. In rows 1, 2, 3 and 4, no significant differences 
were found between the wild-type expression in all three experiments (Fig. 30A, Appendix 
Table 2). However, small significant differences could be seen in number of cells labeled in 
rows 5 and 6 (Fig. 30A). In row 5, less cells were stained in tal1 wild-type siblings than in 
gata2a wild-type siblings (p=0.046), although none of the other pairwise comparisons 
were statistically significant. In row 6, less cells are labeled in tal1 wild-type siblings, with 
statistically significant differences between these embryos and both gata2a (p=0.027) and 
gata3 wild-type siblings (Fig. 30A; p=0.021; Appendix Table 2). In row 7, no statistically 
significant difference was detected, most likely due to the fact that very few cells are 
labeled in this row in any of the experiments. The lower number of cells in dorsal rows 
labeled with sox1a in tal1 wild-type siblings is also seen when the values are combined 
from rows 4 and above (Fig. 30E). It appears that tal1 wild-type siblings have less cells than 
both gata2a and gata3 wild-type siblings, but a statistically significant difference could be 
detected only between tal1 wild-type siblings and gata3 wild-type siblings in this case 
(Fig. 30E, Appendix Table 2). This suggests that the tal1 embryos might have been slightly 
younger and/or the probe did not stain as well in this particular tal1 experiment as in the 
other experiments.  
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Similarly, no differences are observed between expression of sox1b in wild-type 
sibling embryos that come from incrosses of all three mutants in individual rows 1-4 (Fig. 
30B, Appendix Table 2). However, there is a small variation in cell counts in rows 5, and 7, 
with no statistically significant difference in the number of cells of row 6. gata2a wild-type 
siblings appear to have most cells labeled in row 5, with statistically significant differences 
between gata2a wild-type siblings and both tal1 (p=0.045), and gata3 wild-type siblings 
(p=0.031) (Fig. 30B, Appendix Table 2). However, in row 7, the tal1 wild-type siblings have 
most cells labeled, with statistically significant differences only between tal1 wild-type 
siblings and gata3 wild-type siblings (Fig. 30B; p=0.040; Appendix Table 2). When the 
values from row 4 and above are combined, no statistically significant difference can be 
found between the number of cells labeled in either of the experiments (Fig. 30F). Again, 
the differences in individual rows most likely occurred due to difficulties identifying the 
exact position of cells far away from the notochord in the individual embryos. 
 The number of GABAergic cells also differs only within occasional individual rows 
between all three experiments. In rows 1-3, and in row 5 there is no statistically significant 
difference between numbers of cells labeled by gads in wild-type sibling embryos from 
either experiment (Fig. 30C). However, in row 4, the least cells are labeled in tal1 wild-type 
siblings, with a statistically significant difference between this experiment and the gata3 
wild-type siblings (Fig. 30C). At the same time, in row 6 the tal1 wild-type siblings appear 
to have the most cells labeled with gads, with statistically significant differences found 
between this experiment and both gata2a (p=0.007), and gata3 wild-type siblings 
(p=0.016). No statistically significant difference was detected between the more dorsal 
rows. The difference in individual row counts between the tal1 wild-type siblings and other 
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experiments is not apparent when cells from row 4 and above are combined, as no 
statistically significant difference was detected in either comparison (Fig. 30G, Appendix 
Table 2). 
 In case of cell counts performed on wild-type embryos labeled with foxn4 in 
experiments from all three mutant lines, the difference is visible only in row 3 out of all 
rows labeled (Fig. 30D, Appendix Table 2). In row 3 of tal1 wild-type siblings, the number 
of cells is statistically significantly lower than in gata3 wild-type siblings (Fig. 30D). 
Understandably, the same trend is visible when cells from row 4 and above are pooled 
together (Fig. 30H). However, foxn4 appears to label only one cell population (most likely 
early V2b, sometimes probably just after division) that might not be consistently 
positioned within one specific row, but is found in rows 3-5. Therefore, I decided that a 
comparison that would better reflect the actual phenotype would be to compare the total 
number of cells. In this case, there is no significant difference between the number of foxn4-
labeled cells in wild-type sibling embryos from either of the experiments. 
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Figure 30. 
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Figure 30. Expression of sox1a, sox1b, gads and foxn4 in wild-type embryos from 
different experiments. Graphs show average number of cells that express indicated genes 
in a 5 somite length of spinal cord adjacent to somites 6-10. Counts are for both sides of the 
spinal cord and at least 4 embryos were counted in each case. Cells were counted in 
individual rows along the dorsal-ventral axis with row 1 being the most ventral row, which 
is located just above the notochord. Embryos are from incrosses of tal1t21384, gata2aum27 
and gata3sa0234 heterozygous mutants and were either genotyped (wild-type), or assessed 
by the clearly visible phenotype in approx. 25% of embryos (sibling). (A-D) show cell 
counts in each individual row. (E-H) show the same values for rows 1, 2 and 3, with values 
from row 4 and above grouped together. Statistically significant (p<0.05) differences as 
assessed by Student’s t-test are indicated by brackets and stars (* p<0.05, **p<0.01, 
***p<0.001). Error bars represent SEM. 
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3.3 Other potential markers of V2b and/or KA cells 
Several additional candidate genes that might be expressed in V2b and/or KA cells 
were identified via either literature searches and/or from another project in the lab that 
investigated the expression profiles of various zebrafish spinal cord cell types via 
microarray. In parallel to my examination of gata3, gata2a and tal1 mutants, I also 
examined the expression of some of these genes in the hope of finding genes that label 
specifically V2b, KA’ or KA” cells, since most transcription factors described to date are 
expressed by all three of these cell types. I performed GFP immunohistochemistry and in 
situ hybridization with these genes in the Tg(gata1:GFP) line that labels KA cells and a 
subpopulation of V2b cells to investigate whether those candidate genes are expressed by 
either V2b or KA cells. As shown in Fig. 31, several markers had a partly overlapping 
expression with Tg(gata1:GFP) cells. 
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Figure 31.
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Figure 31. Genes that are candidates for being expressed by V2b and/or KA cells in 
zebrafish spinal cord. Lateral views of 24h spinal cords of Tg(gata1:GFP) embryos with 
GFP expression in green and insm1a (A), mnx1 (B), her6 (C), crb1 (D) and sp8a (E) mRNA 
expression in red. Each panel represents a merge of multiple projections from one side of 
the spinal cord followed by a merged image of both green and red channels. White stars 
indicate cells that are double-labeled. Panels in A’, B’, C’ and D’ show single confocal plane 
of the area marked with white box in panels A, B, C and D, respectively. Scale bar: 50μm  
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insm1a was initially identified from the microarray screen by another student in the 
lab (Paul Campbell). My double labels show that this gene is expressed by a subset of 
Tg(gata1:GFP) cells (Fig. 31A). The cells that express both insm1a and Tg(gata1:GFP) are 
located at positions that correspond to all three populations: KA”, KA’ and V2b cells. 
Interestingly, these co-labeled cells are sporadic, and overall this gene does not seem to be 
expressed by all members of any one population. However, because of the significant 
background in those embryos, it is difficult for me to confidently determine the precise 
number of co-expressing cells. 
mnx1 was also identified by another student in lab (Paul Campbell) from the 
microarray screen. It does not appear to be expressed by Tg(gata1:GFP) KA” cells 
(Fig. 31B). However, there are a small number of more dorsal cells (3 cells that I could 
identify across both sides of the spinal cord of embryo in Fig. 31B) that are co-labeled by 
both Tg(gata1:GFP) and mnx1. Those cells could potentially be V2b or KA’ cells. This would 
be consistent with the literature that shows that some mnx1-expressing cells have a V2b-
like morphology and are GABAergic at 24hpf (Seredick et al., 2012). Interestingly though, in 
my experiment I could see Tg(gata1:GFP)-positive cells with a V2b morphology that did not 
express mnx1, which indicates that perhaps only some V2b cells express mnx1. This marker 
is also expressed in primary motoneurons, together with other members of the mnx family 
(Seredick et al., 2012). Therefore, despite the fact that the mnx1 appears to be expressed by 
some V2b cells, it is not a V2b-specific marker. 
I identified her6 from the microarray project during my rotation in the lab as a 
marker that might be expressed by inhibitory neurons. As shown in Fig. 31C, her6 appears 
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to be expressed by some KA cells, but also by many more cells in the ventral rows where 
KA cells are located. The ventral expression of her6 appears to be restricted to rows ventral 
to the position of V2b cells, and none of the GFP-positive cells with V2b-like morphology 
co-expressed her6. However, this gene seems to be also expressed in cells located in the 
dorsal spinal cord (Fig. 31C). Interestingly, when Alex Nichitean investigated the 
expression pattern of this gene in mindbomb mutants in which Notch signaling is 
inactivated, the expression of her6 was largely abolished. This suggests that her6 is 
expressed by cells that depend on Notch signaling for their formation. This group includes 
KA cells, which is consistent with her6 being expressed by KA cells. Therefore, her6 may be 
expressed by a subset of KA cells, but is not a KA-specific marker due to the more extensive 
ventral her6-expressing domain and the dorsal expression domain. 
crb1 (crumbs family member 1, photoreceptor morphogenesis associated) was also 
identified by myself during my rotation from the microarray screen as a marker potentially 
expressed in V2b or KA cells. As opposed to all other genes investigated in this thesis, crb1 
does not encode for a transcription factor but for a transmembrane protein. Interestingly, it 
appears to be expressed by KA cells, as it is co-expressed with Tg(gata1:GFP) (Fig. 31D). 
Also, it appears that crb1 might be expressed by additional cells in row 1, which suggests 
that it might be expressed by other cells in the lateral floor plate region, perhaps p3 or V3 
populations. In row 2, all of the Tg(gata1:GFP) cells appear to co-express crb1, which 
suggests that all or most of the KA’ cells express this gene. None of the cells located more 
dorsally to this region were found to express crb1. This is perhaps one of the most exciting 
results, as it suggests that only KA cells and not V2b cells express crb1. However, this 
marker is not KA-specific because of the additional crb1-expressing cells in the first row 
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above notochord. Hopefully, future experiments will reveal the identity of those cells and 
possibly the role of crb1 in KA cells.  
sp8a was also identified from the microarray screen as a gene upregulated in 
inhibitory (versus excitatory) cells of zebrafish spinal cord. However, it does not appear to 
be expressed by any of the Tg(gata1:GFP) cells (Fig. 31E) although, interestingly, it is 
expressed by cells that are roughly in the KA’ and/or V2b position. It is likely that not all 
V2b cells are labeled by this transgenic line based on my other results, and sp8a could be 
potentially expressed by non-GFP positive V2b cells. However, since none of the sp8a-
labeled cells co-label with Tg(gata1:GFP), it is also likely that this gene is not expressed by 
either V2b or KA cells. 
Overall, I identified several genes that are expressed by KA’, KA” and/or V2b cells in 
zebrafish spinal cord (as summarized in Table 14). crb1 and her6 are expressed by either a 
subset or all of both of the KA cell populations. insm1a may be expressed by a subset of all 
three populations, as well as other cells, but this result needs to be repeated with a 
stronger probe before a final conclusion can be made. mnx1 may be expressed by some V2b 
cells, but this result needs to be confirmed at a later stage when there are more 
Tg(gata1:GFP) cells with a V2b morphology, or by co-labeling with a known V2b marker. In 
all of these cases, the genes are also expressed by additional cell populations and are, 
therefore, not exclusive to KA”, KA’ and/or V2b cells. I also showed that sp8a is not 
expressed by KA or V2b cells.  
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Table 14. Summary of conclusions about novel candidate genes that may be 
expressed by V2b and/or KA cells. This table shows the general conclusions that may 
be drawn from experiments that establish the expression pattern of candidate genes at 
24hpf in zebrafish embryos. The conclusions are simplifications based on the 
experiments presented in this thesis and also supported by published literature, as 
discussed in text. Evidence that comes from this thesis is referenced to the respective 
figures in the last column.  
Gene 
name 
Expression profile 
Comments 
Reference 
figure V2 domain KA domain 
foxn4 
Subset of early 
V2b cells 
Absent - 11-14 
sox1a 
Likely most V2b 
cells 
All KA cells 
May be in a few 
additional cells 
9-10 
sox1b 
Likely most V2b 
cells 
All KA cells 
May be in a few 
additional cells 
9-10 
insm1a Some V2b cells 
Some KA 
cells 
Also in many 
additional cells 
31 
mnx1 A few V2b cells Absent Also in motoneurons 31 
her6 Absent Most KA cells 
Also in some dorsal 
cells, and in additional 
cells in KA domain 
31 
sp8a Absent Absent - 31 
crb1 Absent All KA cells 
Likely in some other 
cells in KA D-V 
position 
31 
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4. Discussion  
The primary goal of this study was to better understand the molecular pathways 
that establish GABAergic V2b and KA cells in zebrafish spinal cord. Previous reports 
showed that formation of many inhibitory GABAergic spinal cord cells depends on the 
PAX2 transcription factor in both mouse (Pillai et al., 2007), and zebrafish (Batista and 
Lewis, 2008). Interestingly, V2b cells in mouse, and both V2b and KA cells in zebrafish, are 
the only GABAergic spinal cord cells that do not express Pax2 (Pillai et al., 2007; Batista and 
Lewis, 2008). As would be expected, in the absence of PAX2 and other highly related PAX 
transcription factors those ventrally located neurons retain their GABAergic phenotype 
(Pillai et al., 2007; Batista and Lewis, 2008). This indicates that another, pax2-independent 
mechanism must specify the GABAergic phenotype of those cells. Furthermore, evidence 
from knock-down studies in zebrafish indicates that there is a difference in how mature KA’ 
and KA” form – expression of at least some genes in KA” cells requires gata2a and not 
gata3, and KA’ cells require gata3 but not gata2a for their correct specification (Yang et al., 
2010). This is a very interesting result, but morpholino experiments can sometimes cause 
non-specific phenotypes due to off-target effects (Eisen and Smith, 2008; Shulte-Merker 
and Steiner, 2014). Therefore, it was important to confirm this result in mutant fish. Also, 
this result raised the possibility that transcription factor genes expressed by zebrafish KA”, 
KA’ and V2b cells might play distinct roles in formation of those cells. In this thesis I 
investigate whether tal1, gata2a, or gata3 are required for V2b or KA specification by 
examining single mutations in these genes. I also investigated whether other transcription 
factors are expressed by V2b and/or KA cells.  In this discussion, first, I will discuss my 
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analyses of sox1a, sox1b and foxn4 expression in wild-type embryos. Then, I will describe 
my analyses of KA”, KA’ and V2b cells in tal1, gata2a and gata3 mutants. Finally, I will 
briefly describe my more preliminary results on other potential markers expressed by V2b 
and/or KA cells. For reference, the expression patterns of each gene in wild-type embryos 
are gathered together in Fig. 32. 
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Figure 32. Expression patterns of V2b and/or KA genes in wild-type embryos at 24hpf. Graph shows average number of 
cells in each row labeled by in situ hybridization for different genes (represented by different colors). This data is a 
compilation of all the genotyped wild-type embryo cell counts from incrosses of heterozygous mutants (from at least 2-3 
separate experiments). Values in this figure are a combination of values from earlier figures that show expression patterns of 
these genes presented in the results section. Lines above the bars indicate the expected positions of KA”, KA’ and V2b cells in 
the zebrafish spinal cord based on current knowledge.  
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4.1 sox1a and sox1b are expressed by V2b and KA cells 
As explained in the introduction, sox1a and sox1b are zebrafish orthologs of mouse 
Sox1. There are two zebrafish sox1 genes because of the additional whole genome 
duplication event that occurred in teleosts (Amores et al., 1998; Taylor et al., 2003; 
Glasauer and Neuhauss, 2014). In amniotes, Sox1 is broadly expressed in the chicken spinal 
cord (Okuda et al., 2006) and in mouse spinal cord progenitor cells (Pevny et al., 1998) and 
post-mitotic V2c cells (Panayi et al., 2010). In zebrafish, sox1a and sox1b expression had 
been observed mostly in the retina and brain, but it was reported that it was not detected 
in the spinal cord at any stage examined (12 and 21 somite, and 25hpf) (Okuda et al., 
2006). However, I think the authors may have missed expression of sox1a and sox1b in the 
spinal cord, as I can see weak expression in their photographed embryos at 25hpf (Okuda 
et al., 2006). Also, direct data submission to the zebrafish expression database by the 
Thisse lab shows sox1a expression in spinal cord at 24hpf (Thisse et al., 2004; ZFIN.org). In 
this thesis, I confirm that both sox1a and sox1b are expressed at 24hpf in zebrafish spinal 
cord. In addition, another student in the lab (Alex Nichitean) detected spinal cord 
expression of sox1a at 20hpf, 22hpf and 27hpf (data not shown).  
V2b, KA’ and KA” cells in zebrafish all express tal1, gata2a and gata3, and are 
GABAergic (Batista et al., 2008; Yang et al., 2010; Bernhardt et al., 1992). All of these cells 
are also labeled by Tg(gata1:GFP), even though they don’t express gata1 (Detrich et al, 
2004) suggesting that this transgene promoter lacks either a spinal cord repressor 
element, or acts as an enhancer trap (Batista et al., 2008). Based on my results, I propose 
that both V2b and KA cells also express sox1a and sox1b, as both of those transcription 
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factors are co-expressed with GFP in Tg(gata1:GFP) embryos (see Fig. 10). However, at 24h 
the Tg(gata1:GFP) line only labels a small number of the V2bs in my experiments (Fig. 10). 
This suggests that either not all of the V2bs are labeled by Tg(gata1:GFP), or that the 
expression of the transgene is delayed in most V2b cells. As a result, it is hard to determine 
whether the sox1a- and sox1b-positive cells that do not co-express GFP are also V2b cells or 
might be an additional cell type. However, all of the Tg(gata1:GFP) cells express sox1a and 
sox1b, which suggests that both of those transcription factors are expressed by all KA cells, 
and at least the subset of V2bs that was labeled by the transgenic line (Fig. 10 and Table 8).  
In mouse, Sox1 is expressed in V2b cells but also in V2c cells that no longer express 
the V2b marker gata3 (Panayi et al., 2010). I was not able to establish whether V2c cells 
also exist in zebrafish. Given that both sox1a and sox1b are expressed in a few more cells 
than gata3, gata2a and tal1, especially in row 6 and 7, it is possible that these more dorsal 
cells are V2c cells, although they could also be a different cell type (especially given their 
more dorsal location). The overall similarity of sox1a and sox1b expression to that of other 
V2b markers, and the fact that in mouse Sox1 is transiently expressed by V2b cells (Panayi 
et al., 2010) suggests that sox1a and sox1b are expressed by V2b cells. In addition, in all 
three of the tal1/gata2a/gata3 mutants, expression of at least one of the sox genes is 
altered in a manner similar to that of other V2b and KA markers, consistent with these 
genes being expressed by KA and V2b cells in zebrafish.  Double in situ hybridization 
experiments between sox1a/sox1b and other V2b cell markers (e.g. tal1, gata2a or gata3) 
could confirm whether sox1a/b are only expressed in V2b cells, or whether they also are 
expressed by additional cells. To see whether V2c cells exist in zebrafish however, 
transgenic lines that would allow for lineage tracing would be needed. This would allow for 
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identifying cells that once were V2b cells (e.g. expressed gata3), but later express only 
sox1a and/or sox1b (become a new subpopulation, V2c). Since degradation time of GFP is 
quite long after protein is fully folded, use of traditional lines (e.g. Tg(gata1:GFP) would not 
suffice, as it would be difficult to establish whether cells are still V2b cells or already 
became V2c cells. However, a transgenic line (e.g. Tg(gata3:eGFP)) line could be made to 
trace the origin of the sox1a/sox1b-expressing cells to cells that once expressed gata3. Such 
lineage tracing lines are used in mouse and are also available in zebrafish (Hans et al., 
2009). However, currently a line that specifically enables tracing of V2b/V2c fate is not 
available. 
In contrast to V2b cells, KA cells are consistently labeled by the Tg(gata1:GFP)  line: 
the number of GFP-positive cells is equivalent to the number of KA cells in the first two to 
three rows of the spinal cord. The co-expression of both sox1a and sox1b in these GFP-
positive cells shows that KA cells express both of those transcription factor genes. 
Currently there is no evidence from other organisms that indicates expression of sox1a and 
sox1b in cells that contact cerebrospinal fluid (cerebrospinal fluid contacting neurons (CSF-
cNs) in amniotes; KA cells in zebrafish). It is possible that the Sox1-expressing cells in 
mouse might be CSF-cNs. More detailed examination by either co-labeling with a CSF-cN 
specific marker such as pkd2l1 (Djenoune et al., 2014), or looking at the morphology of the 
cells that express Sox1 could establish whether expression of Sox1 in CSF-cNs is conserved 
in zebrafish and amniotes. 
In zebrafish, there are temporal and spatial differences in the expression of sox1 
genes in many tissues (Okuda et al., 2006). For example, in retina sox1a is expressed a 
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number of hours before sox1b is expressed (Okuda et al., 2006). In addition, sox1b is 
expressed only in the forebrain, whereas sox1a is expressed in both forebrain and 
hindbrain (Okuda et al., 2006). Therefore, despite the fact that those genes are very closely 
related and both show high similarity at a sequence level to human and mouse SOX1 
(Okuda et al., 2006), their expression and functions in specific cell types might differ. The 
phenotypes of zebrafish single mutants analyzed in this study support the idea that sox1a 
and sox1b are regulated differently, which might also suggest distinct roles for these genes 
in the development of V2b and KA cells. In KA” cells in gata2a mutants, I observed that only 
sox1b is lost, while sox1a expression is unaffected. In contrast, sox1b expression is lost in 
V2b cells in tal1 mutants, while sox1a expression in those cells is only slightly reduced. 
Similarly, in V2b cells in gata3 mutants, around half of the cells lose sox1b expression, while 
no significant change is observed in expression of sox1a. This suggests that sox1b may be 
downstream of tal1 and gata3 in V2b cells, and sox1a downstream of gata2a in KA” cells.  
Different functions and/or regulation of orthologous genes is often a consequence of 
additional whole genome duplication events such as the one that occurred at the base of 
the teleost lineage (Glasauer and Neuhauss, 2014). A study that investigated changes in 
non-coding elements (CNEs) surrounding all of the soxB genes (to which sox1a and sox1b 
belong) in the pufferfish showed that about half of the CNEs were split apart after the 
genome duplication event, suggesting that subfunctionalization may have occurred for 
those genes (Woolfe and Elgar, 2007). For example, subfunctionalization during evolution 
occurred in the functions of co-orthologs sox9a and sox9b, where the craniofacial and 
pectoral fin phenotypes of single mutants are different from each other but are additive in 
double mutants (Yan et al., 2005). Therefore, it is possible that sox1a and sox1b in zebrafish 
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have subdivided more ancestral functions. Alternatively, it is possible that both sox1a and 
sox1b genes have retained similar functions in zebrafish, but their expression is regulated 
differently. In case of another zebrafish sox ortholog pair, sox11a and sox11b, the sequence 
of their enhancers has evolved to varying degrees, but the sequence of the genes has 
remained similar, and as a result expression of the genes is regulated differently, but the 
resulting proteins have similar functions (Navralitova et al., 2010). Given the difference 
between expression of sox1a and sox1b in response to loss of gata2a, gata3 and tal1, it is 
likely that sox1a and sox1b genes are regulated differently. To test whether they have 
different functions, mutants of sox1a and sox1b would be needed, which are not available at 
this time. 
4.2 foxn4 is expressed by early V2 cells 
foxn4, as explained in the introduction, is probably expressed by zebrafish V2 cells 
relatively early, as shown by co-expression of foxn4 and vsx1 mRNA in the Tg(vsx1:GFP) line 
at 18hpf (Kimura et al., 2006). It is interesting, however, that Tg(vsx1:GFP) labeled V2a cells 
so early, as in my experiments I could not clearly see spinal cord cells at 24hpf, and only 
sporadic cells were labeled at 27hpf. Also, my double in situ hybridization labeling shows 
that foxn4 is co-expressed with gata2a, with all the cells that are foxn4-positive expressing 
also gata2a. However, there are many cells that are not foxn4-positive that express gata2a. 
This means that either only a subset of gata2a-expressing V2b cells express foxn4, or that 
most likely foxn4 is expressed early in V2b cells and then downregulated. In this case, the 
foxn4-negative, gata2a-positive cells would represent more mature V2b cells. Double ISH 
co-labeling with some of the p2 progenitor/very early V2 cell markers nkx6.1 and nkx6.2 is 
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consistent with this hypothesis, as many foxn4 cells still express both of those markers. 
Therefore, I postulate that foxn4 is expressed early by V2b (and V2a) cells, but its 
expression is transient and quickly downregulated as the cells progress to more mature 
stages.  
As discussed in the introduction, in mouse, Foxn4 is expressed in cells that are 
common precursors of both V2a and V2b cells, while in chicken there is a significant 
overlap between expression of Foxn4 and Gata2-expressing V2b cells, but no overlap with 
Vsx2-expressing V2a cells (delBarrio et al., 2007).  In both mouse and chicken Foxn4 plays a 
crucial role in specification of V2b cell fate (Fig. 3; Li et al., 2005; delBarrio et al., 2007; 
Misra et al., 2014). Foxn4 is both required for Tal1 expression in mouse and sufficient to 
induce Tal1 expression in chicken, while loss of Tal1 has no effect on expression of Foxn4 in 
mouse (delBarrio et al., 2007). Also, Foxn4 is sufficient to induce Gata2 and Gata3 
expression in chicken embryos, with Gata2 expression observed before Tal1 and Gata3 
expressions (delBarrio et al., 2007). Also, the number of Vsx2-expressing V2a cells 
decreases in chicken after forced expression of Foxn4 (delBarrio et al., 2007). In mouse, 
Foxn4 has recently been shown to be responsible for establishing and maintaining the 
Delta-Notch signaling that is crucial for development of V2a/V2b cells (Misra et al., 2014). 
This suggests that in amniotes, Foxn4 is upstream of Tal1, Gata2 and Gata3 during V2b cell 
differentiation, which is in agreement with my observations in zebrafish.  
Currently there is no zebrafish foxn4 null mutant available that would help to 
confirm whether foxn4 is upstream of other V2b genes. However, I investigated whether 
foxn4 expression is altered by absence of tal1 gata2a, or gata3. The number of foxn4-
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expressing cells in each of the three mutants does not change.  This supports the idea that 
foxn4 is upstream of tal1, gata2a, and gata3 during V2b formation. Also, previous research 
that attempted to investigate the role of foxn4 in V2b development of zebrafish shows that 
overexpression of full-length transcript in embryos results in roughly a 25% increase in the 
number of GABAergic V2b cells, and a similar decrease in the number of Tg(Vsx2:GFP) V2a 
cells (Li Lin, 2008 Master’s Thesis). This would further support the idea that foxn4 is 
responsible for the specification of V2b versus V2a cell fate in both zebrafish and amniotes. 
In addition, my results indicate that the dorsoventral position at which V2b cells are 
born might change over time. Alternatively, mature V2b cells might migrate in a similar 
way to V2a cells in zebrafish (Kimura et al., 2006). If foxn4 is expressed only transiently and 
early in differentiation of V2 cells in zebrafish, as it is in amniotes (del Barrio et al., 2007; 
Misra et al., 2014), my results would suggest that the dorsoventral position at which V2b 
cells form changes over time (Fig. 12), as more dorsal cells express foxn4 at later stages. At 
the same time, V2b cells at 24hpf are found in the same rows but also slightly more dorsally 
than foxn4-expressing cells at and/or before 24hpf, which would suggest that cells might 
migrate slightly dorsally to their final positions, after expressing foxn4. Also, the total 
number of cells that express foxn4 changes only slightly, with about 15-17 cells on average 
expressing foxn4 at any of the stages between 20hpf-30hpf that I examined. Since foxn4 is 
expressed only in a subset of cells that express V2b markers, but V2b cells are present in all 
rows where foxn4 is expressed, I think foxn4 may be transiently expressed in forming V2b 
cells. Also, I think that young V2 cells that express foxn4 are born more dorsally, but later 
might also migrate slightly more dorsally before becoming fully mature. Given that some 
V2 cells are ventral to foxn4-expressing cells at 24hpf (Fig. 12; Fig. 32; Table 7), I propose 
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that these cells could be older V2b cells born from early foxn4-expressing cells that had 
already migrated but do not continue to move to even more dorsal positions. This would be 
partly consistent with observations of Kimura and colleagues which show that more dorsal 
V2a cells are older than ventral V2a cells (Kimura et al., 2006). As described earlier, the tool 
used by this team was Tg(vsx1:Kaede) zebrafish line that labels vsx1-expressing cells and 
enables conversion of the Kaede chromophore from green to red at specific times (Kimura 
et al., 2006). vsx1 labels V2a cells, but is expressed relatively early in V2 differentiation, 
together with foxn4 and gata2a (Kimura et al., 2006). Since red (older) cells were found 
more dorsally, the result was interpreted that V2a cells are born ventrally and then migrate 
dorsally (Kimura et al., 2006). In addition my results suggest that the position of early V2 
cells that express foxn4 becomes more dorsal. It is possible that in previous experiments 
even some of the Tg(vsx1:Kaede) cells were being born more dorsally (Kimura et al, 2006), 
but then after conversion of chromophore they migrated even further to their final 
positions. Even though my interpretation of the results differs from the one presented in 
the paper describing V2a migration (Kimura et al., 2006), both scenarios are possible given 
the available data, and my results support the hypothesis that at least part of the migration 
of V2 cells occurs before the cells become fully differentiated.  
Finally, my results suggest that V2b cells are still forming at 30hpf, based on the 
premise that foxn4 is expressed by early V2 cells. The similarity in the total number of 
foxn4-expressing cells suggests that the V2 cells differentiate in similar numbers at 20hpf, 
22hpf, 24 hpf, 27hpf and 30hpf. The slight increase in total numbers of cells labeled by 
foxn4 at later stages might suggest that even more V2 cells form at later stages, as 
compared to earlier stages. This would be in agreement with the evidence for 
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differentiation of V2a cells at later stages, as vsx2 (also known as vsx2, another V2a marker) 
mRNA can be detected as late as 48hpf (Kimura et al., 2006). Also, vsx2 expression at late 
stages (e.g. 32hpf) is found relatively dorsally to that of earlier stages (Kimura et al., 2006). 
Since V2a and V2b cells are born simultaneously by the Notch-signaling-mediated lateral 
inhibition mechanism (Kimura et al., 2008; Batista et al., 2008), it is likely that V2b cells are 
also born at stages past 24hpf. Alternatively, it is possible that at stages other than 24hpf 
cells other than V2 cells express foxn4 in zebrafish, but currently there is no evidence that 
would support this. Previous study of foxn4 expression in zebrafish mentions that ‘no 
staining in neural tube is seen after neuronal differentiation is completed’ (Danilova et al., 
2004), it is unclear however what the authors meant by this, and even though later stages 
were investigated, no spinal cord photographs past 22hpf are provided. Perhaps, 
investigation of expression pattern at even later stages and/or double ISH experiments 
with V2b and/or other spinal cord cell markers at later stages could resolve which cells 
express foxn4 past 24hpf. 
4.3 Regulatory network that leads to formation of KA” cells 
As described in the introduction, KA” and KA’ cells, contact the central canal and are 
important for regulation of swimming behaviors in zebrafish (Wyart et al., 2009). Both of 
these cell types express tal1, gata2a, gata3 (Batista et al., 2008), as well as tal2 (Pinheiro et 
al., 2004) and sox1a and sox1b (this thesis) and are GABAergic (Bernhardt et al., 1992). 
Previous knockdown studies in zebrafish suggested that KA” cells depend on gata2a but 
not on gata3 for their correct specification (Yang et al., 2010). Also, the GABAergic 
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phenotype of KA” cells may require tal2, but tal2 is not required for expression of other KA” 
markers such as gata3 or gata2a (Yang et al., 2010). 
Interestingly, gata3 seems to be expressed more weakly in KA” cells of wild-type 
embryos than in more dorsally located cells (Neave et al., 1995; Figs 6A, 18A, 21A, 25A in 
this thesis), which might potentially reflect its function in KA” cells. However, no similar 
difference between levels of expression in different types of cells was observed for tal1 or 
gata2a. 
My results using single mutants show that tal1 and gata3 are not required for 
correct formation of KA” cells, but gata2a is required for expression of most KA” markers. 
The KA” phenotype in gata3 mutants is consistent with the morpholino knock-down 
phenotypes described above, but the gata2a mutant phenotype differs in certain aspects 
(Yang et al., 2010). My data show that gata2a is required for the correct expression of the 
majority of KA” markers since tal1, gata3, sox1a, as well as the GABAergic phenotype of the 
cells are all lost in row 1 of gata2a mutant zebrafish. Interestingly though, both tal2 and 
sox1b expression are retained in gata2a mutant embryos.  
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Figure 33. Schematic representation of possible genetic hierarchies in KA”, KA’ and 
V2b cells. Schematics show the potential genetic hierarchies that regulate development of 
KA” cells (A), KA’ cells (B), and V2b cells (C), based on results presented in this thesis. 
Arrows indicate genes that appear to be downstream of each other. Black color represents 
interactions with strong supporting evidence, and grey arrows represent potential 
interactions that are less strongly supported.  Further investigation will be necessary to 
test the latter and reveal remaining interactions. 
 
 
180 
 
  
 
The fact that expression of tal2 is retained in KA’’ cells in gata2a mutants is in sharp 
contrast to previous knockdown studies, where tal2 was lost in row 1 in gata2a morphants 
(Yang et al., 2010). Yang et al., 2010 propose that tal2 is downstream of gata2a in KA” cells, 
as gata2a morpholino injections abolished expression of tal2 in these cells, but tal2 
morpholino injections did not affect expression of gata2a in KA” cells.   
The differences between my results and the results of Yang and colleagues could 
have several explanations. First, it is possible that the morpholino injections exhibited off-
target effects that are additional to abolishment of gata2a function, and that the effect is, 
therefore, not seen in gata2a mutants. We know that many morpholinos are prone to 
exhibiting such off-target effects, as the amount of morpholino injected is often in 
overwhelming excess of target RNA that is available for binding (Bedell et al., 2011; 
Shulte-Merker and Steiner, 2014). Given the difficulty in distinguishing the effects of off-
target binding phenotype from the phenotype of knocking down the target mRNA function, 
it is strongly recommended that the mutant phenotype takes precedence over a 
morpholino-based phenotype (Schulte-Merker and Steiner, 2014). In case of tal2 marker, 
the phenotype of tal2 expression in KA” cells caused by knocking down gata2a with 
morpholinos is not validated by my observations in the gata2a mutant. 
In addition, we know that tal2 is expressed in KA” cells, but that also a subset of 
tal2-expressing cells co-expresses nkx2.2b, indicating that tal2 is also expressed in 
progenitor p3 cells (Schafer et al., 2007). It is possible that if KA” cells do not form in 
gata2a mutant embryos, those cells might be still ‘locked’ in their very late p3 state from 
which the KA” form. In that case, the cells would express the tal2 marker, but not have a 
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mature KA” identity. In this case the tal2-expressing cells in gata2a mutants could be very 
early KA” cells, that do not express other transcription factors normally expressed by these 
cells. This scenario would mean that, contrary to the mechanism proposed by Yang et al., 
2010, tal2 is either upstream of gata2a in formation of KA” cells, or its expression is 
independent of gata2a.  
tal2 is also expressed by V3 cells in zebrafish that express sim1a (Schafer et al., 
2007), and by Sim1-expressing V3 cells in mouse (Zhang et al., 2008). However, since V3 
cells do not form until later stages of development (Schafer et al., 2007), the lack of change 
in tal2 expression at 24hpf is unlikely to be related to V3 cells. It would be interesting to 
test whether a mutation in gata2a would cause KA” cells to change into V3 cells by 
examining expression of sim1a. Previous studies suggest that at 48hpf morpholino knock-
down of gata2a or of gata3 does not affect vglut2.1 or sim1a expression, however most of 
these results were ‘data not shown’ (Yang et al., 2010) and I was not that convinced by the 
data that was shown. The researchers do not show the effect of gata3 morpholino 
injections, and in gata2a-morpholino injected embryos only vglut2.1 result is shown, which 
looks to me from photographs like it might be expressed more strongly and/or by more 
KA” cells (Yang et al., 2010, Supplementary Materials Fig. 2).  
 A similar mechanism to that proposed above could also explain the retention of 
sox1b expression in gata2a mutants. If sox1b is also expressed early in KA’’ cell formation in 
p3 cells, it might be still expressed in the absence of gata2a. In this case, I would 
hypothesize that sox1a, in contrast, is expressed only later in KA” cells and not in p3 cells, 
as this could explain why gata2a mutants lose expression of sox1a but not sox1b in KA” 
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cells. Alternatively, it is possible that the regulation of these sox1a genes differs in KA” cells, 
and only one copy of Sox1 ortholog (sox1a) is regulated by gata2a in specification of KA” 
cells. It would be interesting to see whether abolishment of sox1b (but not of sox1a) results 
in abolishment of KA” formation, to test whether sox1b is upstream of gata2a or acts 
independently of it. However, as mentioned before, currently there are no mutant strains of 
sox1a/b are available and only knockdown experiments would be possible. 
Finally, it is possible that the loss of Gata2a function in our mutant is not complete 
and that even though the DNA-binding function is lost, the transcription factor still exerts 
part of its function by for example binding to other transcription factors. Given that the 
phenotype seen seems specific to KA” cells and, aside from tal2 marker expression, 
resembles the morpholino- based studies, I think it is more likely that the mutant we used 
is a null allele and the phenotype is the consequence of complete loss of gata2a.  
Taken together, based on the results obtained in this study I propose that gata2a is 
required for the correct formation of mature KA” cells and their GABAergic phenotype. 
Gata2 is upstream of tal1, gata3, and sox1a, and in the absence of Gata2 function KA” cells 
do not properly differentiate as functional inhibitory cells. However, gata2a is either 
downstream of tal2 and sox1b, or those markers participate in an alternative, gata2a-
independent pathway in formation of KA” cells. 
4.4 Regulatory network that leads to formation of KA’ cells 
As discussed earlier, KA’ cells are primarily found in row 2 in zebrafish spinal cord, 
but can also occasionally be found in row 3 where, if located medially, they still access the 
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central canal with their sensory tuft (Dr. Claire Wyart, personal communication; Djenoune 
et al., 2014). KA’ cells differ from KA” cells in their dorsoventral position and origin, as they 
are born from the same progenitor domain as motoneurons (pMN progenitor domain) 
(Park et al., 2004). Just like KA’’ cells KA’ cells express gata2a, gata3 and tal1 (Batista et al., 
2008), tal2 (Pinheiro et al., 2004; Schafer et al., 2007) as well as sox1a and sox1b (this 
thesis), and the cells are GABAergic (Bernhardt et al., 1992). 
Loss of Gata2a does not have an effect on the expression of the majority of KA’ cells 
in zebrafish spinal cord, which is consistent with previous morpholino knockdown results 
(Yange et al., 2010). Interestingly, my cell counts show, however, that there is a small loss 
in the number of GABAergic cells in row 2 of gata2a mutants, compared to their wild-type 
siblings (Fig. 19). This suggests that perhaps not all of the KA’ cells are able to become 
GABAergic in the absence of Gata2a. However, this result is slightly different from the 
previous knockdown study, which showed that KA’ cells are still GABAergic after injections 
with gata2a morpholino (Yang et al., 2010). However, since the reduction in KA’ cells that 
express gads that I observed in gata2a mutants is relatively small, it could have been easily 
missed by the team of Yang and colleagues as they didn’t count cells (Yang et al., 2010). 
Also, since only about half of the GABAergic cells are affected in gata2a mutants, future 
work should probably repeat this experiment to confirm that this phenotype is not due to 
subtle differences in embryo stages. I took great care during the staging and fixing 
processes of my experiments to make sure that embryos were always at 24hpf, however it 
is possible that subtle variabilities in stage may have sometimes occurred due to small 
changes in the temperature of the incubator and/or other variables.  
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However, similar phenotypic changes in KA’ cells of gata2a mutant was found with 
sox1a marker. Since the expression of sox1a is almost completely abolished in row 2 of 
gata2a mutants, it suggests that gata2a is required for correct expression of both sox1a and 
GABAergic phenotypes in KA’ cells. Given that sox1b expression remains unaffected in the 
KA’ cells, it again suggests that those two co-orthologs are differently regulated in specific 
cell types of the zebrafish spinal cord.  
While gata2a is required for sox1a expression and potentially the GABAergic 
phenotype of KA’ cells, it most likely acts downstream of tal1 and gata3 in these cells, since 
gata2a expression is abolished in KA’ cells in both tal1 and gata3 mutants. Loss of tal1, 
causes loss of all markers of KA’ cells (Figs. 21-24), placing it near the top of the genetic 
hierarchy that leads to formation of KA’ cells. In addition to counting cells in each 
dorsal/ventral spinal cord row, I repeated my cell counts to distinguish between lateral 
V2b cells and medial KA’ cells in row 3. These analyses showed that in tal1 mutants only 
very sporadic cells could be found that might be a KA’ cell. Similarly, loss of gata3 leads to 
the abolishment of all examined markers that label KA’ cells: no medially located cells in 
row 2 or 3 express any KA’ markers (Fig. 33). This is consistent with morpholino 
knockdown results, which show that abolishment of gata3 results in loss of tal2 and 
GABAergic markers in KA’ cells (Yang et al., 2010). Based on those published results, and 
on the loss of expression of additional markers in KA’ cells in the gata3 mutants, it appears 
that gata3 is required for the specification of the global cell fate of KA’ cells. In addition, my 
results show that tal1 is required for the specification of the global cell fate of KA’ cells, 
which is the first time that tal1 has been shown to be required for KA/ CSF-cN specification 
in any vertebrate. 
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Interestingly loss of tal1 also results in loss of tal1 expression in KA’ cells but not in 
other cells, suggesting that most likely KA’ cells are lost. A similar observation was made in 
gata3 mutants in which gata3 expression seems to be reduced in KA’ cells. However, in 
gata3 mutant all the other cells also expressed gata3 much more weakly when compared 
to the sibling embryos, which might indicate that gata3 RNA is subject to nonsense 
mediated decay in gata3 mutants. Since expression of both tal1 and gata3 as well as all 
other KA’ markers are lost in KA’ cells of both single mutants, both tal1 and gata3 are 
required on their own for correct formation of KA’ cells. It would be interesting to see 
whether those cells die, or whether KA’ cells become other cells in absence of tal1 and 
gata3. Since, as mentioned before, KA’ cells form from the same progenitor domain as 
motoneurons do (Park et al., 2004), it would be interesting to see whether number of cells 
that express motoneuron markers (e.g. islet1/2) increases in tal1 and gata3 mutants.  
 It would be also interesting to see whether tal1 and gata3 act together in 
specification of KA’ cells by forming a larger complex, or whether they act independently of 
each other to specify KA’ cells. Studies that involve investigation of protein-protein 
interactions, such as co-immunoprecipitation experiments, would be needed to answer this 
question directly.  
It is also possible that a larger complex that includes Gata3 and Tal1 forms in KA’ 
cells, given that in other tissues similar complexes form. For example during blood 
development, TAL1 and GATA proteins (e.g. GATA-1), are known to form complexes. TAL1 
has an ability to bind to E-boxes (consensus sequence CANNTG) (Church et al., 1985), the 
boxes are however sometimes positioned in a way that also requires both TAL1 and GATA 
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protein binding to DNA for transcriptional activity (Tripic et al., 2009). In those cases, 
binding of both TAL1 and GATA proteins together enables formation of a larger complex 
that may include nuclear non-DNA binding proteins (e.g. lmo2), and only then downstream 
genes can be expressed (Wadman et al., 1997). Also, sometimes TAL1 is required for 
transcriptional activity but acts as a cofactor, and does not need to directly bind to DNA. 
For example, TAL1 acts together with GATA3 (and LMO) in T-cell acute lymphoblastic 
leukemia, where the full complex binds to DNA through the GATA site, and TAL1 must be 
present in the GATA3-LMO-TAL1 complex for full transcriptional activity to take place (Ho 
et al., 1998). Also, GATA protein binding has a large influence on binding specificity and 
mode of action of TAL1 (repression/activation of target gene expression), and the binding 
of GATAs appears to regulate the ability of TAL1 to activate or repress transcription 
depending on the cell type in mouse cell cultures (Tripic et al., 2009; Wu et al., 2014). In 
fact, binding of GATA proteins appears to be a stronger determinant of specific TAL1 
binding than even the presence of E-boxes to which TAL1 binds in mouse blood cell 
cultures (Ono et al., 1998; Wu et al., 2014). It is therefore possible that in zebrafish spinal 
cord Gata3 and Tal1 act together in specification of KA’ cells, especially since my results 
show largely similar phenotypes in KA’ cells resulting from either loss of tal1 or gata3. 
However, it is not possible to conclude based on my results whether Tal1 acts as a co-factor 
for Gata3 transcription factors, or whether they bind to DNA independently. Given that 
both DNA-binding domains are truncated in the mutants, both scenarios are possible and 
could result in a similar phenotype. More mechanistic studies, such as experiments 
involving ChIP analysis would enable to better understand this process in KA’s of zebrafish. 
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Overall, my results are in agreement with the knockdown experiments that suggest 
that abolishment of gata3 in zebrafish embryos leads to the loss of KA’ cells (Yang et al, 
2010). My research confirms this as all of the genes I examined are lost in KA’ cells in gata3 
mutant embryos. Similarly, my results confirm that gata2a is dispensable for KA’ 
specification, with two major exceptions. First, GABAergic specification, which was 
unaffected in morpholino-injected embryos (Yang et al., 2010), is abolished in about half of 
the row 2 cells in gata2a mutants (Fig. 19). Also, the expression of sox1a is reduced in 
gata2a mutants. These two results, suggest some aspects of KA’ differentiation might be 
affected by loss of gata2a. In addition, loss of tal1 leads to abolishment of KA’ cells in all 
cases, which is a phenotype not described by any previous studies. I conclude that tal1 and 
gata3 are required for correct KA’ specification, while gata2a is dispensable for formation 
of KA’s but might be required for the expression of sox1a and the KA’ GABAergic 
phenotype. 
4.5 Regulatory network that leads to formation of V2b cells 
To determine the functions of tal1, gata2a and gata3 in V2b cell specification I 
examined expression of genes expressed by these cells in the single mutants for each of 
these genes. V2b cells are most extensively studied of the three cell types I investigated 
during this thesis. As mentioned before, they express Tal1, Gata2 and Gata3 in amniotes 
(Karunaratne et al., 2002; Peng et al., 2007; delBarrio et al., 2007) and in zebrafish (Batista 
et al., 2008; Kimura et al., 2008). Tal1 is expressed in amniotes soon after the beginning of 
V2b differentiation, after a progenitor cell differentiates into a V2a and V2b cell and the V2a 
cell downregulates Gata2 (Smith et al., 2002; Muroyama et al., 2005). In mouse ventricular 
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zone of the spinal cord, all of the cells that express Tal1 express Gata2, with some cells 
present that express only Gata2 (Peng et al., 2007). Gata3 in amniotes is expressed by the 
most mature V2b cells, and is an established marker of V2b cells, marking most laterally 
located post-mitotic inhibitory V2b neurons (Smith et al., 2002, Karunaratne et al., 2002, Li 
et al., 2005, Muroyama et al., 20005). In zebrafish V2b cells, tal1 and gata2a begin to be 
expressed between 16-somite stage and 18-somite stage, while gata3 is expressed later 
(after 18-somite stage), but at 24hpf the cells express all three of those markers (Batista et 
al., 2008).  
In this thesis, as discussed above – I also show that sox1a and sox1b are expressed 
by at least some V2b cells although they may also be expressed by additional cells. Also, I 
confirm that tal2 is expressed in a subset of V2b cells. Therefore, in addition to gata2a, 
gata3 and tal1 I also examined expression of sox1a, sox1b and tal2 in potential V2b cells in 
each of the three single mutants. 
The changes in expression of known V2b markers (i.e. tal1, gata2a and gata3 
markers) in each of the three mutants are always relatively small, with no more than half of 
the cells being lost in the V2b domain. This suggests that redundancy may exist between 
these transcription factors. Interestingly, my results also show that the expression of some 
genes is lost whereas others are retained in V2b cells in mutant embryos, which suggests 
that neither tal1, gata2a nor gata3 are required for global V2b specification. My single 
mutant results allow me to draw some conclusions about V2b development but do not fully 
explain the genetic hierarchy between tal1, gata2a and gata3 in these cells.  
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In V2b cells in gata2a mutants, the only phenotypes observed are small changes in 
GABAergic phenotype, as well as in gata3 expression. Given however that only an average 
of about 3 cells lost expression of either gads or gata3, these differences may not be very 
meaningful. For example, gata2a mutants show slightly more GABAergic cells in row 3 as 
compared to the wild-type, which might mean that overall number of V2b cells stays the 
same and the small differences are due to errors in determining the cell row that a cell is 
present in.  It is however possible that the loss of a few cells might reflect a genuine 
regulation of gata3 and/or gads by gata2a, although in this case the effect is subtle. I 
counted cells in only 4 embryos in this particular case, so perhaps looking at more embryos 
or repeating this experiment could re-confirm the conclusion of this result. No significant 
change was found in expression of other markers (tal2, sox1a, sox1b, tal1 and foxn4) in the 
V2b domain of gata2a mutant.  
These results are in sharp contrast to amniotic spinal cord, where Gata2 is required 
for specification of both V2a and V2b cells, as at early stage of mouse embryonic 
development (E10.5) both Vsx2 and Gata3 are attenuated in mouse Gata2 mutant (Fig.3, 
Zhou et al., 2000; Francius et al., 2014). However, later stage studies in mouse mutant are 
not possible due to early lethality of embryos right around E10 (Zhou et al., 2000). 
However, conditional knockout of gata2a results in co-expression of both Vsx2 and Gata3 
markers by the same cells at a later stage, showing that gata2a plays an important role in 
the correct decision between V2a and V2b fate (Francius et al., 2014). Interestingly, cells 
still express Gata3 and Vsx2 in the conditional mice in what appears to be larger numbers 
than in null Gata2 mutant, but unfortunately the comparison of those numbers is not 
provided (Francius et al., 2014). It is possible that at least some of the mutant phenotype 
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observed in mouse is related to disruptions and/or slight delay in overall mutant 
development, which does not happen in the conditional knockout mouse. Nevertheless, it 
seems that in absence of Gata2 V2b cells do not form correctly in mouse (Zhou et al., 2000; 
Francius et al., 2014). It cannot be ruled out that gata2a plays a similar role in zebrafish, 
and that even though number cells that express V2b markers does not change, those cells 
might in addition express V2a markers.  
Also, my data suggests that loss of tal1 results in slightly reduced gata3 expression, 
but gata2a expression is not significantly affected in V2b cells. This indicates that tal1 may 
be partly required for gata3 expression or maintenance. Since the gata3 mutation also 
results in a loss of about half of tal1-expressing cells, it is possible that a regulatory 
feedback loop might exist between those genes. In addition, it is also possible that both 
Tal1 and Gata3 operate together in a complex that maintains expression of their own genes, 
as discussed later.  
 This is again in sharp contrast to the mechanism showed in mouse, where nerve-
tissue specific loss of Tal1 results in attenuation of Gata2, and complete loss of Gata3 
expression (Muroyama et al., 2005). Also, in chicken, Tal1 is sufficient to induce GATA3 
expression, while causing attenuation of V2a marker VSX2 (Muroyama et al., 2005; Peng et 
al., 2007). My results suggest that tal1 on its own is not required for gata2a expression, 
while gata3 may only partly depend on tal1 in zebrafish V2b cells. It is however interesting 
that in the manner similar to mouse described above, I also see a more drastic change in 
the expression of gata3 than in gata2a expression in tal1 mutant. This suggests that tal1 
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might be important for maintenance of at least gata3 expression, in which case 
experiments at a later stage would show a more prominent change in phenotype.  
Interestingly, mutation in tal1 results in an almost complete loss of sox1b expression 
in V2b cells. At the same time, V2b cells still express sox1a.  This suggests that tal1 is 
upstream of sox1b but not of sox1a in V2b cells. This is another case where sox1a and sox1b 
are regulated differently in specific cell populations. Also, in tal1 mutants, tal2 expression is 
completely abolished in the few cells that would normally belong to the V2b domain at 
24hpf, but also earlier at 22hpf and later at 27hpf. In addition, the GABAergic phenotype is 
lost in most cells dorsal to row 4. Since there are cells that are GABAergic dorsally to row 4 
that don’t belong to the V2b population (e.g. V1 cells, where tal1 is not normally 
expressed), it is likely that some of those remaining cells are not V2bs. However, as also I 
explained in the results section, the remaining expression of gads is generally weaker in 
any cells that are not KA”s, which might be a result of embryos being generally a little 
sicker and/or the other cells not forming correctly in absence of other cells that would 
normally be in the spinal cord. Since KA” cells still express gads normally, as discussed 
before, it is however unlikely that the tal1 mutant embryos are sick, unless those cells 
would form early enough not to be affected. Overall, it appears that tal1 is required for 
expression of sox1b and tal2, and for correct specification of GABAergic phenotype in the 
V2b cells. 
This is interesting, since Tal1 (otherwise known as Scl) and Tal2 are closely related, 
and at least Tal1 is known to form transcriptional complexes with GATA proteins that 
specify of many cell types, most notably blood (Bockamp et al., 1994; Tripic et al., 2009). 
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However, in developing mouse midbrain, a conditional knockout of Tal1 does not affect the 
expression of Tal2 (and other markers of GABAergic neurons of that region, including 
Gata2 and Gata3) (Achim et al, 2013). However, knockout of Tal2 abolishes expression of 
Tal1 and reduces Gata2, Gata3, expression and the GABAergic marker Gad1 (Achim et al., 
2013). The double Tal1/Tal2 knockout does not have a more severe effect on Gata2/3, but 
completely abolishes the GABAergic phenotype of those cells. This suggests that at least in 
some GABAergic midbrain cells, Tal2 is responsible for expression of Tal1, and that both of 
those transcription factors are required for correct specification of GABAergic midbrain 
cells (Achim et al., 2013). It is possible that Tal2 and Tal1 play similarly complementary 
roles in specification of the GABAergic phenotype of V2b cells in spinal cord, but their 
dependence on each other is reversed. My results indicate that at least in V2b cells, tal1 
(tal1) regulates expression of tal2.  This might mean that the loss of the GABAergic 
phenotype in those cells is due to lack of both tal1/tal1 and therefore tal2, or tal1 might be 
solely responsible for the change in GABAergic phenotype. Experiments that involve 
abolishment of tal2 would be necessary to distinguish between those possibilities. 
Overall, it seems that in absence of tal1 V2b cells still form, but lose expression of 
some genes and their GABAergic phenotype. It is possible that sox1b and tal2 belong to the 
pathway that specifies the GABAergic phenotype of V2 cells, as their expression in these 
cells is also lost in tal1 mutants. This result is in contract to gata2a and gata3 mutants 
where most V2b cells are still GABAergic. This suggests that Tal1 but not Gata2a or Gata3 is 
required for the GABAergic phenotype of V2b cells.  
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My results suggest that gata3 is also not required for expression of most V2b 
markers. However, subtle changes can be observed in expression of some of the V2b 
markers. Most strikingly, the number of tal1-expressing cells decreases by half in gata3 
mutant embryos (Fig. 26). This is the most drastic change in expression pattern observed 
in V2b cells in gata3 mutants, and it suggests that gata3 regulates expression of tal1 in V2b 
cells to some extent. The fact that tal1 expression is not completely lost could be explained 
by either compensation for lack of gata3 by another transcription factor (which could 
include Tal1 autoregulation or Gata2a), or it is possible that gata3 is only required for the 
maintenance of tal1 expression in V2b cells and that more cells would lose tal1 expression 
at later stages. gata2a expression is also affected in gata3 mutants, but to a much smaller 
extent (only about 3 cells are lost, which is a statistically significant difference). This might 
mean that some aspect of gata2a expression is regulated by gata3 in V2b cells, although it 
may also be just biological noise in my experiments.  
Interestingly, overexpression experiments in chicken suggest that GATA3 is 
sufficient to induce expression of GATA2 (Karunaratne et al., 2002). Also, both Gata2 and 
Gata3 have 5’ regulatory sequences that can bind other GATA-family proteins (Karunaratne 
et al., 2002).  Despite the fact that Gata3 has so far been considered to be the most terminal 
V2b marker in amniotes, it is possible that Gata3 regulates some aspects of Tal1 and Gata2 
expression in V2b cells. Investigation of the expression of tal1 and gata2a at later stages in 
gata3 mutant could resolve whether gata3 would be required for maintenance of tal1 
and/or gata2a expression. 
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Interestingly, gata3 mutants also lose about one-third of sox1b-expressing cells in 
rows 4 and above, while no change in sox1a expression is observed. In addition, both of 
those markers are lost in row 3 cells, where many cells are V2bs. This suggests that at least 
some V2b cells that express sox1b are lost in the gata3 mutant. If V2c cells exist in 
zebrafish, it is also possible that some of the lost cells correspond to V2c cells. However, it 
should also be noted that many more sox1a-expressing cells were observed than sox1b 
expressing cells in wild-type embryos from gata3 incross. Also, since about half of the tal1-
expressing cells and some of the sox1b-positive cells are lost in gata3 mutants, but almost 
all sox1b-expressing cells are lost in tal1 mutants in V2b domain, it is possible that sox1b 
expression is lost because tal1 not being present in the cells. In addition, I observed that 
some GABAergic cells are lost in V2b domains in gata3 mutants, and even more GABAergic 
cells were lost in tal1 mutants. If tal1 is required for GABAergic phenotype of V2b cells, and 
gata3 is required for correct tal1 expression in at least a subset of V2b cells, loss of 
GABAergic phenotype in V2b cells in gata3 mutants might be mediated by loss of tal1. 
Therefore, one possible interpretation of my results would suggest that gata3 is required 
for at least some aspect of tal1 expression, and loss of tal1 leads to loss of sox1b and 
GABAergic phenotype of V2b cells.  
Overall, I propose here that the mechanism of V2b specification in zebrafish differs 
from the mechanism in amniotes. Most notably, none of the genes tal1, gata2a or gata3 are 
required for correct expression of tal1, gata2a or gata3 or global specification of V2b cells 
on their own. Instead, I propose that in V2b domain of zebrafish spinal cord at 24hpf, tal1 is 
required for correct expression of sox1b, tal2 and the GABAergic phenotype of the V2b 
cells. Also, gata2a might be required for maintenance of gata3 expression to a small extent, 
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and gata3 is required for the correct expression (or maintenance of) about a half of tal1 
and sox1b expression in V2b cells. This is summarized in the schematic (Fig. 33C).  
In conclusion, my mutant analyses have provided novel insights into the regulatory 
network that specifies V2b and KA cells. Further research on double mutants, performed by 
Dr. Banerjee in the Lewis lab, will hopefully help us to even better understand the 
interactions between tal1, gata2a and gata3 and their roles in specification of these cells. 
4.7 Other candidate genes that may be expressed by V2b 
and/or KA cells 
The final aspect of this thesis that I will discuss is my analyses of other candidate 
genes that I thought might be expressed by V2b or KA cells. I will discuss my results for 
each of these genes in turn. 
4.7.1 crb1 
crb1 (crumbs family member 1, photoreceptor morphogenesis associated) encodes a 
transmembrane protein that is a member of the Crumbs family. crb1 was first identified in 
the apical membranes of fly epithelial cells, and recognized as an essential regulator of the 
epithelial cell polarity (Tepass et al., 1990). Proteins of the Crumbs family are known to 
exert their function by assembly of a larger Crumbs complex (Crb) to their intracellular 
domain, and by binding to other ligands via extracellular domain (Le Bivic, 2011; Pocha 
and Knust, 2013). Crb inhibits Notch signaling in the fly (Herranz et al, 2006) and during 
neurogenesis in zebrafish (Ohata et al., 2011). This is exciting, as KA (and V2b 
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specification) in zebrafish and mammals depends on Notch signaling. Expression and 
function of key Crumbs proteins, including Crb1, is well conserved between mammals and 
zebrafish, although in some cases differences exist (Le Bivic, 2011; Bulgakova and Knust, 
2009). 
In zebrafish, expression of crb1 has been identified in the developing brain and 
retina (Omori and Malicki, 2006).  Crb1 can be first detected in developing brain at 24hpf, 
with expression in the retina detected only after 48hpf (Omori and Malicki, 2006). Despite 
experiments being performed at the same developmental stage as my experiments, no 
expression was detected in the spinal cord (Omori and Malicki, 2006). Here, I show for the 
first time that crb1 is expressed in the zebrafish spinal cord at 24hpf and identify a subset 
of crb1-expressing cells as KA” and KA’ cells. My results show that expression of crb1 is 
restricted to the most ventral part of the zebrafish spinal cord, and that at 24hpf crb1 is 
expressed by all KA” cells and by at least a subset of KA’ cells. This is also exciting, as the 
crb1 appears to be one of the very few genes that are expressed solely by KA cells (and not 
V2b cells) in zebrafish spinal cord.  
In mammals, Crb1 is expressed in mouse developing brain, neural tube, and 
developing and adult retina cells (den Hollander at al., 2002). In mouse retina, Crb1 is 
essential for correct polarity and adhesion of specialized photoreceptors (Pellikka et al., 
2002) and glia cells (van de Pavert et al., 2007). Also, in humans mutations in the CRB1 are 
associated with multiple eye dystrophies (den Hollander et al., 2004).  Interestingly, in the 
mouse developing neural tube expression of Crb1 coincides with expression of Nkx2.2, with 
a slightly broader expression of Nkx2.2 than of Crb1 at E10.5 (den Hollander et al., 2002). 
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This was interpreted as Crb1 being expressed by mouse V3 cells (den Hollander et al., 
2002). My results suggest that in zebrafish, V3 (or their progenitor cells) might also 
express crb1, as cells located between the Tg(gata1:GFP) KA’’ cells in the p3/V3 domain 
express this gene. However, no expression of Crb1 was so far identified in cerebrospinal 
fluid contacting neurons (CSF-cNs) of mammals that correspond to zebrafish KA cells. If the 
expression of this gene is conserved between amniotes and zebrafish, my results suggest 
that this gene could potentially be expressed by mammalian CSF-cNs. Further functional 
analysis of this gene is also readily possible, as currently there are several zebrafish mutant 
strains available, and mouse mutants also exist. Given that this gene is expressed by KA 
cells it would also be interesting to see whether its expression is affected by mutations in 
tal1, gata2a or gata3. 
4.7.2 insm1a 
insm1a (insulinoma associated 1a) is a zebrafish ortholog of mammalian Insm1. In 
mammals, Insm1 encodes a transcription factor with five zinc finger domains, and the 
protein appears to be highly conserved between humans, mammals, zebrafish, frog and C. 
elegans (Lan and Breslin, 2009). INSM1 was first identified via screening human genetic 
libraries as a gene associated with the occurrence of insulinoma (Goto et al., 1992). Since 
then, it was shown to be expressed mainly by the nervous and endocrine tissues (Lan and 
Breslin, 2009), and in humans has been associated with at least 35 different types of 
neuroendocrine cancer, including lung, renal, pancreatic carcinomas, as well as 
neuroblastoma and retinoblastoma (Lan and Breslin, 2009). Previous research efforts have 
concentrated mostly on elucidating the role of Insm1 in development of neuroendocrine 
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cells of the brain and other body tissues, and the function in the spinal cord has not yet 
been analyzed (Lan and Breslin, 2009, Jia et al., 2015). 
In developing mouse, Insm1 is expressed in the endocrine cells of pancreas, the 
central and peripheral nervous system, as well as in olfactory epithelium, and it appears to 
be a pan-neuronal marker of developing neurons in the brain (Farkas et al., 2008; 
Osipovich et al., 2014). In the mouse olfactory epithelium, deletion of Insm1a results in 
formation of fewer neurogenic basal progenitors and more apical cells that give rise to 
additional progenitors (Rosenbaum et al., 2011). 
Similarly, loss of function experiments show an increase in number of apical 
progenitor cells in mouse cortex and other neuronal structures and loss of neurons, 
whereas gain-of-function experiments show that cell cycle progression is inhibited upon 
forced insm1a expression (Farkas et al., 2008). However, INSM1 is expressed by not only 
progenitors, but also nascent cells in mouse and human embryonic spinal cords (Duggan et 
al., 2008; Jacob et al., 2009). However INSM1 is only transiently expressed by post-mitotic 
neurons, and is not detected in fully differentiated neurons of either mouse or human CNS 
(Duggan et al., 2008). In addition, in mouse hindbrain, Insm1 acts upstream of Gata2 and is 
required for correct specification of the serotonergic neurotransmitter phenotype of cells 
(Jacob et al., 2009). 
Insm1a has two orthologs in zebrafish that arose during the whole genome 
duplication event in the teleost lineage - insm1a and insm1b. In this thesis, I only 
investigated expression of insm1a. insm1a and insm1b are both expressed in similar 
structures in the zebrafish, but differences can be found between their expression patterns 
199 
 
  
 
(Lukowski et al., 2006). At 24hpf, both co-orthologs insm1a and insm1b are expressed in 
the various structures of the brain including diencephalon and hindbrain, presumptive 
pancreas tissue and both are expressed by spinal cord cells (Lukowski et al. 2006). In the 
spinal cord, expression pattern of insm1b is broader than expression of insm1a. insm1a 
expression is restricted to ventral neurons of the spinal cord, whereas insm1b is expressed 
in three distinctive stripes across the dorsoventral axis (Lukowski et al., 2006). At this 
stage, both co-orthologs appear to be expressed specifically by neurons as their expression 
overlaps with the post-mitotic neuronal marker elavl3, but the expression of insm1b 
appears to be stronger in the cranial neurons than in the spinal cord (Lukowski et al., 
2006). Later in development, expression of only insm1a can be detected in zebrafish retina, 
where it appears to be transiently expressed between the 24hpf and 72hpf stages 
(Lukowski et al., 2006) and expressed much later in adult zebrafish photoreceptor cells 
(Morris et al., 2011). Knockdown studies have shown that insm1a is required for correct 
development of photoreceptor cells in the zebrafish retina (Forbes-Osborne et al., 2012), 
but no spinal cord phenotype was reported.  Interestingly, insm1a appears to be negatively 
regulated by Notch signaling (Forbes-Osborne et al., 2012), and the spinal cord KA and V2b 
cells I investigate in this thesis also depend on Notch signaling for their formation (Batista 
et al., 2008). It would be interesting to see whether expression of the insm1a in spinal cord 
also depends on Notch signaling, for example with use of Notch-deficient mindbomb 
mutant. 
My results show that insm1a is expressed in the zebrafish spinal cord in a pattern 
consisted with previously described expression (Lukowski et al., 2006). My analyses 
suggest that at least some of the insm1a-expressing cells are V2b and/or KA cells, as they 
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co-label with Tg(gata1:GFP)-positive cells. In future, labeling with markers of other cells 
would be needed to establish the identity of the remaining Tg(gata1:GFP)-negative insm1a-
positive cells. Since some V2b and KA cells express insm1a though, it would also be 
interesting to see whether this gene is affected by mutations in tal1, gata2a or gata3. 
4.7.3 her6 
her6 (hairy-related 6), a zebrafish ortholog of mouse Hes1, encodes for a bHLH 
transcription factor of the hairy-related Hes/Her family. These proteins often act as 
transcriptional repressors of neurogenesis and other processes (Kageyama et al., 2007). 
Hes1 appears to be required for the correct formation of neurons from radial glia in the 
mouse brain, and for formation of optic vesicles (Hatakeyama et al., 2004).  
The action of Her/Hes proteins often depends on Notch signaling (Kageyama et al., 
2007). For example, in mouse, Hes1 is expressed in various structures of the brain, where 
its expression can be either Notch-independent or Notch-dependent (Kageyama et al., 
2007). This is interesting, because as discussed above KA and V2b cell formation in 
zebrafish also depends on Notch signaling. In zebrafish brain, her6 expression in the brain 
appears to depend on Notch signaling, as in the diencephalon and hindbrain of mindbomb 
(mib) mutants, her6 expression is reduced (Cunliffe, 2004), but the spinal cord expression 
in this mutant was not described.  
Expression of her6 has been described in several zebrafish tissues, but spinal cord 
expression has not yet been described. Her6 expression in zebrafish can already be 
detected at 70% epiboly, with a segmental pattern of expression in the prospective 
forebrain, hindbrain, and the midline becoming clear near the tailbud stage (Pasini et al., 
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2001). Later during development, her6 is expressed in rhombomeres of the hindbrain, with 
the expression varying between specific rhombomere segments dependent on the stage 
(Pasini et al., 2001). Also, during somitogenesis, her6 can be found in the notochord, 
somites, and in the pre-somatic mesoderm (Pasini et al., 2001), where it is required for the 
expression of the cyclic genes that are involved in somite formation (Pasini et al., 2004). 
Also, in the zebrafish thalamus her6 appears to be required but not sufficient for the 
GABAergic phenotype of the neurons, and the cells adopt a glutamatergic phenotype in 
absence of her6 (Scholpp et al., 2009). In contrast, ectopic GABAergic cells form after forced 
expression of her6 via a heatshock mechanism, although this is thought to be achieved via 
resulting repression of neurog1 by her6 (Scholpp et al., 2009). 
During my rotation project, I showed that her6 is also expressed in zebrafish spinal 
cord. Also, another rotation student, Alex Nichitean, showed that her6 expression depends 
on Notch signaling in the spinal cord, as the expression of her6 in mib mutants is 
significantly reduced (data not shown). Since the expression of her6 appears to be located 
in domains where KA” and KA’ cells would be found, I further investigated whether this 
gene is expressed in these cells using double labels. In this thesis I show that her6 co-labels 
with Tg(gata1:GFP) positive KA cells, demonstrating that her6 is a novel marker of KA cells. 
This is exciting, as her6 appears to be the one of the very few transcription factors that are 
expressed by KAs but not by the V2bs. Further experiments will hopefully reveal whether 
her6 acts downstream of either tal1, gata2a or gata3 in KA formation. 
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4.7.4 mnx1 
mnx1 (motor neuron and pancreas homeobox 1; also known as Hb9) encodes for a 
transcription factor with a homeobox-binding domain. Expression of human MNX1 was 
first described in pancreas and lymphatic tissues (Najfeld et al., 1992; Harrison et al., 
1994). Mutations in this gene were later associated with Currarino syndrome (Ross et al., 
1998), in which erroneous secondary neurulation is thought to lead to a series of 
malformations around the sacral area. More recently, mutations in MNX1 were also found 
in association with neonatal diabetes cases (Bonnefond et al., 2013; Flanagan et al., 2014). 
In mouse, Mnx1 is required for correct specification of pancreatic β-cells and production of 
insulin (Harrison et al., 1999; Pan et al., 2015).  
Expression of this gene in the spinal cord was first described in frog, and was 
localized to motoneurons (Saha et al., 1997). Since then, studies have shown that Mnx1 is 
required for correct formation of motoneurons in both mouse and zebrafish (Tannabe et 
al., 1998; Arber et al., 1999; Seredick et al., 2012), and sufficient for specification of somatic 
motoneurons in chicken (Tannabe et al., 1998). Expression of Mnx1 in amniote spinal cord 
depends on Sonic hedgehog (Shh) signaling (Tannabe et al., 1998).  Also, in mouse Mnx1 is 
expressed by excitatory (glutamatergic) interneurons which are involved in locomotor 
networks (Kwan et al., 2009; Hinckley et al., 2010).  
In zebrafish spinal cord, mnx1 is expressed by both post-mitotic motoneurons and 
by V2b cells (Seredick et al., 2012). It is first expressed by V2b cells at 16hpf, but its 
expression persists until at least 24hpf (Seredick et al., 2012). However, mnx1 alone is not 
required for formation of primary motoneurons or V2b cells zebrafish (Seredick et al., 
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2012). Instead, knockdown analysis showed that mnx1 together with other mnx genes 
(mnx2a and mnx2b) are required for correct formation of a specific subtype of 
motoneurons (MiP) (Seredick et al., 2012). In absence of Mnx proteins, MiPs form V2a 
interneuron-like characteristics (Seredick et al., 2012). 
Since mnx1 is expressed by zebrafish V2b cells (Seredick et al., 2012), I was 
interested whether it might also be expressed by KA cells. The experiments in zebrafish 
show that mnx1 is not co-expressed with V2a marker vsx2 or with glutamatergic 
neurotransmitter markers, and that it is expressed by GABAergic cells (Seredick et al., 
2012). Since KA cells are also GABAergic, I was interested to see whether some of those 
cells express mnx1. I hypothesized that especially KA’ cells might express this gene, as both 
KA’ cells and motoneurons form from the same progenitor domain (Park et al., 2004). 
Alternatively, it would also be exciting if mnx1 was expressed by V2b cells but not KA cells, 
as all genes identified so far as being expressed by V2b cells are also expressed by KA cells. 
Therefore, mnx1 could potentially be a V2b-specific marker that distinguishes between 
those cell types. However, my experiments show that only very few Tg(gata1:GFP)-positive 
cells co-localize with mnx1, which could potentially be KA’ or V2b cells. Also, my results 
indicate that only some V2b cells express mnx1, as some cells with V2b-like morphology 
were observed that did not express mnx1. Given that mnx1 is not expressed by all V2b cells, 
and is also expressed by other cell types, I conclude that this gene is not a good V2b-specific 
marker.  
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4.7.5 sp8a 
sp8a (sp8 transcription factor a; formerly known as sp8) is a zebrafish ortholog of 
mammalian Sp8(specificity protein 8) gene. Homologous buttonhead (btd) gene was first 
identified in Drosophila, (Wimmer et al., 1993), and in this species it is responsible for early 
neurogenesis (Younossi-Hartenstein et al., 1997) and growth of appendages (Estella et al., 
2003). More recently, Drosophila btd was found to maintain the early progenitor state of 
intermediate progenitor cells and prevent their differentiation into more mature neurons 
(Xie et al., 2014). Also, in frog (X. tropicalis), sp8 controls development of the inner ear 
(Chung et al., 2014).  
In mouse, Sp8 is expressed in apical ectodermal ridge (AER), where it is required for 
dorsoventral patterning of the forming limb bud (Bell et al., 2003; Kawakami et al., 2004; 
Haro et al., 2014). In addition, in mouse brain Sp8 is required for correct formation of 
GABAergic neurons of the olfactory bulb (Waclaw et al., 2006). Also, expression of Sp8 was 
detected in amniote spinal cord, where it was located to the ventral domain (Bell et al., 
2003; Kawakami et al., 2004). Interestingly, in mouse spinal cord expression of Sp8 was 
further localized to a subset of Lhx3-expressing V2 cells, En1-expressing V1 cells and Olig2 
expressing motoneuron progenitor (pMN) cells (Li et al., 2014). Notably, none of the Sp8-
expressing cells co-expressed Gata3 V2b marker (Li et al., 2014), which is consistent with 
my finding in zebrafish that sp8a is most likely not expressed by V2b cells. Further analysis 
in amniotes reveals that Sp8 and Nkx2.2 co-repress each other, and that Sp8 acts together 
with Pax6 to establish the pMN/p3 boundary (Li et al., 2014).  
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In zebrafish, sp8a is present in the AER (Norton et al., 2005) and in regenerating tail 
fins (Stoick-Cooper et al., 2007). Also, expression in was described in the anterior neural 
tube, with especially strong staining in the midbrain/hindbrain boundary (Correa et al., 
2005). However, spinal cord expression in zebrafish was documented for the first time by 
the Lewis lab in a the direct data submission to ZFIN database (England et al., 2014). In this 
thesis, I show that sp8a does not co-localize with Tg(gata1:GFP) cells, which shows that this 
gene is not expressed by KA and most likely by V2b cells. Since it appears to be expressed 
approximately in a similar dorsoventral position to Tg(gata1:GFP), it is possible that this 
gene  is expressed by earlier V2, V1 cells and/or by pMN cells, as it is in mouse. Further 
analysis (e.g. by double in situ hybridization with markers of those cell types) could reveal 
whether sp8a expression in spinal cord is conserved between zebrafish and amniotes.  
4.8 Conclusions 
In this thesis I show that sox1a and sox1b, orthologs of mammalian Sox1, are 
expressed by V2b and KA cells in zebrafish spinal cord. My results also suggest that 
expression of sox1a and sox1b is regulated differently in KA”, KA’ and V2b cells.  
Also, I show that foxn4 is expressed by early V2 cells that express gata2a, and that 
the position of foxn4- expressing cells becomes more dorsal over time, but the total number 
of cells that express foxn4 does not drastically increase.  
In addition, I demonstrate the importance of gata2a, tal1 and gata3 for developing 
V2b and KA cells. My results indicate that gata2a is required for correct specification of KA” 
cells (either their global cell fate or expression of vast majority of markers), and that both 
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tal1 and gata3 are required for correct specification of global cell fate of KA’ cells. In 
addition, tal1 is required for the GABAergic phenotype and expression of tal2 and sox1b in 
V2b cells, but not for expression of many other genes normally expressed by these cells. My 
results also indicate that in zebrafish neither gata2a nor gata3 are required for correct 
specification of the V2b GABAergic phenotype or the global cell fate of these cells. Finally, I 
identify potential novel markers of KA and V2b cells: crb1 and her6 are expressed by KA 
and not by V2b cells, insm1a is expressed by a few members of both KA or V2b populations, 
mnx1 may be expressed by very few V2b and/or KA’ cells. All of those markers are also 
expressed by additional cells, and are, therefore, not specific to one population. However, 
her6 and crb1 could be good markers to distinguish KA cells from V2b cells. I also show that 
sp8a is not expressed by either V2b and/or KA cells at 24hpf in zebrafish.  
4.9 Future work 
Future work building on this research should answer remaining questions about 
V2b and KA development. For example, even though I show in this thesis that sox1a and 
sox1b are expressed by KA and at least some V2b cells, I was unable to show whether they 
are expressed by all V2b cells in zebrafish. Also, it remains to be investigated whether these 
genes are always co-expressed by the same cells, and whether either of them is expressed 
by additional cell populations in the zebrafish spinal cord. Hopefully, future double in situ 
hybridization experiments will answer these questions. In addition, I was not able to test 
whether V2c cells exist in zebrafish, and further experiments (as discussed in this thesis) 
would be needed to investigate this. Since sox1a and sox1b appear to be regulated 
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differently in KA”, KA’ and V2b cells, it would be also exciting in future to investigate 
whether those genes play different roles in specification of these cell types.  
It would also be interesting to investigate whether the transcription factors Tal1, 
Gata2 and/or Gata3 act together in specifying KA and/or V2b cells. To this end, 
investigation of double mutants in these genes are currently being carried by Dr. Santanu 
Banerjee in the Lewis lab.  Since my results show that gata2a is required for expression of 
most KA” markers (but not tal2 and sox1b), it would be interesting to see whether 
abolishment of either tal1 and/or gata3 in addition to gata2a results in a loss of tal2 or 
sox1b expression in KA’’ cells. Also, since my work shows that only tal1 is required for the 
correct specification of the GABAergic phenotype of V2b cells, it would be particularly 
interesting to see whether double mutant combinations of tal1, gata2a and gata3 affect this 
and/or other aspects of V2b cell development.  
I also hope that the novel markers that I identified for KA but not V2b cells (her6, 
crb1) will help with investigations of the mechanisms that specify KA cells. For a long time, 
more detailed investigations of KA cells in zebrafish have been hindered by a lack of 
molecular markers that are expressed specifically by these cells. However, a gene encoding 
for calcium-permeable polycystic kidney disease 2-like 1 (PKD2L1) channel, first 
discovered in heart, retina and kidney (Basora et al., 2002), has now been shown to be 
expressed in CSF-cNs of both brain stem and spinal cord in postnatal P1-P4 (Huang et al., 
2006) and adult (Orts-Del'immagine et al., 2012) mouse. PKD2L1 is conserved across 
vertebrates, and in the spinal cord it is specifically expressed by CSF-cNs in mouse and 
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macaque and KA cells in zebrafish (Djenoune et al., 2014).  In future, this KA-specific 
marker may also enable additional investigation of specification of KA cells in zebrafish.  
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Appendix Tables:  
Table 1. p-values of Student’s t-test comparison of cell counts of foxn4-labeled cells in wild-type embryos at 4 different 
developmental stages. Values correspond to Fig. 12. 4 embryos were counted in each case. Statistically significant differences 
(p<0.05) are indicated in bold. All statistical tests were performed with Student’s t-test. 
 
Developmental stage  
(in hours post-fertilization) 
p-value 
(Student's t-test) 
20vs22 0.700 
20vs24 0.093 
20vs27 0.172 
20vs30 0.063 
22vs24 0.100 
22vs27 0.069 
22vs30 0.042 
24vs27 0.386 
24vs30 1.000 
27vs30 0.266 
In bold: p<0.05 
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Table 2. p-values from pairwise comparisons of wild-type embryos from incrosses of tal1t21384, gata2aum27 and gata3sa0234 
heterozygous mutants. Values correspond to Figs 29 and 30. Statistically significant differences (p<0.05) are indicated in bold and 
are on the pink background. Values that approach significance threshold (p<0.065) are italicized and are on the light blue 
background. All statistical tests were performed with Student’s t-test.  
Wild-types from 
incross of: Marker 
Row number 
mutant 1 mutant 2 1 2 3 4 5 6 7 8 TOTAL 4+ 
gata2a tal1 gata3 1.000 0.100 0.423 0.048 0.175 0.129 N/A N/A 0.212 0.672 
gata3 tal1 gata2 0.053 0.228 0.181 0.390 0.673 0.017 N/A N/A 0.540 0.759 
tal1 gata2a 
scl 
0.086 0.183 0.488 0.279 0.011 0.018 0.058 N/A 0.012 0.009 
tal1 gata3 0.156 0.211 0.256 0.013 0.172 0.005 0.058 N/A 0.021 0.006 
gata2a gata3 0.488 0.055 0.552 0.095 0.033 0.147 N/A N/A 0.907 0.178 
tal1 gata2a 
sox1a 
0.169 0.116 0.178 0.939 0.046 0.027 0.428 N/A 0.000 0.059 
tal1 gata3 0.739 0.581 0.518 0.338 0.131 0.021 0.428 N/A 0.029 0.017 
gata2a gata3 0.098 0.086 0.071 0.178 0.765 0.229 0.067 N/A 0.067 0.375 
tal1 gata2a 
sox1b 
0.076 0.271 0.142 0.152 0.045 1.000 0.148 N/A 0.221 0.300 
tal1 gata3 0.362 0.127 0.519 0.539 0.418 0.360 0.041 N/A 0.439 0.349 
gata2a gata3 0.429 0.052 0.051 0.740 0.031 0.541 0.215 N/A 0.116 0.078 
tal1 gata2a 
tal2 
0.449 0.620 0.967 0.173 0.584 0.133 N/A N/A 0.260 0.159 
tal1 gata3 0.783 0.567 0.587 0.218 1.000 0.043 N/A N/A 0.360 0.842 
gata2a gata3 0.659 0.138 0.561 0.052 0.558 0.178 N/A N/A 0.096 0.165 
tal1 gata2a 
gads 
0.837 0.277 1.000 0.409 0.348 0.007 1.000 1.000 0.065 0.088 
tal1 gata3 0.878 0.055 0.811 0.010 0.455 0.016 0.161 0.188 0.048 0.124 
gata2a gata3 1.000 0.193 0.904 0.041 0.751 0.311 0.066 0.322 0.726 0.562 
tal1 gata2a 
foxn4 
N/A N/A 0.355 0.051 0.951 N/A N/A N/A 0.209 0.080 
tal1 gata3 N/A N/A 0.008 0.088 0.532 N/A N/A N/A 0.507 0.060 
gata2a gata3 N/A N/A 0.242 0.795 0.460 N/A N/A N/A 0.079 0.060 
211 
 
 
 
References 
Achim, K., Peltopuro, P., Lahti, L., Tsai, H. H., Zachariah, A., Astrand, M., Salminen, M., 
Rowitch, D. and Partanen, J. (2013) 'The role of Tal2 and Tal1 in the differentiation 
of midbrain GABAergic neuron precursors', Biol Open: Vol. 10. England, pp. 990-7. 
Al-Mosawie, a., Wilson, J. M. and Brownstone, R. M. (2007) 'Heterogeneity of V2-derived 
interneurons in the adult mouse spinal cord', The European journal of neuroscience, 
26(11), pp. 3003-15. 
Amores, A., Force, A., Yan, Y. L., Joly, L., Amemiya, C., Fritz, A., Ho, R. K., Langeland, J., Prince, 
V., Wang, Y. L., Westerfield, M., Ekker, M. and Postlethwait, J. H. (1998) 'Zebrafish hox 
clusters and vertebrate genome evolution', Science, 282(5394), pp. 1711-4. 
Arber, S., Han, B., Mendelsohn, M., Smith, M., Jessell, T. M. and Sockanathan, S. (1999) 
'Requirement for the homeobox gene Hb9 in the consolidation of motor neuron 
identity', Neuron, 23(4), pp. 659-74. 
Basora, N., Nomura, H., Berger, U. V., Stayner, C., Guo, L., Shen, X. and Zhou, J. (2002) 'Tissue 
and cellular localization of a novel polycystic kidney disease-like gene product, 
polycystin-L', J Am Soc Nephrol, 13(2), pp. 293-301. 
Batista, M. F., Jacobstein, J. and Lewis, K. E. (2008) 'Zebrafish V2 cells develop into 
excitatory CiD and Notch signalling dependent inhibitory VeLD interneurons', Dev 
Biol, 322(2), pp. 263-75. 
Batista, M. F. and Lewis, K. E. (2008) 'Pax2/8 act redundantly to specify glycinergic and 
GABAergic fates of multiple spinal interneurons', Dev Biol, 323(1), pp. 88-97. 
Bedell, V. M., Westcot, S. E. and Ekker, S. C. (2011) 'Lessons from morpholino-based 
screening in zebrafish', Brief Funct Genomics, 10(4), pp. 181-8. 
 
212 
 
  
 
Begley, C. G., Aplan, P. D., Denning, S. M., Haynes, B. F., Waldmann, T. A. and Kirsch, I. R. 
(1989) 'The gene SCL is expressed during early hematopoiesis and encodes a 
differentiation-related DNA-binding motif', Proc Natl Acad Sci U S A, 86(24), 
pp. 10128-32. 
Bell, S. M., Schreiner, C. M., Waclaw, R. R., Campbell, K., Potter, S. S. and Scott, W. J. (2003) 
'Sp8 is crucial for limb outgrowth and neuropore closure', Proc Natl Acad Sci U S A, 
100(21), pp. 12195-200. 
Ben-Ari, Y. (2002) 'Excitatory actions of GABA during development: the nature of the 
nurture', Nat Rev Neurosci, 3(9), pp. 728-39. 
Bernhardt, R. R., Chitnis, A. B., Lindamer, L. and Kuwada, J. Y. (1990) 'Identification of spinal 
neurons in the embryonic and larval zebrafish', J Comp Neurol, 302(3), pp. 603-16. 
Bernhardt, R. R., Patel, C. K., Wilson, S. W. and Kuwada, J. Y. (1992) 'Axonal trajectories and 
distribution of GABAergic spinal neurons in wildtype and mutant zebrafish lacking 
floor plate cells', J Comp Neurol, 326(2), pp. 263-72. 
Blacklaws, J., Deska-Gauthier, D., Jones, C. T., Petracca, Y. L., Liu, M., Zhang, H., Fawcett, J. P., 
Glover, J. C., Lanuza, G. M. and Zhang, Y. (2015) 'Sim1 is required for the migration 
and axonal projections of V3 interneurons in the developing mouse spinal cord', Dev 
Neurobiol, 75(9):1003-17. 
Bonnefond, A., Vaillant, E., Philippe, J., Skrobek, B., Lobbens, S., Yengo, L., Huyvaert, M., Cavé, 
H., Busiah, K., Scharfmann, R., Polak, M., Abdul-Rasoul, M., Froguel, P. and Vaxillaire, 
M. (2013) 'Transcription factor gene MNX1 is a novel cause of permanent neonatal 
diabetes in a consanguineous family', Diabetes Metab, 39(3), pp. 276-280. 
Borowska, J., Jones, C. T., Zhang, H., Blacklaws, J., Goulding, M. and Zhang, Y. (2013) 
'Functional subpopulations of V3 interneurons in the mature mouse spinal cord', 
J Neurosci, 33(47), pp. 18553-18565. 
 
213 
 
  
 
Briegel, K., Lim, K. C., Plank, C., Beug, H., Engel, J. D. and Zenke, M. (1993) 'Ectopic 
expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid 
differentiation in a hormone-dependent manner', Genes Dev, 7(6), pp. 1097-109. 
Briscoe, J., Pierani, A., Jessell, T. M. and Ericson, J. (2000) 'A homeodomain protein code 
specifies progenitor cell identity and neuronal fate in the ventral neural tube', Cell, 
101(4), pp. 435-45. 
Brown, C. R., Butts, J. C., McCreedy, D. A. and Sakiyama-Elbert, S. E. (2014) 'Generation of 
V2a interneurons from mouse embryonic stem cells', Stem Cells Dev, 23(15), pp. 
1765-76. 
Bucher, K., Sofroniew, M. V., Pannell, R., Impey, H., Smith, A. J. H., Torres, E. M., Dunnett, S. B., 
Jin, Y., Baer, R. and Rabbitts, T. H. (2000) 'The T Cell Oncogene Tal2 Is Necessary for 
Normal Development of the Mouse Brain', Dev Biol, 227(2), pp. 533-544. 
Bulgakova, N. A. and Knust, E. (2009) 'The Crumbs complex: from epithelial-cell polarity to 
retinal degeneration', J Cell Sci, 122(15), pp. 2587-2596. 
Burch, J. B. (2005) 'Regulation of GATA gene expression during vertebrate development', 
Semin Cell Dev Biol: Vol. 1. England, pp. 71-81. 
Bussmann, J., Bakkers, J. and Schulte-Merker, S. (2007) 'Early endocardial morphogenesis 
requires Scl/Tal1', PLoS Genet, 3(8), pp. e140. 
Butko, E., Distel, M., Pouget, C., Weijts, B., Kobayashi, I., Ng, K., Mosimann, C., Poulain, F. E., 
McPherson, A., Ni, C. W., Stachura, D. L., Del Cid, N., Espin-Palazon, R., Lawson, N. D., 
Dorsky, R., Clements, W. K. and Traver, D. (2015) 'Gata2b is a restricted early 
regulator of hemogenic endothelium in the zebrafish embryo', Development, 142(6), 
pp. 1050-61. 
 
 
214 
 
  
 
Chen, Q., Yang, C. Y., Tsan, J. T., Xia, Y., Ragab, A. H., Peiper, S. C., Carroll, A. and Baer, R. 
(1990) 'Coding sequences of the tal-1 gene are disrupted by chromosome 
translocation in human T cell leukemia', J Exp Med, 172(5), pp. 1403-8. 
Chi, N. C., Shaw, R. M., De Val, S., Kang, G., Jan, L. Y., Black, B. L. and Stainier, D. Y. (2008) 
'Foxn4 directly regulates tbx2b expression and atrioventricular canal formation', 
Genes Dev, 22(6), pp. 734-9. 
Chung, H. A., Medina-Ruiz, S. and Harland, R. M. (2014) 'Sp8 regulates inner ear 
development', Proc Natl Acad Sci U S A, 111(17), pp. 6329-34. 
Church, G. M., Ephrussi, A., Gilbert, W. and Tonegawa, S. (1985) 'Cell-type-specific contacts 
to immunoglobulin enhancers in nuclei', Nature, 313(6005), pp. 798-801. 
Correa, R. G., Matsui, T., Tergaonkar, V., Rodriguez-Esteban, C., Izpisua-Belmonte, J. C. and 
Verma, I. M. (2005) 'Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB 
activity', Curr Biol, 15(14), pp. 1291-5. 
Craven, S. E., Lim, K. C., Ye, W., Engel, J. D., de Sauvage, F. and Rosenthal, A. (2004) 'Gata2 
specifies serotonergic neurons downstream of sonic hedgehog',  Development, 
131(5), pp. 1165-73. 
Cunliffe, V. T. (2004) 'Histone deacetylase 1 is required to repress Notch target gene 
expression during zebrafish neurogenesis and to maintain the production of 
motoneurones in response to hedgehog signalling', Development, 131(12), pp. 2983-
95. 
Dale, N., Roberts, A., Ottersen, O. P. and Storm-Mathisen, J. (1987) 'The morphology and 
distribution of 'Kolmer-Agduhr cells', a class of cerebrospinal-fluid-contacting 
neurons revealed in the frog embryo spinal cord by GABA immunocytochemistry', 
Proc R Soc Lond B Biol Sci, 232(1267), pp. 193-203. 
 
 
215 
 
  
 
Dasen, J. S., O'Connell, S. M., Flynn, S. E., Treier, M., Gleiberman, A. S., Szeto, D. P., 
Hooshmand, F., Aggarwal, A. K. and Rosenfeld, M. G. (1999) 'Reciprocal interactions 
of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary 
cell types', Cell, 97(5), pp. 587-98. 
Del Barrio, M. G., Taveira-Marques, R., Muroyama, Y., Yuk, D. I., Li, S., Wines-Samuelson, M., 
Shen, J., Smith, H. K., Xiang, M., Rowitch, D. and Richardson, W. D. (2007) 'A 
regulatory network involving Foxn4, Mash1 and delta-like 4/Notch1 generates V2a 
and V2b spinal interneurons from a common progenitor pool', Development, 
134(19), pp. 3427-36. 
den Hollander, A. I., Ghiani, M., de Kok, Y. J. M., Wijnholds, J., Ballabio, A., Cremers, F. P. M. 
and Broccoli, V. (2002) 'Isolation of Crb1, a mouse homologue of Drosophila crumbs, 
and analysis of its expression pattern in eye and brain', Mech of Dev, 110(1–2), 
pp. 203-207. 
Detrich, H. W., 3rd, Kieran, M. W., Chan, F. Y., Barone, L. M., Yee, K., Rundstadler, J. A., Pratt, 
S., Ransom, D. and Zon, L. I. (1995) 'Intraembryonic hematopoietic cell migration 
during vertebrate development', Proc Natl Acad Sci U S A, 92(23), pp. 10713-7. 
Djenoune, L., Khabou, H., Joubert, F., Quan, F. B., Nunes Figueiredo, S., Bodineau, L., Del 
Bene, F., Burcklé, C., Tostivint, H. and Wyart, C. (2014) 'Investigation of spinal 
cerebrospinal fluid-contacting neurons expressing PKD2L1: evidence for a 
conserved system from fish to primates', Front Neuroanat, 8, pp. 26. 
Dougherty, K. J., Zagoraiou, L., Satoh, D., Rozani, I., Doobar, S., Arber, S., Jessell, T. M. and 
Kiehn, O. (2013) 'Locomotor rhythm generation linked to the output of spinal shox2 
excitatory interneurons', Neuron, 80(4), pp. 920-33. 
Duggan, A., Madathany, T., de Castro, S. C., Gerrelli, D., Guddati, K. and Garcia-Anoveros, J. 
(2008) 'Transient expression of the conserved zinc finger gene INSM1 in 
progenitors and nascent neurons throughout embryonic and adult neurogenesis', J 
Comp Neurol, 507(4), pp. 1497-520. 
216 
 
  
 
Eisen, J. S. and Smith, J. C. (2008) 'Controlling morpholino experiments: don't stop making 
antisense', Development, 135(10), pp. 1735-1743. 
El Wakil, A., Francius, C., Wolff, A., Pleau-Varet, J. and Nardelli, J. (2006) 'The GATA2 
transcription factor negatively regulates the proliferation of neuronal progenitors',  
Development: Vol. 11. England, pp. 2155-65. 
England, S., Batista, M. F., Mich, J. K., Chen, J. K. and Lewis, K. E. (2011) 'Roles of Hedgehog 
pathway components and retinoic acid signalling in specifying zebrafish ventral 
spinal cord neurons', Development, 138(23), pp. 5121-34. 
England, S., Hilinski, W., de Jager, S., Andrzejczuk, L., Campbell, P., Chowdhury, T., Demby, C., 
Fancher, W., Gong, Y., Lin, C., Machikas, A., Rodriguez-Larrain, G., Roman Rivera, V. 
and Lewis, K. E. 2014. ‘Identifying Transcription Factors Expressed by Ventral 
Spinal Cord Interneurons’. ZFIN Direct Data Submission (http://zfin.org). 
Ericson, J., Rashbass, P., Schedl, A., Brenner-Morton, S., Kawakami, A., van Heyningen, V., 
Jessell, T. M. and Briscoe, J. (1997) 'Pax6 controls progenitor cell identity and 
neuronal fate in response to graded Shh signaling', Cell, 90(1), pp. 169-80. 
Estella, C., Rieckhof, G., Calleja, M. and Morata, G. (2003) 'The role of buttonhead and Sp1 in 
the development of the ventral imaginal discs of Drosophila', Development, 130(24), 
pp. 5929-41. 
Farkas, L. M., Haffner, C., Giger, T., Khaitovich, P., Nowick, K., Birchmeier, C., Pääbo, S. and 
Huttner, W. B. (2008) 'Insulinoma-Associated 1 Has a Panneurogenic Role and 
Promotes the Generation and Expansion of Basal Progenitors in the Developing 
Mouse Neocortex', Neuron, 60(1), pp. 40-55. 
Finger, L. R., Kagan, J., Christopher, G., Kurtzberg, J., Hershfield, M. S., Nowell, P. C. and 
Croce, C. M. (1989) 'Involvement of the TCL5 gene on human chromosome 1 in T-
cell leukemia and melanoma', Proc Natl Acad Sci U S A, 86(13), pp. 5039-43. 
  
217 
 
  
 
Flanagan, Sarah E., De Franco, E., Lango Allen, H., Zerah, M., Abdul-Rasoul, Majedah M., 
Edge, Julie A., Stewart, H., Alamiri, E., Hussain, K., Wallis, S., de Vries, L., Rubio-
Cabezas, O., Houghton, Jayne A. L., Edghill, Emma L., Patch, A.-M., Ellard, S. and 
Hattersley, Andrew T. (2014) 'Analysis of Transcription Factors Key for Mouse 
Pancreatic Development Establishes NKX2-2 and MNX1 Mutations as Causes of 
Neonatal Diabetes in Man', Cell Metabolism, 19(1), pp. 146-154. 
Forbes-Osborne, M. A., Wilson, S. G. and Morris, A. C. (2013) 'Insulinoma-associated 1a 
(Insm1a) is required for photoreceptor differentiation in the zebrafish retina', Dev 
Biol, 380(2), pp. 157-171. 
Francius, C., Ravassard, P., Hidalgo-Figueroa, M., Mallet, J., Clotman, F. and Nardelli, J. 
(2014) 'Genetic dissection of Gata2 selective functions during specification of V2 
interneurons in the developing spinal cord', Dev Neurobiol, 75(7), pp. 721-37. 
Frigon, A. (2012) 'Central pattern generators of the mammalian spinal cord', Neuroscientist, 
18(1), pp. 56-69. 
Gering, M., Rodaway, A. R., Gottgens, B., Patient, R. K. and Green, A. R. (1998) 'The SCL gene 
specifies haemangioblast development from early mesoderm', EMBO J, 17(14), 
pp. 4029-45. 
Gillis, W. Q., St John, J., Bowerman, B. and Schneider, S. Q. (2009) 'Whole genome 
duplications and expansion of the vertebrate GATA transcription factor gene family', 
BMC Evol Biol, 9, pp. 207. 
Glasauer, S. M. and Neuhauss, S. C. (2014) 'Whole-genome duplication in teleost fishes and 
its evolutionary consequences', Mol Genet Genomics, 289(6), pp. 1045-60. 
Goto, Y., De Silva, M. G., Toscani, A., Prabhakar, B. S., Notkins, A. L. and Lan, M. S. (1992) 'A 
novel human insulinoma-associated cDNA, IA-1, encodes a protein with "zinc-
finger" DNA-binding motifs', J Biol Chem, 267(21), pp. 15252-7. 
  
218 
 
  
 
Gouge, A., Holt, J., Hardy, A. P., Sowden, J. C. and Smith, H. K. (2001) 'Foxn4 - a new member 
of the forkhead gene family is expressed in the retina', Mech Dev, 107(1-2), pp. 203-
6. 
Goulding, M. (2009) 'Circuits controlling vertebrate locomotion: moving in a new direction', 
Nat Rev Neurosci, 10(7), pp. 507-18. 
Goulding, M. and Pfaff, S. L. (2005) 'Development of circuits that generate simple rhythmic 
behaviors in vertebrates', Curr Opin Neurobiol, 15(1), pp. 14-20. 
Griener, A., Zhang, W., Kao, H., Wagner, C. and Gosgnach, S. (2015) 'Probing diversity within 
subpopulations of locomotor-related V0 interneurons', Dev Neurobiol, 75(11), 
pp.1189-203  
Hans, S., Kaslin, J., Freudenreich, D. and Brand, M. (2009) 'Temporally-controlled 
site-specific recombination in zebrafish', PLoS One, 4(2), pp. e4640. 
Haro, E., Delgado, I., Junco, M., Yamada, Y., Mansouri, A., Oberg, K. C. and Ros, M. A. (2014) 
'Sp6 and Sp8 transcription factors control AER formation and dorsal-ventral 
patterning in limb development', PLoS Genet, 10(8), pp. e1004468. 
Harrison, K. A., Druey, K. M., Deguchi, Y., Tuscano, J. M. and Kehrl, J. H. (1994) 'A novel 
human homeobox gene distantly related to proboscipedia is expressed in lymphoid 
and pancreatic tissues', J Biol Chem, 269(31), pp. 19968-75. 
Hatakeyama, J., Bessho, Y., Katoh, K., Ookawara, S., Fujioka, M., Guillemot, F. and Kageyama, 
R. (2004) 'Hes genes regulate size, shape and histogenesis of the nervous system by 
control of the timing of neural stem cell differentiation', Development, 131(22), pp. 
5539-50. 
Heicklen-Klein, A., McReynolds, L. J. and Evans, T. (2005) 'Using the zebrafish model to 
study GATA transcription factors', Semin Cell Dev Biol 16(1), pp. 95-106. 
  
219 
 
  
 
Herberth, B., Minkó, K., Csillag, A., Jaffredo, T. and Madarász, E. (2005) 'SCL, GATA-2 and 
Lmo2 expression in neurogenesis', International Journal of Dev Neurosci, 23(5), 
pp. 449-463. 
Herranz, H., Stamataki, E., Feiguin, F. and Milán, M. (2006) 'Self-refinement of Notch activity 
through the transmembrane protein Crumbs: modulation of gamma-secretase 
activity', EMBO Rep, 7(3), pp. 297-302. 
Higashijima, S., Mandel, G. and Fetcho, J. R. (2004a) 'Distribution of prospective 
glutamatergic, glycinergic, and GABAergic neurons in embryonic and larval 
zebrafish', J Comp Neurol, 480(1), pp. 1-18. 
Higashijima, S., Schaefer, M. and Fetcho, J. R. (2004b) 'Neurotransmitter properties of spinal 
interneurons in embryonic and larval zebrafish', J Comp Neurol, 480(1), pp. 19-37. 
Hinckley, C. A., Wiesner, E. P., Mentis, G. Z., Titus, D. J. and Ziskind-Conhaim, L. (2010) 
'Sensory modulation of locomotor-like membrane oscillations in Hb9-expressing 
interneurons', J Neurophysiol, 103(6), pp. 3407-23. 
Ho, I. C., Vorhees, P., Marin, N., Oakley, B. K., Tsai, S. F., Orkin, S. H. and Leiden, J. M. (1991) 
'Human GATA-3: a lineage-restricted transcription factor that regulates the 
expression of the T cell receptor alpha gene', EMBO J, 10(5), pp. 1187-1192. 
Hong, J. Y., Lee, S. H., Lee, S. C., Kim, J. W., Kim, K. P., Kim, S. M., Tapia, N., Lim, K. T., Kim, J., 
Ahn, H. S., Ko, K., Shin, C. Y., Lee, H. T., Scholer, H. R., Hyun, J. K. and Han, D. W. (2014) 
'Therapeutic potential of induced neural stem cells for spinal cord injury',  J Biol 
Chem: Vol. 47. United States: 2014 by The American Society for Biochemistry and 
Molecular Biology, Inc., pp. 32512-25. 
Huang, A. L., Chen, X., Hoon, M. A., Chandrashekar, J., Guo, W., Tränkner, D., Ryba, N. J. and 
Zuker, C. S. (2006) 'The cells and logic for mammalian sour taste detection', Nature, 
442(7105), pp. 934-8. 
  
220 
 
  
 
Jacob, J., Storm, R., Castro, D. S., Milton, C., Pla, P., Guillemot, F., Birchmeier, C. and Briscoe, J. 
(2009) 'Insm1 (IA-1) is an essential component of the regulatory network that 
specifies monoaminergic neuronal phenotypes in the vertebrate hindbrain', 
Development, 136(14), pp. 2477-85. 
Jacobstein, J. (2008) Development and Function of V2 Spinal Interneurons. Master's Thesis, 
University of Cambridge, Cambridge, UK. 
Jessell, T. M. (2000) 'Neuronal specification in the spinal cord: inductive signals and 
transcriptional codes', Nat Rev Genet, 1(1), pp. 20-9. 
Jia, S., Wildner, H. and Birchmeier, C. (2015) 'Insm1 controls the differentiation of 
pulmonary neuroendocrine cells by repressing Hes1', Dev Biol. 
Jonas, P., Bischofberger, J. and Sandkühler, J. (1998) 'Corelease of two fast 
neurotransmitters at a central synapse', Science, 281(5375), pp. 419-24. 
Joshi, K., Lee, S., Lee, B., Lee, J. W. and Lee, S.-K. (2009) 'LMO4 controls the balance between 
excitatory and inhibitory spinal V2 interneurons', Neuron, 61(6), pp. 839-51. 
Joulin, V., Bories, D., Eléouet, J. F., Labastie, M. C., Chrétien, S., Mattéi, M. G. and Roméo, P. H. 
(1991) 'A T-cell specific TCR delta DNA binding protein is a member of the human 
GATA family', The EMBO Journal, 10(7), pp. 1809-1816. 
Kageyama, R., Ohtsuka, T. and Kobayashi, T. (2007) 'The Hes gene family: repressors and 
oscillators that orchestrate embryogenesis', Development, 134(7), pp. 1243-51. 
Kala, K., Haugas, M., Lillevali, K., Guimera, J., Wurst, W., Salminen, M. and Partanen, J. (2009) 
'Gata2 is a tissue-specific post-mitotic selector gene for midbrain GABAergic 
neurons', Development 136(2), pp. 253-62. 
Kane, D. A., Warga, R. M. and Kimmel, C. B. (1992) 'Mitotic domains in the early embryo of 
the zebrafish', Nature, 360(6406), pp. 735-7. 
  
221 
 
  
 
Kang, K., Lee, D., Hong, S., Park, S.-G. and Song, M.-R. (2013) 'The E3 Ligase Mind Bomb-1 
(Mib1) Modulates Delta-Notch Signaling to Control Neurogenesis and Gliogenesis in 
the Developing Spinal Cord', The Journal of Biological Chemistry, 288(4), pp. 2580-
2592. 
Karunaratne, A., Hargrave, M., Poh, A. and Yamada, T. (2002) 'GATA proteins identify a 
novel ventral interneuron subclass in the developing chick spinal cord', Dev Biol, 
249(1), pp. 30-43. 
Kassouf, M. T., Chagraoui, H., Vyas, P. and Porcher, C. (2008) 'Differential use of SCL/TAL-1 
DNA-binding domain in developmental hematopoiesis', Blood, 112(4), pp. 1056-67. 
Kawakami, Y., Esteban, C. R., Matsui, T., Rodriguez-Leon, J., Kato, S. and Izpisua Belmonte, J. 
C. (2004) 'Sp8 and Sp9, two closely related buttonhead-like transcription factors, 
regulate Fgf8 expression and limb outgrowth in vertebrate embryos', Development, 
131(19), pp. 4763-74. 
Kimura, Y., Okamura, Y. and Higashijima, S. (2006) 'alx, a zebrafish homolog of Chx10, 
marks ipsilateral descending excitatory interneurons that participate in the 
regulation of spinal locomotor circuits', J Neurosci, 26(21), pp. 5684-97. 
Kimura, Y., Satou, C. and Higashijima, S. (2008) 'V2a and V2b neurons are generated by the 
final divisions of pair-producing progenitors in the zebrafish spinal cord', 
Development, 135(18), pp. 3001-5. 
Kizil, C., Kyritsis, N., Dudczig, S., Kroehne, V., Freudenreich, D., Kaslin, J. and Brand, M., 2012. 
Regenerative neurogenesis from neural progenitor cells requires injury-induced 
expression of Gata3. Developmental cell, 23(6), pp.1230-1237. 
Ko, L. J., Yamamoto, M., Leonard, M. W., George, K. M., Ting, P. and Engel, J. D. (1991) 
'Murine and human T-lymphocyte GATA-3 factors mediate transcription through a 
cis-regulatory element within the human T-cell receptor delta gene enhancer', 
Molecular and Cellular Biology, 11(5), pp. 2778-2784.  
222 
 
  
 
Kobayashi, I., Ono, H., Moritomo, T., Kano, K., Nakanishi, T. and Suda, T. (2010) 
'Comparative gene expression analysis of zebrafish and mammals identifies 
common regulators in hematopoietic stem cells', Blood, 115(2), pp. e1-9. 
Kwan, A. C., Dietz, S. B., Webb, W. W. and Harris-Warrick, R. M. (2009) 'Activity of Hb9 
interneurons during fictive locomotion in mouse spinal cord', J Neurosci, 29(37), 
pp. 11601-13. 
Lan, M. S. and Breslin, M. B. (2009) 'Structure, expression, and biological function of INSM1 
transcription factor in neuroendocrine differentiation', FASEB J, 23(7), pp. 2024-33. 
Lanuza, G. M., Gosgnach, S., Pierani, A., Jessell, T. M. and Goulding, M. (2004) 'Genetic 
identification of spinal interneurons that coordinate left-right locomotor activity 
necessary for walking movements',  Neuron: Vol. 3. United States, pp. 375-86. 
Le Bivic, A. (2013) 'Evolution and cell physiology. 4. Why invent yet another protein 
complex to build junctions in epithelial cells?', Am J Physiol Cell Physiol, 305(12), 
pp. C1193-201. 
Leonard, M., Brice, M., Engel, J. D. and Papayannopoulou, T. (1993) 'Dynamics of GATA 
transcription factor expression during erythroid differentiation', Blood, 82(4), 
pp. 1071-9. 
Lewis, K. E. (2006) 'How do genes regulate simple behaviours? Understanding how 
different neurons in the vertebrate spinal cord are genetically specified', Philos 
Trans R Soc Lond B Biol Sci, 361(1465), pp. 45-66. 
Lewis, K. E. and Eisen, J. S. (2003) 'From cells to circuits: development of the zebrafish 
spinal cord', Prog Neurobiol: 69(6), pp. 419-49. 
Li, K. and Xu, E. (2008) 'The role and the mechanism of gamma-aminobutyric acid during 
central nervous system development', Neurosci Bull, 24(3), pp. 195-200. 
  
223 
 
  
 
Li, S., Misra, K., Matise, M. P. and Xiang, M. (2005) 'Foxn4 acts synergistically with Mash1 to 
specify subtype identity of V2 interneurons in the spinal cord', Proc Natl Acad Sci U S 
A, 102(30), pp. 10688-93. 
Li, X., Liu, Z., Qiu, M. and Yang, Z. (2014) 'Sp8 plays a supplementary role to Pax6 in 
establishing the pMN/p3 domain boundary in the spinal cord', Development, 
141(14), pp. 2875-2884. 
Lukowski, C. M., Ritzel, R. G. and Waskiewicz, A. J. (2006) 'Expression of two insm1-like 
genes in the developing zebrafish nervous system', Gene Expr Patterns, 6(7), 
pp. 711-8. 
Lupo, G., Harris, W. A. and Lewis, K. E. (2006) 'Mechanisms of ventral patterning in the 
vertebrate nervous system',  Nat Rev Neurosci 7(2), pp. 103-14. 
Maden, M. (2002) 'Retinoid signalling in the development of the central nervous system', 
Nat Rev Neurosci, 3(11), pp. 843-53. 
Merika, M. and Orkin, S. H. (1993) 'DNA-binding specificity of GATA family transcription 
factors', Molecular and Cellular Biology, 13(7), pp. 3999-4010. 
Mori, S., Sugawara, S., Kikuchi, T., Tanji, M., Narumi, O., Stoykova, A., Nishikawa, S.-I. and 
Yokota, Y. (1999) 'The leukemic oncogene tal-2 is expressed in the developing 
mouse brain', Molecular Brain Research, 64(2), pp. 199-210. 
Muroyama, Y., Fujiwara, Y., Orkin, S. H. and Rowitch, D. H. (2005) 'Specification of 
astrocytes by bHLH protein SCL in a restricted region of the neural tube', Nature, 
438(7066), pp. 360-3. 
Najfeld, V., Menninger, J., Ballard, S. G., Deguchi, Y., Ward, D. C. and Kehrl, J. H. (1992) 'Two 
diverged human homeobox genes involved in the differentiation of human 
hematopoietic progenitors map to chromosome 1, bands q41-42.1', Genes 
Chromosomes Cancer, 5(4), pp. 343-7.  
224 
 
  
 
Nardelli, J., Thiesson, D., Fujiwara, Y., Tsai, F. Y. and Orkin, S. H. (1999) 'Expression and 
genetic interaction of transcription factors GATA-2 and GATA-3 during development 
of the mouse central nervous system', Dev Biol, 210(2), pp. 305-21. 
Navratilova, P., Fredman, D., Lenhard, B. and Becker, T. S. (2010) 'Regulatory divergence of 
the duplicated chromosomal loci sox11a/b by subpartitioning and sequence 
evolution of enhancers in zebrafish', Mol Genet Genomics, 283(2), pp. 171-84. 
Neave, B., Rodaway, A., Wilson, S. W., Patient, R. and Holder, N. (1995) 'Expression of 
zebrafish GATA 3 (gta3) during gastrulation and neurulation suggests a role in the 
specification of cell fate', Mechanisms of Development, 51(2–3), pp. 169-182. 
Norton, W. H., Ledin, J., Grandel, H. and Neumann, C. J. (2005) 'HSPG synthesis by zebrafish 
Ext2 and Extl3 is required for Fgf10 signalling during limb development', 
Development, 132(22), pp. 4963-73. 
Ohata, S., Aoki, R., Kinoshita, S., Yamaguchi, M., Tsuruoka-Kinoshita, S., Tanaka, H., Wada, H., 
Watabe, S., Tsuboi, T., Masai, I. and Okamoto, H. (2011) 'Dual Roles of Notch in 
Regulation of Apically Restricted Mitosis and Apicobasal Polarity of Neuroepithelial 
Cells', Neuron, 69(2), pp. 215-230. 
Omori, Y. and Malicki, J. (2006) 'oko meduzy and related crumbs genes are determinants of 
apical cell features in the vertebrate embryo', Curr Biol, 16(10), pp. 945-57. 
Ono, Y., Fukuhara, N. and Yoshie, O. (1998) 'TAL1 and LIM-Only Proteins Synergistically 
Induce Retinaldehyde Dehydrogenase 2 Expression in T-Cell Acute Lymphoblastic 
Leukemia by Acting as Cofactors for GATA3', Molecular and Cellular Biology, 18(12), 
pp. 6939-6950. 
Orkin, S. H. (1992) 'GATA-binding transcription factors in hematopoietic cells', Blood, 
80(3), pp. 575-81. 
  
225 
 
  
 
Orts-Del'immagine, A., Wanaverbecq, N., Tardivel, C., Tillement, V., Dallaporta, M. and 
Trouslard, J. (2012) 'Properties of subependymal cerebrospinal fluid contacting 
neurones in the dorsal vagal complex of the mouse brainstem', J Physiol, 590(16), 
pp. 3719-41. 
Osipovich, A. B., Long, Q., Manduchi, E., Gangula, R., Hipkens, S. B., Schneider, J., Okubo, T., 
Stoeckert, C. J., Takada, S. and Magnuson, M. A. (2014b) 'Insm1 promotes endocrine 
cell differentiation by modulating the expression of a network of genes that includes 
Neurog3 and Ripply3', Development, 141(15), pp. 2939-2949. 
Pan, F. C., Brissova, M., Powers, A. C., Pfaff, S. and Wright, C. V. (2015) 'Inactivating the 
permanent neonatal diabetes gene Mnx1 switches insulin-producing β-cells to a δ-
like fate and reveals a facultative proliferative capacity in aged β-cells', Development, 
142(21), pp. 3637-48. 
Panayi, H., Panayiotou, E., Orford, M., Genethliou, N., Mean, R., Lapathitis, G., Li, S., Xiang, M., 
Kessaris, N., Richardson, W. D. and Malas, S. (2010) 'Sox1 is required for the 
specification of a novel p2-derived interneuron subtype in the mouse ventral spinal 
cord', J Neurosci, 30(37), pp. 12274-80. 
Park, H. C., Shin, J. and Appel, B. (2004) 'Spatial and temporal regulation of ventral spinal 
cord precursor specification by Hedgehog signaling', Development, 131(23), pp. 
5959-69. 
Pasini, A., Henrique, D. and Wilkinson, D. G. (2001) 'The zebrafish Hairy/Enhancer-of-split-
related gene her6 is segmentally expressed during the early development of 
hindbrain and somites', Mech Dev, 100(2), pp. 317-321. 
Pasini, A., Jiang, Y. J. and Wilkinson, D. G. (2004) 'Two zebrafish Notch-dependent 
hairy/Enhancer-of-split-related genes, her6 and her4, are required to maintain the 
coordination of cyclic gene expression in the presomitic mesoderm', Development, 
131(7), pp. 1529-41. 
  
226 
 
  
 
Pellikka, M., Tanentzapf, G., Pinto, M., Smith, C., McGlade, C. J., Ready, D. F. and Tepass, U. 
(2002) 'Crumbs, the Drosophila homologue of human CRB1/RP12, is essential for 
photoreceptor morphogenesis', Nature, 416(6877), pp. 143-149. 
Peng, C. Y., Yajima, H., Burns, C. E., Zon, L. I., Sisodia, S. S., Pfaff, S. L. and Sharma, K. (2007) 
'Notch and MAML signaling drives Scl-dependent interneuron diversity in the spinal 
cord', Neuron, 53(6), pp. 813-27. 
Pillai, A., Mansouri, A., Behringer, R., Westphal, H. and Goulding, M. (2007) 'Lhx1 and Lhx5 
maintain the inhibitory-neurotransmitter status of interneurons in the dorsal spinal 
cord', Development, 134(2), pp. 357-66. 
Pinheiro, P., Gering, M. and Patient, R. (2004) 'The basic helix-loop-helix transcription 
factor, Tal2, marks the lateral floor plate of the spinal cord in zebrafish', Gene Expr 
Patterns, 4(1), pp. 85-92. 
Pocha, Shirin M. and Knust, E. (2013) 'Complexities of Crumbs Function and 
Regulation in Tissue Morphogenesis', Curr Biol, 23(7), pp. R289-R293. 
Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F. W. and Orkin, S. H. (1996) 'The T cell 
leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic 
lineages', Cell, 86(1), pp. 47-57. 
Postlethwait, J. H., Yan, Y. L., Gates, M. A., Horne, S., Amores, A., Brownlie, A., Donovan, A., 
Egan, E. S., Force, A., Gong, Z., Goutel, C., Fritz, A., Kelsh, R., Knapik, E., Liao, E., Paw, 
B., Ransom, D., Singer, A., Thomson, M., Abduljabbar, T. S., Yelick, P., Beier, D., Joly, J. 
S., Larhammar, D., Rosa, F., Westerfield, M., Zon, L. I., Johnson, S. L. and Talbot, W. S. 
(1998) 'Vertebrate genome evolution and the zebrafish gene map', Nat Genet, 18(4), 
pp. 345-9. 
Ravet, E., Reynaud, D., Titeux, M., Izac, B., Fichelson, S., Romeo, P. H., Dubart-Kupperschmitt, 
A. and Pflumio, F. (2004) 'Characterization of DNA-binding-dependent and -
independent functions of SCL/TAL1 during human erythropoiesis', Blood, 103(9), 
pp. 3326-35. 
227 
 
  
 
Rosenbaum, J. N., Duggan, A. and García-Añoveros, J. (2011) 'Insm1 promotes the transition 
of olfactory progenitors from apical and proliferative to basal, terminally dividing 
and neuronogenic', Neural Dev, 6, pp. 6. 
Ross, A. J., Ruiz-Perez, V., Wang, Y., Hagan, D. M., Scherer, S., Lynch, S. A., Lindsay, S., Custard, 
E., Belloni, E., Wilson, D. I., Wadey, R., Goodman, F., Orstavik, K. H., Monclair, T., 
Robson, S., Reardon, W., Burn, J., Scambler, P. and Strachan, T. (1998) 'A homeobox 
gene, HLXB9, is the major locus for dominantly inherited sacral agenesis', Nat Genet, 
20(4), pp. 358-61. 
Saha, M. S., Miles, R. R. and Grainger, R. M. (1997) 'Dorsal-ventral patterning during neural 
induction in Xenopus: assessment of spinal cord regionalization with xHB9, a 
marker for the motor neuron region', Dev Biol, 187(2), pp. 209-23. 
Schafer, M., Kinzel, D. and Winkler, C. (2007) 'Discontinuous organization and specification 
of the lateral floor plate in zebrafish', Dev Biol, 301(1) pp. 117-29. 
Scholpp, S., Delogu, A., Gilthorpe, J., Peukert, D., Schindler, S. and Lumsden, A. (2009) 'Her6 
regulates the neurogenetic gradient and neuronal identity in the thalamus', Proc 
Natl Acad Sci U S A, 106(47), pp. 19895-900. 
Schulte-Merker, S. and Stainier, D. Y. (2014) 'Out with the old, in with the new: reassessing 
morpholino knockdowns in light of genome editing technology', Development, 
141(16), pp. 3103-4. 
Seredick, S. D., Van Ryswyk, L., Hutchinson, S. A. and Eisen, J. S. (2012) 'Zebrafish Mnx 
proteins specify one motoneuron subtype and suppress acquisition of interneuron 
characteristics', Neural Dev, 7, pp. 35. 
Shin, J., Poling, J., Park, H. C. and Appel, B. (2007) 'Notch signaling regulates neural 
precursor allocation and binary neuronal fate decisions in zebrafish', Development, 
134(10), pp. 1911-20. 
  
228 
 
  
 
Smith, E., Hargrave, M., Yamada, T., Begley, C. G. and Little, M. H. (2002) 'Coexpression of 
SCL and GATA3 in the V2 interneurons of the developing mouse spinal cord', Dev 
Dyn, 224(2), pp. 231-7. 
Stoick-Cooper, C. L., Weidinger, G., Riehle, K. J., Hubbert, C., Major, M. B., Fausto, N. and 
Moon, R. T. (2007) 'Distinct Wnt signaling pathways have opposing roles in 
appendage regeneration', Development, 134(3), pp. 479-89. 
Tanabe, Y., William, C. and Jessell, T. M. (1998) 'Specification of motor neuron identity by 
the MNR2 homeodomain protein', Cell, 95(1), pp. 67-80. 
Tepass, U., Theres, C. and Knust, E. (1990) 'crumbs encodes an EGF-like protein expressed 
on apical membranes of Drosophila epithelial cells and required for organization of 
epithelia', Cell, 61(5), pp. 787-99. 
Tindemans, I., Serafini, N., Di Santo, J. P. and Hendriks, R. W. (2014) 'GATA-3 function in 
innate and adaptive immunity', Immunity, 41(2), pp. 191-206. 
Tripic, T., Deng, W., Cheng, Y., Zhang, Y., Vakoc, C. R., Gregory, G. D., Hardison, R. C. and 
Blobel, G. A. (2009) 'SCL and associated proteins distinguish active from repressive 
GATA transcription factor complexes', Blood, 113(10), pp. 2191-201. 
van de Pavert, S. A., Sanz, A. S., Aartsen, W. M., Vos, R. M., Versteeg, I., Beck, S. C., Klooster, J., 
Seeliger, M. W. and Wijnholds, J. (2007) 'Crb1 is a determinant of retinal apical 
Müller glia cell features', Glia, 55(14), pp. 1486-97. 
Waclaw, R. R., Allen, Z. J., 2nd, Bell, S. M., Erdelyi, F., Szabo, G., Potter, S. S. and Campbell, K. 
(2006) 'The zinc finger transcription factor Sp8 regulates the generation and 
diversity of olfactory bulb interneurons', Neuron, 49(4), pp. 503-16. 
Wadman, I. A., Osada, H., Grütz, G. G., Agulnick, A. D., Westphal, H., Forster, A. and Rabbitts, 
T. H. (1997) 'The LIM‐only protein Lmo2 is a bridging molecule assembling an 
erythroid, DNA‐binding complex which includes the TAL1, E47, GATA‐1 and 
Ldb1/NLI proteins', EMBO J, 16(11), pp. 3145-3157. 
229 
 
  
 
Wan, Y. Y. (2014) 'GATA3: a master of many trades in immune regulation', Trends Immunol, 
35(6), pp. 233-42. 
Willett, R. T. and Greene, L. A. (2011) 'Gata2 is required for migration and differentiation of 
retinorecipient neurons in the superior colliculus', J Neurosci, 31(12), pp. 4444-55. 
Wimmer, E. A., Cohen, S. M., Jackle, H. and Desplan, C. (1997) 'buttonhead does not 
contribute to a combinatorial code proposed for Drosophila head development', 
Development, 124(8), pp. 1509-17. 
Woolfe, A. and Elgar, G. (2007) 'Comparative genomics using Fugu reveals insights into 
regulatory subfunctionalization', Genome Biol, 8(4), pp. R53. 
Wu, W., Morrissey, C. S., Keller, C. A., Mishra, T., Pimkin, M., Blobel, G. A., Weiss, M. J. and 
Hardison, R. C. (2014) 'Dynamic shifts in occupancy by TAL1 are guided by GATA 
factors and drive large-scale reprogramming of gene expression during 
hematopoiesis', Genome Res, 24(12), pp. 1945-62. 
Wyart, C., Del Bene, F., Warp, E., Scott, E. K., Trauner, D., Baier, H. and Isacoff, E. Y. (2009a) 
'Optogenetic dissection of a behavioural module in the vertebrate spinal cord', 
Nature, 461(7262), pp. 407-10. 
Xia, Y., Brown L Fau - Yang, C. Y., Yang Cy Fau - Tsan, J. T., Tsan Jt Fau - Siciliano, M. J., 
Siciliano Mj Fau - Espinosa, R., 3rd, Espinosa R 3rd Fau - Le Beau, M. M., Le Beau Mm 
Fau - Baer, R. J. and Baer, R. J. (1991) 'TAL2, a helix-loop-helix gene activated by the 
(7;9)(q34;q32) translocation in human T-cell leukemia', Proc. Nadl. Acad. Sci. USA, 
88(24), pp. 11416-20. 
  
230 
 
  
 
Xie, Y., Li, X., Zhang, X., Mei, S., Li, H., Urso, A. and Zhu, S. (2014) 'The Drosophila Sp8 
transcription factor Buttonhead prevents premature differentiation of intermediate 
neural progenitors', eLife, 3, pp. e03596. 
Yamamoto, M., Ko, L. J., Leonard, M. W., Beug, H., Orkin, S. H. and Engel, J. D. (1990) 'Activity 
and tissue-specific expression of the transcription factor NF-E1 multigene family', 
Genes Dev, 4(10), pp. 1650-62. 
Yan, Y. L., Willoughby, J., Liu, D., Crump, J. G., Wilson, C., Miller, C. T., Singer, A., Kimmel, C., 
Westerfield, M. and Postlethwait, J. H. (2005) 'A pair of Sox: distinct and overlapping 
functions of zebrafish sox9 co-orthologs in craniofacial and pectoral fin 
development', Development, 132(5), pp. 1069-83. 
Yang, L., Rastegar, S. and Strähle, U. (2010) 'Regulatory interactions specifying Kolmer-
Agduhr interneurons', Development, 137(16), pp. 2713-22. 
Yeo, S. Y. and Chitnis, A. B. (2007) 'Jagged-mediated Notch signaling maintains proliferating 
neural progenitors and regulates cell diversity in the ventral spinal cord', Proc Natl 
Acad Sci U S A, 104(14), pp. 5913-8. 
Younossi-Hartenstein, A., Green, P., Liaw, G. J., Rudolph, K., Lengyel, J. and Hartenstein, V. 
(1997) 'Control of early neurogenesis of the Drosophila brain by the head gap genes 
tll, otd, ems, and btd', Dev Biol, 182(2), pp. 270-83. 
Zhang, J., Lanuza, G. M., Britz, O., Wang, Z., Siembab, V. C., Zhang, Y., Velasquez, T., Alvarez, F. 
J., Frank, E. and Goulding, M. (2014) 'V1 and v2b interneurons secure the alternating 
flexor-extensor motor activity mice require for limbed locomotion', Neuron, 82(1), 
pp. 138-50. 
Zhang, Y., Narayan, S., Geiman, E., Lanuza, G. M., Velasquez, T., Shanks, B., Akay, T., Dyck, J., 
Pearson, K., Gosgnach, S., Fan, C. M. and Goulding, M. (2008) 'V3 spinal neurons 
establish a robust and balanced locomotor rhythm during walking', Neuron, 60(1), 
pp. 84-96. 
231 
 
  
 
Zhou, Y., Lim, K. C., Onodera, K., Takahashi, S., Ohta, J., Minegishi, N., Tsai, F. Y., Orkin, S. H., 
Yamamoto, M. and Engel, J. D. (1998) 'Rescue of the embryonic lethal hematopoietic 
defect reveals a critical role for GATA-2 in urogenital development', EMBO J, 17(22), 
pp. 6689-700. 
Zhu, C., Smith, T., McNulty, J., Rayla, A. L., Lakshmanan, A., Siekmann, A. F., Buffardi, M., 
Meng, X., Shin, J., Padmanabhan, A., Cifuentes, D., Giraldez, A. J., Look, A. T., Epstein, J. 
A., Lawson, N. D. and Wolfe, S. A. (2011) 'Evaluation and application of modularly 
assembled zinc-finger nucleases in zebrafish', Development, 138(20), pp. 4555-64. 
 
 
232 
 
  
 
VITA 
NAME:  Liwia Anna Andrzejczuk (also known as Livia A. Andrzejczuk) 
PLACE OF BIRTH:  Pila, Poland 
DATE OF BIRTH:  27th January, 1988 
EDUCATION:    
2015 M.S. in Biology  
Syracuse University, Syracuse, New York 
Thesis 
‘Specification of V2b and KA neurons in the zebrafish spinal cord.’ 
Advisor: Dr. Kate Lewis 
2012 BSc (Hons) in Biological Sciences (Cell and Molecular Biology), 1st 
Honors degree 
Heriot – Watt University, Scotland, United Kingdom 
Thesis 
‘The influence of ZnO and Ag nanoparticles on human kidney cells.’ 
Advisor: Dr. Vicki Stone 
PUBLICATIONS: 
England, S., W. Hilinski, S. de Jager, L. Andrzejczuk, P. Campbell, T. Chowdhury, C. Demby, 
W. Fancher, Y. Gong, C. Lin, A. Machikas, G. Rodriguez-Larrain, V. Roman Rivera and K. E. 
Lewis (2014) “Identifying Transcription Factors Expressed by Ventral Spinal Cord 
Interneurons.” ZFIN Direct Data Submission, http://zfin.org. 
Kermanizadeh, A., S. Vranic, S. Boland, K. Moreau, A. Baeza-Squiban, B. K. Gaiser,                          
L. A. Andrzejczuk and V. Stone (2013) "An in vitro assessment of panel of engineered 
nanomaterials using a human renal cell line: cytotoxicity, pro-inflammatory response, 
oxidative stress and genotoxicity." BMC Nephrol 14: 96. 
HONORS AND AWARDS 
2012  Fitzpatrick Prize (for the best biotechnology-related project at University) 
  Heriot-Watt University, Edinburgh, UK 
2013-2015 Women in Science and Engineering Future Professionals Program Fellow,  
Syracuse University, Syracuse, New York 
2013-2015 Graduate School Future Professoriate Program Fellow,  
Syracuse University, Syracuse, New York 
 
